<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">
<head>
<meta http-equiv="default-style" content="text/html; charset=utf-8"/>
<title>Vascular and Interventional Imaging</title>
<link rel="stylesheet" type="text/css" href="../styles/Elsevier_eBook.css"/>
<link rel="stylesheet" type="text/css" href="../styles/media.css"/>
</head>
<body>
<section epub:type="chapter">
<section epub:type="subchapter">
<div id="P278" epub:type="pagebreak" title="278" />
<div class="boxg1" id="b0245">
<p class="b1title">Answers</p>
<p class="b1subt">Case 136</p>
<section><a id="s0930" />
<p class="b11hd" id="st0815">Cavitary Lung-Mass Embolization</p>
<a id="p3600" />
<a id="l0725" />
<div><?mpslid S573?>
<p class="b1numlista" id="o2870"><a id="Case0136-1" href="chp003.xhtml#Case136-1">1</a>.&#160;<a id="p3605" /><strong>B.</strong> There is a hypertrophied left bronchial artery, which is selectively catheterized on the third image. Horizontally oriented intercostal arteries are also noted at multiple levels.</p><?mpslid E573?><?mpslid S574?>
<p class="b1numlista" id="o2875"><a id="Case0136-2" href="chp003.xhtml#Case136-2">2</a>.&#160;<a id="p3610" /><strong>D.</strong> Massive hemoptysis is the most typical presentation, although these patients commonly also have a cough and chest pain.</p><?mpslid E574?><?mpslid S575?>
<p class="b1numlista" id="o2880"><a id="Case0136-3" href="chp003.xhtml#Case136-3">3</a>.&#160;<a id="p3615" /><strong>C.</strong> Most commonly, the bronchial arteries arise from the aorta at the level of T5 to T6. Significant variation exists in origin and branching pattern. However, commonly there are two left and one right bronchial arteries.</p><?mpslid E575?><?mpslid S576?>
<p class="b1numlista" id="o2885"><a id="Case0136-4" href="chp003.xhtml#Case136-4">4</a>.&#160;<a id="p3620" /><strong>B.</strong> Particles are preferred for most distal embolization. Re-bleeding is common in these patients, and other agents such as coils can inhibit re-embolization.</p><?mpslid E576?>
</div>
<section><a id="s0935" />
<p class="b12hd" id="st0820">Comment</p>
<section><a id="s0940" />
<p class="b13hd" id="st0825">Etiology and Initial Evaluation</p>
<p id="p3625" class="b1textfl">Common causes of severe hemoptysis include cystic fibrosis, chronic obstructive pulmonary disease, bronchiectasis, and vascular tumors. Additionally, cavitary lung masses from aspergilloma, tuberculosis (TB), and squamous cell carcinoma can lead to massive hemoptysis. Bronchoscopy is routinely performed before arteriographic evaluation of hemoptysis, in order to determine which bronchial segment contains the bleeding source. This greatly helps the angiographer, because many patients have enlarged bronchial arteries bilaterally with no evidence of contrast extravasation. The angiographer can then direct therapy to the artery thought likely to be causing the bleeding based upon bronchoscopy.</p>
</section>
<section><a id="s0945" />
<p class="b13hd" id="st0830">Endovascular Management</p>
<p id="p3630" class="b1textfl">As seen in the figures, this patient has a cavitary lung mass with hypertrophied left bronchial artery (<a href="chp004_a.xhtml#f2710">Figures S136-1</a> to S136-3). The left bronchial arterial branches are hypertrophied and tortuous (<a href="chp004_a.xhtml#f2720">Figure S136-3</a>). There are multiple areas of vascular splaying suggesting necrosis. The differential diagnosis includes primary lung carcinoma, metastatic disease, and infectious lesions such as TB and fungal disease (which was the case in the patient shown). In the vast majority of cases, contrast extravasation is not visualized. In this patient, treatment was performed using embolization with polyvinyl alcohol particles, with subsequent cessation of bleeding with subsequent lobectomy (<a href="chp004_a.xhtml#f2725">Figure S136-4</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0130" />
<h3 class="ref2hd" id="st0835">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0385">1. Barben J, Robertson D, Olinsky A, et al. Bronchial artery embolization for hemoptysis in young patients with cystic fibrosis. <em>Radiology</em>. 2002;224:124&#8211;130.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0390">2. Fernando HC, Stein M, Benfield JR, et al. Role of bronchial artery embolization in the management of hemoptysis. <em>Arch Surg</em>. 1998;133:862&#8211;866.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0090" />
<h3 class="ref2hd" id="st0840">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0395">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 174&#8211;176.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0130" />
<span id="P279" epub:type="pagebreak" title="279" />
<h2 class="h1hd" id="sc0130tit">Case 137</h2>
<a id="p3635" />
<div class="boxg1" id="b0250"><a id="p3640" />
<div class="pageavoid" id="f0250"><figure class="fig"><img src="../images/F000039b03-49-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 137-1</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0255"><figure class="fig"><img src="../images/F000039b03-50-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 137-2</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<section><a id="s0950" /><section><a id="s0955" /><section><a id="s0960" /><section><a id="s0965" />
<p class="b14hd" id="st0845">History</p>
<p id="p3645" class="b1textfl">A 44-year-old female with primary sclerosing cholangitis presents with recurrent right upper quadrant pain and chills.<a id="l0730" /></p>
<div><?mpslid S577?>
<p class="b1numlista" id="o2890"><a id="Case137-1" href="#Case0137-1">1</a>.&#160;<a id="p3650" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l0735" /></p><?mpslid S578?>
<p class="b1numlist1a" id="o2895">A.&#160;<a id="p3655" />Cholangiocarcinoma</p><?mpslid E578?><?mpslid S579?>
<p class="b1numlist1a" id="o2900">B.&#160;<a id="p3660" />Biliary stones</p><?mpslid E579?><?mpslid S580?>
<p class="b1numlist1a" id="o2905">C.&#160;<a id="p3665" />Normal variant</p><?mpslid E580?><?mpslid S581?>
<p class="b1numlist1a" id="o2910">D.&#160;<a id="p3670" />Hepatocellular carcinoma</p><?mpslid E581?><?mpslid E577?><?mpslid S582?>
<p class="b1numlista" id="o2915"><a id="Case137-2" href="#Case0137-2">2</a>.&#160;<a id="p3675" />Which noninvasive modality has the highest sensitivity in detecting the distal common bile duct disease?<a id="l0740" /></p><?mpslid S583?>
<p class="b1numlist1a" id="o2920">A.&#160;<a id="p3680" />Ultrasound</p><?mpslid E583?><?mpslid S584?>
<p class="b1numlist1a" id="o2925">B.&#160;<a id="p3685" />Computed tomography (CT)</p><?mpslid E584?><?mpslid S585?>
<p class="b1numlist1a" id="o2930">C.&#160;<a id="p3690" />Magnetic resonance cholangiopancreatography (MRCP)</p><?mpslid E585?><?mpslid S586?>
<p class="b1numlist1a" id="o2935">D.&#160;<a id="p3695" />Endoscopic retrograde cholangiopancreatography (ERCP)</p><?mpslid E586?><?mpslid E582?><?mpslid S587?>
<p class="b1numlista" id="o2940"><a id="Case137-3" href="#Case0137-3">3</a>.&#160;<a id="p3700" />Which of the following is the usual first-line treatment in uncomplicated cases?<a id="l0745" /></p><?mpslid S588?>
<p class="b1numlist1a" id="o2945">A.&#160;<a id="p3705" />Cholecystectomy</p><?mpslid E588?><?mpslid S589?>
<p class="b1numlist1a" id="o2950">B.&#160;<a id="p3710" />Whipple procedure</p><?mpslid E589?><?mpslid S590?>
<p class="b1numlist1a" id="o2955">C.&#160;<a id="p3715" />Sphincterotomy</p><?mpslid E590?><?mpslid S591?>
<p class="b1numlist1a" id="o2960">D.&#160;<a id="p3720" />Conservative management</p><?mpslid E591?><?mpslid E587?><?mpslid S592?>
<p class="b1numlista" id="o2965"><a id="Case137-4" href="#Case0137-4">4</a>.&#160;<a id="p3725" />If the first-line treatment is not successful, what can the interventional radiologist (IR) offer to help this patient? (Choose all that apply.)<a id="l0750" /></p><?mpslid S593?>
<p class="b1numlist1a" id="o2970">A.&#160;<a id="p3730" />Percutaneous cholecystostomy</p><?mpslid E593?><?mpslid S594?>
<p class="b1numlist1a" id="o2975">B.&#160;<a id="p3735" />Transjugular intrahepatic portosystemic shunt</p><?mpslid E594?><?mpslid S595?>
<p class="b1numlist1a" id="o2980">C.&#160;<a id="p3740" />Percutaneous biliary drainage</p><?mpslid E595?><?mpslid S596?>
<p class="b1numlist1a" id="o2985">D.&#160;<a id="p3745" />Percutaneous stone removal<a epub:type="noteref" href="#fn0135" id="Cfn0135">*</a></p><?mpslid E596?><?mpslid E592?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0135">
<a href="#Cfn0135"><sup>*</sup></a><a id="np0135" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0690tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P280" epub:type="pagebreak" title="280" />
<div class="boxg1" id="b0255">
<p class="b1title">Answers</p>
<p class="b1subt">Case 137</p>
<section><a id="s0970" />
<p class="b11hd" id="st0850">Complex Biliary Stone Management</p>
<a id="p3750" />
<a id="l0755" />
<div><?mpslid S597?>
<p class="b1numlista" id="o2990"><a id="Case0137-1" href="#Case137-1">1</a>.&#160;<a id="p3755" /><strong>B.</strong> There are multiple filling defects in the dilated biliary tree. These are discontinuous, making cholangiocarcinoma unlikely. Hepatocellular carcinoma would not have this appearance, and this is certainly not normal.</p><?mpslid E597?><?mpslid S598?>
<p class="b1numlista" id="o2995"><a id="Case0137-2" href="#Case137-2">2</a>.&#160;<a id="p3760" /><strong>C.</strong> Although ultrasound is very useful as an initial screening method to assess biliary stones, MRCP can provide more of a global evaluation of the biliary system and surrounding structures as well as pathological conditions within the common bile duct. CT is useful in the evaluation of the liver and biliary tree but is being replaced by MRCP by many clinicians. ERCP and percutaneous cholangiography are the most specific modalities but are invasive.</p><?mpslid E598?><?mpslid S599?>
<p class="b1numlista" id="o3000"><a id="Case0137-3" href="#Case137-3">3</a>.&#160;<a id="p3765" /><strong>C.</strong> ERCP with stone extraction and sphincterotomy, when possible, is the treatment of choice. However, in some patients this is not possible due to stone burden, stone size, and anatomy (Roux-en-Y).</p><?mpslid E599?><?mpslid S600?>
<p class="b1numlista" id="o3005"><a id="Case0137-4" href="#Case137-4">4</a>.&#160;<a id="p3770" /><strong>C and D.</strong> IRs can assist by confirming the diagnosis with percutaneous cholangiography followed by drainage initially. Once the patient is noninfectious, the IR can perform stone extraction with many different methods, including choledochoscopy as shown in this case.</p><?mpslid E600?>
</div>
<section><a id="s0975" />
<p class="b12hd" id="st0855">Comment</p>
<section><a id="s0980" />
<p class="b13hd" id="st0860">Main Teaching Point</p>
<p id="p3775" class="b1textfl">Patients with choledocholithiasis and/or complex biliary stones can present with acute severe symptomatology (due to impaction of a mid-sized or large calculus within the common bile duct) or with chronic intermittent symptoms. Imaging commonly assists in determining the stone burden and localization of occlusion (<a href="chp004_a.xhtml#f2730">Figures S137-1</a> and <a href="chp004_a.xhtml#f2735">S137-2</a>). Patients with symptoms suggesting the presence of cholangitis must be treated urgently with either stone removal or biliary drainage to rapidly relieve the obstruction. Afebrile patients with acute symptoms are usually managed with ERCP as the first-choice option.</p>
</section>
<section><a id="s0985" />
<p class="b13hd" id="st0865">Percutaneous Management</p>
<p id="p3780" class="b1textfl">If ERCP fails or is not possible, then the patient may be referred for percutaneous biliary drainage and percutaneous management. Percutaneous treatment methods include delivery of the stone into the gut with the use of a balloon, extraction with several possible devices, fragmentation, or a combination of these methods (<a href="chp004_a.xhtml#f2740">Figures S137-3</a> through <a href="chp004_a.xhtml#f2750">S137-5</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0135" />
<h3 class="ref2hd" id="st0870">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0400">1. Dasika NL. Percutaneous choledochoscopy: access, technique, ancillary procedures, results and complications of 174 procedures. <em>J Vasc Interv Radiol</em>. 2006;17(Suppl):S29.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0405">2. Ierardi AM, Fontana F, Petrillo M, et al. Percutaneous transhepatic endoscopic holmium laser lithotripsy for intrahepatic and choledochal biliary stones. <em>Int J Surg</em>. 2013;11:S36&#8211;S39.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0410">3. Peng YC, Chow WK. Alternative percutaneous approach for endoscopic inaccessible common bile duct stones. <em>Hepatogastroenterology</em>. 2011;58:705&#8211;708.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0095" />
<h3 class="ref2hd" id="st0875">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0415">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 471&#8211;473.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0135" />
<span id="P281" epub:type="pagebreak" title="281" />
<h2 class="h1hd" id="sc0135tit">Case 138</h2>
<a id="p3785" />
<div class="boxg1" id="b0260"><a id="p3790" />
<div class="pageavoid" id="f0260"><figure class="fig"><img src="../images/F000039b03-51-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 138-1</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0265"><figure class="fig"><img src="../images/F000039b03-52-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 138-2</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<section><a id="s0990" /><section><a id="s0995" /><section><a id="s1000" /><section><a id="s1005" />
<p class="b14hd" id="st0880">History</p>
<p id="p3795" class="b1textfl">A 42-year-old male presents to the emergency department with complaints of painless, penile swelling of 72 hours&#8217; duration after pelvic trauma during sexual intercourse.<a id="l0760" /></p>
<div><?mpslid S601?>
<p class="b1numlista" id="o3010"><a id="Case138-1" href="#Case0138-1">1</a>.&#160;<a id="p3800" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l0765" /></p><?mpslid S602?>
<p class="b1numlist1a" id="o3015">A.&#160;<a id="p3805" />High-flow priapism</p><?mpslid E602?><?mpslid S603?>
<p class="b1numlist1a" id="o3020">B.&#160;<a id="p3810" />Internal iliac artery embolism</p><?mpslid E603?><?mpslid S604?>
<p class="b1numlist1a" id="o3025">C.&#160;<a id="p3815" />Internal pudendal artery pseudoaneurysm formation</p><?mpslid E604?><?mpslid S605?>
<p class="b1numlist1a" id="o3030">D.&#160;<a id="p3820" />Pelvic arterial venous malformation</p><?mpslid E605?><?mpslid E601?><?mpslid S606?>
<p class="b1numlista" id="o3035"><a id="Case138-2" href="#Case0138-2">2</a>.&#160;<a id="p3825" />Which of the following arteries supplies the penis?<a id="l0770" /></p><?mpslid S607?>
<p class="b1numlist1a" id="o3040">A.&#160;<a id="p3830" />Inferior gluteal artery</p><?mpslid E607?><?mpslid S608?>
<p class="b1numlist1a" id="o3045">B.&#160;<a id="p3835" />Posterior scrotal artery</p><?mpslid E608?><?mpslid S609?>
<p class="b1numlist1a" id="o3050">C.&#160;<a id="p3840" />Inferior rectal artery</p><?mpslid E609?><?mpslid S610?>
<p class="b1numlist1a" id="o3055">D.&#160;<a id="p3845" />Internal pudendal artery</p><?mpslid E610?><?mpslid E606?><?mpslid S611?>
<p class="b1numlista" id="o3060"><a id="Case138-3" href="#Case0138-3">3</a>.&#160;<a id="p3850" />Which vessel in commonly injured in the high-flow form of this pathological condition?<a id="l0775" /></p><?mpslid S612?>
<p class="b1numlist1a" id="o3065">A.&#160;<a id="p3855" />Internal pudendal artery</p><?mpslid E612?><?mpslid S613?>
<p class="b1numlist1a" id="o3070">B.&#160;<a id="p3860" />Cavernous artery</p><?mpslid E613?><?mpslid S614?>
<p class="b1numlist1a" id="o3075">C.&#160;<a id="p3865" />Interior iliac artery</p><?mpslid E614?><?mpslid S615?>
<p class="b1numlist1a" id="o3080">D.&#160;<a id="p3870" />Inferior rectal artery</p><?mpslid E615?><?mpslid E611?><?mpslid S616?>
<p class="b1numlista" id="o3085"><a id="Case138-4" href="#Case0138-4">4</a>.&#160;<a id="p3875" />Which structure has its blood outflow obstructed in the low-flow form of this pathological condition?<a id="l0780" /></p><?mpslid S617?>
<p class="b1numlist1a" id="o3090">A.&#160;<a id="p3880" />Glans penis</p><?mpslid E617?><?mpslid S618?>
<p class="b1numlist1a" id="o3095">B.&#160;<a id="p3885" />Corpus spongiosum</p><?mpslid E618?><?mpslid S619?>
<p class="b1numlist1a" id="o3100">C.&#160;<a id="p3890" />Corpus cavernosum</p><?mpslid E619?><?mpslid S620?>
<p class="b1numlist1a" id="o3105">D.&#160;<a id="p3895" />Urethra<a epub:type="noteref" href="#fn0140" id="Cfn0140">*</a></p><?mpslid E620?><?mpslid E616?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0140">
<a href="#Cfn0140"><sup>*</sup></a><a id="np0140" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0695tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P282" epub:type="pagebreak" title="282" />
<div class="boxg1" id="b0265">
<p class="b1title">Answers</p>
<p class="b1subt">Case 138</p>
<section><a id="s1010" />
<p class="b11hd" id="st0885">Priapism</p>
<a id="p3900" />
<a id="l0785" />
<div><?mpslid S621?>
<p class="b1numlista" id="o3110"><a id="Case0138-1" href="#Case138-1">1</a>.&#160;<a id="p3905" /><strong>A.</strong> The images shown are portraying cases of high-flow priapism. There are two forms of priapism, high-flow and low-flow. It is vital to recognize this pathological condition as it can lead to permanent impotence via the development of fibrosis.</p><?mpslid E621?><?mpslid S622?>
<p class="b1numlista" id="o3115"><a id="Case0138-2" href="#Case138-2">2</a>.&#160;<a id="p3910" /><strong>D.</strong> The artery that supplies the penis is the internal pudendal artery, which is a branch of the anterior division of the internal iliac artery. The other arteries that are listed are also branches of the internal iliac artery, but the internal pudendal is the artery that supplies the penis.</p><?mpslid E622?><?mpslid S623?>
<p class="b1numlista" id="o3120"><a id="Case0138-3" href="#Case138-3">3</a>.&#160;<a id="p3915" /><strong>B.</strong> The injured artery that most commonly leads to a high-flow priapism is the cavernous artery. Damage to the cavernous artery via trauma to the pelvis or perineum creates an arteriolacunar fistula in which there is constant blood flow into the erectile tissue. The dorsal penile artery may also be injured in some cases, as shown in this example.</p><?mpslid E623?><?mpslid S624?>
<p class="b1numlista" id="o3125"><a id="Case0138-4" href="#Case138-4">4</a>.&#160;<a id="p3920" /><strong>C.</strong> The pathophysiology of low-flow priapism is outflow obstruction of the corpus cavernosum. The obstruction leads to tumescence of the corpus cavernosum with sparing of the glans penis and corpus spongiosum. This leads to vascular congestion causing a lactic acidosis and eventual fibrosis leading to permanent impotence.</p><?mpslid E624?>
</div>
<section><a id="s1015" />
<p class="b12hd" id="st0890">Comment</p>
<section><a id="s1020" />
<p class="b13hd" id="st0895">Main Teaching Point</p>
<p id="p3925" class="b1textfl">High-flow priapism is a rare arterial abnormality that results from direct trauma to the perineum or penis. Laceration of the cavernous or dorsal penile artery results in development of an angiographically visible arteriolacunar fistula (<a href="chp004_a.xhtml#f2755">Figures S138-1</a> through <a href="chp004_a.xhtml#f2765">S138-3</a>) with direct, constant entry of arterial blood into the vascular lacuna of the erectile tissue. It helps to be familiar with the normal minor arterial blush at the base of the corpus cavernosum to be able to clearly distinguish this normal finding from the more robust enhancement associated with a true arteriolacunar fistula. Low-flow priapism is caused by venous outflow obstruction of the corpus cavernosum (<a href="chp004_a.xhtml#f2775">Figures S138-5</a> and <a href="chp004_a.xhtml#f2780">S138-6</a>). The venous congestion results in a decrease of the P<span class="smallcaps">O</span>
<sub>2</sub> of the erectile tissue. This causes a lactic acidosis and resultant fibrosis leading to permanent impotence. Thus, this condition must be treated as an emergency.</p>
</section>
<section><a id="s1025" />
<p class="b13hd" id="st0900">Treatment Methods</p>
<p id="p3930" class="b1textfl">The most commonly used treatment is percutaneous embolization of the distal internal pudendal artery or feeding branch vessel (<a href="chp004_a.xhtml#f2770">Figure S138-4</a>). Autologous blood clot and Gelfoam, both temporary agents, have been used most extensively but have a significant rate of recurrence due to subsequent recanalization. Permanent agents, such as microcoils and bucrylate glue, have also been used. Surgical ligation of the cavernous artery is also an effective treatment, but because it produces permanent occlusion it can have damaging effects on the underlying tissues.</p>
</section>
<section><a id="s1030" />
<p class="b13hd" id="st0905">Complications</p>
<p id="p3935" class="b1textfl">The feared complication of both treatment and failure to treat is the development of impotence. Although many patients report a long history of high-flow priapism with normal sexual function, long-standing persistent priapism has been reported to result in fibrosis with associated erectile dysfunction. Because it is difficult to determine which patients will develop fibrosis and impotence, the timing of intervention remains controversial.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0140" />
<h3 class="ref2hd" id="st0910">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0420">1. Ciampalini S, Savoca G, Buttazzi L, et al. High-flow priapism: treatment and long-term follow-up. <em>Urology</em>. 2002;59:110&#8211;113.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0425">2. Monkhouse SJ, Bell S. Low-flow priapism needs recognition and early treatment. <em>Emerg Med J</em>. 2007;24:209&#8211;210.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0430">3. Zhao S, Zhou J, Zhang YF, et al. Therapeutic embolization of high-flow priapism 1 year follow up with color Doppler sonography. <em>Eur J Radiol</em>. 2013;82:769&#8211;774.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0100" />
<h3 class="ref2hd" id="st0915">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0435">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 226&#8211;227.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0140" />
<span id="P283" epub:type="pagebreak" title="283" />
<h2 class="h1hd" id="sc0140tit">Case 139</h2>
<a id="p3940" />
<div class="boxg1" id="b0270"><a id="p3945" />
<div class="pageavoid" id="f0270"><figure class="fig"><img src="../images/F000039b03-53-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 139-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0275"><figure class="fig"><img src="../images/F000039b03-54-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 139-2</span></figcaption></figure></div>
<section><a id="s1035" /><section><a id="s1040" /><section><a id="s1045" /><section><a id="s1050" />
<p class="b14hd" id="st0920">History</p>
<p id="p3950" class="b1textfl">A 57-year-old male with left flank pain and hematuria presents for evaluation. The patient was afebrile.<a id="l0790" /></p>
<div><?mpslid S625?>
<p class="b1numlista" id="o3130"><a id="Case139-1" href="#Case0139-1">1</a>.&#160;<a id="p3955" />Which of the following is the most likely diagnosis given the imaging and clinical findings presented?<a id="l0795" /></p><?mpslid S626?>
<p class="b1numlist1a" id="o3135">A.&#160;<a id="p3960" />Pyelonephritis</p><?mpslid E626?><?mpslid S627?>
<p class="b1numlist1a" id="o3140">B.&#160;<a id="p3965" />Renal calculus</p><?mpslid E627?><?mpslid S628?>
<p class="b1numlist1a" id="o3145">C.&#160;<a id="p3970" />Renal cell carcinoma</p><?mpslid E628?><?mpslid S629?>
<p class="b1numlist1a" id="o3150">D.&#160;<a id="p3975" />Angiomyolipoma</p><?mpslid E629?><?mpslid E625?><?mpslid S630?>
<p class="b1numlista" id="o3155"><a id="Case139-2" href="#Case0139-2">2</a>.&#160;<a id="p3980" />If the patient presented in the middle of the night with flank pain, fever, and chills, what would be the next best step in management?<a id="l0800" /></p><?mpslid S631?>
<p class="b1numlist1a" id="o3160">A.&#160;<a id="p3985" />Nephrectomy</p><?mpslid E631?><?mpslid S632?>
<p class="b1numlist1a" id="o3165">B.&#160;<a id="p3990" />Intravenous (IV) antibiotics and pain control</p><?mpslid E632?><?mpslid S633?>
<p class="b1numlist1a" id="o3170">C.&#160;<a id="p3995" />Urgent nephrostomy tube placement</p><?mpslid E633?><?mpslid S634?>
<p class="b1numlist1a" id="o3175">D.&#160;<a id="p4000" />Elective nephrostomy tube placement in the morning</p><?mpslid E634?><?mpslid E630?><?mpslid S635?>
<p class="b1numlista" id="o3180"><a id="Case139-3" href="#Case0139-3">3</a>.&#160;<a id="p4005" />What is the ideal puncture site for percutaneous nephrostomy tube placement?<a id="l0805" /></p><?mpslid S636?>
<p class="b1numlist1a" id="o3185">A.&#160;<a id="p4010" />Renal pelvis</p><?mpslid E636?><?mpslid S637?>
<p class="b1numlist1a" id="o3190">B.&#160;<a id="p4015" />Posterior calyx</p><?mpslid E637?><?mpslid S638?>
<p class="b1numlist1a" id="o3195">C.&#160;<a id="p4020" />Anterior calyx</p><?mpslid E638?><?mpslid S639?>
<p class="b1numlist1a" id="o3200">D.&#160;<a id="p4025" />Proximal ureter</p><?mpslid E639?><?mpslid E635?><?mpslid S640?>
<p class="b1numlista" id="o3205"><a id="Case139-4" href="#Case0139-4">4</a>.&#160;<a id="p4030" />Which of the following is <em>NOT</em> a potential complication of left upper pole calyx access?<a id="l0810" /></p><?mpslid S641?>
<p class="b1numlist1a" id="o3210">A.&#160;<a id="p4035" />Pneumothorax</p><?mpslid E641?><?mpslid S642?>
<p class="b1numlist1a" id="o3215">B.&#160;<a id="p4040" />Urothorax</p><?mpslid E642?><?mpslid S643?>
<p class="b1numlist1a" id="o3220">C.&#160;<a id="p4045" />Renal artery pseudoaneurysm</p><?mpslid E643?><?mpslid S644?>
<p class="b1numlist1a" id="o3225">D.&#160;<a id="p4050" />Liver injury<a epub:type="noteref" href="#fn0145" id="Cfn0145">*</a></p><?mpslid E644?><?mpslid E640?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0145">
<a href="#Cfn0145"><sup>*</sup></a><a id="np0145" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0700tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P284" epub:type="pagebreak" title="284" />
<div class="boxg1" id="b0275">
<p class="b1title">Answers</p>
<p class="b1subt">Case 139</p>
<section><a id="s1055" />
<p class="b11hd" id="st0925">Percutaneous Access for Nephrolithotomy</p>
<a id="p4055" />
<a id="l0815" />
<div><?mpslid S645?>
<p class="b1numlista" id="o3230"><a id="Case0139-1" href="#Case139-1">1</a>.&#160;<a id="p4060" /><strong>B.</strong> The images show a large left-sided calculus in the renal pelvis with signs of obstruction including dilated calyces. Although many patients may have signs of infection, this patient does not.</p><?mpslid E645?><?mpslid S646?>
<p class="b1numlista" id="o3235"><a id="Case0139-2" href="#Case139-2">2</a>.&#160;<a id="p4065" /><strong>B.</strong> Administration of IV antibiotics and pain control would be the first next step in management in the patient described in this question. Nephrostomy tube placement could be performed urgently. However, antibiotics should be administered prior to needle puncture as the patient could become septic during or immediately after the procedure.</p><?mpslid E646?><?mpslid S647?>
<p class="b1numlista" id="o3240"><a id="Case0139-3" href="#Case139-3">3</a>.&#160;<a id="p4070" /><strong>B.</strong> A zone of relative avascularity known as the avascular plane of Brodel is located posterior to the lateral convex margin of the kidney. Lower pole, posterior calyx access is commonly preferred for simple urinary drainage. Access may change based on location of stone when access is obtained for nephrolithotomy.</p><?mpslid E647?><?mpslid S648?>
<p class="b1numlista" id="o3245"><a id="Case0139-4" href="#Case139-4">4</a>.&#160;<a id="p4075" /><strong>D.</strong> Injury may occur to the liver in upper pole access of the right kidney but would not be expected for left upper pole access. The other choices are potential complications.</p><?mpslid E648?>
</div>
<section><a id="s1060" />
<p class="b12hd" id="st0930">Comment</p>
<section><a id="s1065" />
<p class="b13hd" id="st0935">Main Teaching Point</p>
<p id="p4080" class="b1textfl">The noncontrast computed tomography images demonstrate a large calculus at the left ureteropelvic junction (<a href="chp004_a.xhtml#f2785">Figures S139-1</a> and <a href="chp004_a.xhtml#f2790">S139-2</a>). Urgent percutaneous nephrostomy tube placement is indicated if the patient is febrile. If the patient shows no signs of infection, then percutaneous nephrostomy can be electively performed to preserve renal function and/or to facilitate percutaneous stone removal. In the setting of renal cortical thinning, the presence of significant residual function in the right kidney via renal scintigraphy may be performed before placing a nephrostomy tube in that kidney, although this is no longer commonly practiced.</p>
</section>
<section><a id="s1070" />
<p class="b13hd" id="st0940">Percutaneous Management</p>
<p id="p4085" class="b1textfl">To perform percutaneous stone removal, obtaining optimal access into the renal collecting system is extremely important. Typically the collecting system is accessed and a guidewire is passed into the bladder. A balloon catheter is then used to dilate the subcutaneous tract to accommodate a large (often 26 to 30 F) sheath (<a href="chp004_a.xhtml#f2795">Figure S139-3</a>). Through this sheath, a nephroscope is passed into the renal collecting system, and under direct visualization the stone is fragmented and removed. A nephrostomy catheter, and sometimes a ureteral stent, is left in place after the procedure.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0145" />
<h3 class="ref2hd" id="st0945">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0440">1. Dyer RB, Regan JD, Kavanagh PV, et al. Percutaneous nephrostomy with extensions of the technique: step by step. <em>Radiographics</em>. 2002;22:503&#8211;525.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0445">2. Landman J, Venkatesh R, Lee DI, et al. Combined percutaneous and retrograde approach to staghorn calculi with application of the ureteral access sheath to facilitate percutaneous nephrolithotomy. <em>J Urol</em>. 2003;169:64&#8211;67.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0105" />
<h3 class="ref2hd" id="st0950">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0450">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 495&#8211;499.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0145" />
<span id="P285" epub:type="pagebreak" title="285" />
<h2 class="h1hd" id="sc0145tit">Case 140</h2>
<a id="p4090" />
<div class="boxg1" id="b0280"><a id="p4095" />
<div class="pageavoid" id="f0280"><figure class="fig"><img src="../images/F000039b03-55-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 140-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0285"><figure class="fig"><img src="../images/F000039b03-56-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 140-2</span></figcaption></figure></div>
<section><a id="s1075" /><section><a id="s1080" /><section><a id="s1085" /><section><a id="s1090" />
<p class="b14hd" id="st0955">History</p>
<p id="p4100" class="b1textfl">A 63-year-old asymptomatic female presents with a hepatic mass incidentally visualized on computed tomography (CT).<a id="l0820" /></p>
<div><?mpslid S649?>
<p class="b1numlista" id="o3250"><a id="Case140-1" href="#Case0140-1">1</a>.&#160;<a id="p4105" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l0825" /></p><?mpslid S650?>
<p class="b1numlist1a" id="o3255">A.&#160;<a id="p4110" />Hepatocellular carcinoma (HCC)</p><?mpslid E650?><?mpslid S651?>
<p class="b1numlist1a" id="o3260">B.&#160;<a id="p4115" />Angiosarcoma</p><?mpslid E651?><?mpslid S652?>
<p class="b1numlist1a" id="o3265">C.&#160;<a id="p4120" />Cavernous hemangioma</p><?mpslid E652?><?mpslid S653?>
<p class="b1numlist1a" id="o3270">D.&#160;<a id="p4125" />Hepatic adenoma</p><?mpslid E653?><?mpslid E649?><?mpslid S654?>
<p class="b1numlista" id="o3275"><a id="Case140-2" href="#Case0140-2">2</a>.&#160;<a id="p4130" />Which of the following hepatic tumors does <em>NOT</em> usually exhibit contrast opacification in equilibrium phase/delayed imaging?<a id="l0830" /></p><?mpslid S655?>
<p class="b1numlist1a" id="o3280">A.&#160;<a id="p4135" />Angiosarcoma</p><?mpslid E655?><?mpslid S656?>
<p class="b1numlist1a" id="o3285">B.&#160;<a id="p4140" />Cavernous hemangioma</p><?mpslid E656?><?mpslid S657?>
<p class="b1numlist1a" id="o3290">C.&#160;<a id="p4145" />Cholangiocarcinoma</p><?mpslid E657?><?mpslid S658?>
<p class="b1numlist1a" id="o3295">D.&#160;<a id="p4150" />HCC</p><?mpslid E658?><?mpslid E654?><?mpslid S659?>
<p class="b1numlista" id="o3300"><a id="Case140-3" href="#Case0140-3">3</a>.&#160;<a id="p4155" />Which of the following hepatic tumors has a largely idiopathic etiology?<a id="l0835" /></p><?mpslid S660?>
<p class="b1numlist1a" id="o3305">A.&#160;<a id="p4160" />Angiosarcoma</p><?mpslid E660?><?mpslid S661?>
<p class="b1numlist1a" id="o3310">B.&#160;<a id="p4165" />Hepatic adenoma</p><?mpslid E661?><?mpslid S662?>
<p class="b1numlist1a" id="o3315">C.&#160;<a id="p4170" />HCC</p><?mpslid E662?><?mpslid S663?>
<p class="b1numlist1a" id="o3320">D.&#160;<a id="p4175" />Cavernous hemangioma</p><?mpslid E663?><?mpslid E659?><?mpslid S664?>
<p class="b1numlista" id="o3325"><a id="Case140-4" href="#Case0140-4">4</a>.&#160;<a id="p4180" />Which of the following hepatic tumors is most likely seen in this case?<a id="l0840" /></p><?mpslid S665?>
<p class="b1numlist1a" id="o3330">A.&#160;<a id="p4185" />Cavernous hemangioma</p><?mpslid E665?><?mpslid S666?>
<p class="b1numlist1a" id="o3335">B.&#160;<a id="p4190" />HCC</p><?mpslid E666?><?mpslid S667?>
<p class="b1numlist1a" id="o3340">C.&#160;<a id="p4195" />Hepatic adenoma</p><?mpslid E667?><?mpslid S668?>
<p class="b1numlist1a" id="o3345">D.&#160;<a id="p4200" />Angiosarcoma<a epub:type="noteref" href="#fn0150" id="Cfn0150">*</a></p><?mpslid E668?><?mpslid E664?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0150">
<a href="#Cfn0150"><sup>*</sup></a><a id="np0150" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0705tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P286" epub:type="pagebreak" title="286" />
<div class="boxg1" id="b0285">
<p class="b1title">Answers</p>
<p class="b1subt">Case 140</p>
<section><a id="s1095" />
<p class="b11hd" id="st0960">Cavernous Hemangioma of the Liver</p>
<a id="p4205" />
<a id="l0845" />
<div><?mpslid S669?>
<p class="b1numlista" id="o3350"><a id="Case0140-1" href="#Case140-1">1</a>.&#160;<a id="p4210" /><strong>A, B, C, and D.</strong> The angiographic images demonstrate multiple foci of dense, discrete, nodular contrast opacification, scattered throughout the hepatic parenchyma. All of the above pathologies can manifest in such a manner on angiography.</p><?mpslid E669?><?mpslid S670?>
<p class="b1numlista" id="o3355"><a id="Case0140-2" href="#Case140-2">2</a>.&#160;<a id="p4215" /><strong>D.</strong> The hallmark of 90% of cases of HCC is rapid washout, causing isointensity or hypointensity of the lesion as compared to the surrounding hepatic parenchyma on more delayed imaging. The above images demonstrate persistent contrast opacification on delayed imaging, which can be seen in all of the other mentioned answer choices.</p><?mpslid E670?><?mpslid S671?>
<p class="b1numlista" id="o3360"><a id="Case0140-3" href="#Case140-3">3</a>.&#160;<a id="p4220" /><strong>D.</strong> Angiosarcoma, while a rare entity, has been shown to be associated with environmental risk factors such as Thorotrast, arsenic and vinyl chloride exposure. Hepatic adenomas are most frequently seen in young women who are taking oral contraceptive pills. HCC is most strongly associated with cirrhosis, either due to alcohol or viral (hepatitis B or C) etiologies. Hemochromatosis, alpha-1 antitrypsin deficiency, Wilson&#8217;s disease, and exposure to aflatoxins are additional risk factors. Cavernous hemangiomas have no well-defined predisposing factors and largely occur sporadically.</p><?mpslid E671?><?mpslid S672?>
<p class="b1numlista" id="o3365"><a id="Case0140-4" href="#Case140-4">4</a>.&#160;<a id="p4225" /><strong>A.</strong> The above angiographic images demonstrate multiple foci of dense, discrete, nodular contrast opacification, scattered throughout the hepatic parenchyma. The pattern of contrast pooling is likened to a &#8220;cotton wool&#8221; appearance. The feeding vessels are of normal caliber with no evidence of neovascularity or arteriovenous shunting. Furthermore, progressive centripedal contrast opacification with persistence of contrast fill-in beyond the venous phase is observed. This constellation of findings is typical for a hepatic cavernous hemangioma. Although hemangiomas have characteristic angiographic features, the use of angiography is not recommended in the initial diagnosis of this entity, given the diagnostic capabilities of less invasive techniques, such as CT and magnetic resonance imaging.</p><?mpslid E672?>
</div>
<section><a id="s1100" />
<p class="b12hd" id="st0965">Comment</p>
<section><a id="s1105" />
<p class="b13hd" id="st0970">Main Teaching Point</p>
<p id="p4230" class="b1textfl">Hemangiomas are the most common benign hepatic tumors and are typically found incidentally during cross-sectional imaging. Pathologically, they comprise endothelium-lined vascular spaces divided by thin septations and suspended in a loose fibroblastic stroma. They typically remain stable in size over time, but occasionally they grow quite large. When a hemangioma is present, symptoms are commonly related to the neoplasm size, but they rarely are due to rupture or platelet sequestration.</p>
</section>
<section><a id="s1110" />
<p class="b13hd" id="st0975">Imaging Interpretation</p>
<p id="p4235" class="b1textfl">The arteriographic appearance is characteristic. The feeding vessels are typically normal in size unless the lesion is very large. Dense nodular opacification of the lesion starts at the periphery (<a href="chp004_a.xhtml#f2800">Figure S140-1</a>) and progresses inward (<a href="chp004_a.xhtml#f2805">Figures S140-2</a> and <a href="chp004_a.xhtml#f2810">S140-3</a>). The lesions are well circumscribed and have dilated, irregular, nodule-like vascular spaces. Contrast opacification persisting well into the venous phase differentiates this lesion from other hepatic neoplasms except for the rare angiosarcoma that can mimic a hemangioma.</p>
</section>
<section><a id="s1115" />
<p class="b13hd" id="st0980">Differential Diagnoses</p>
<p id="p4240" class="b1textfl">Other hepatic lesions that exhibit vascular pooling tend to be malignant tumors, including HCC and metastases. Similar to cross-sectional imaging characteristics, these can typically be differentiated by the shorter period of pooling, less uniform enhancement, enlargement of the feeding artery, and neovascularity.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0150" />
<h3 class="ref2hd" id="st0985">Reference</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0455">1. Giavraglou C, Economou H, Oannidis I. Arterial embolization of giant hepatic hemangiomas. <em>Cardiovasc Intervent Radiol</em>. 2003;26:92&#8211;96.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0110" />
<h3 class="ref2hd" id="st0990">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0460">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 253&#8211;254.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0150" />
<span id="P287" epub:type="pagebreak" title="287" />
<h2 class="h1hd" id="sc0150tit">Case 141</h2>
<a id="p4245" />
<div class="boxg1" id="b0290"><a id="p4250" />
<div class="pageavoid" id="f0290"><figure class="fig"><img src="../images/F000039b03-57-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 141-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0295"><figure class="fig"><img src="../images/F000039b03-58-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 141-2</span></figcaption></figure></div>
<section><a id="s1120" /><section><a id="s1125" /><section><a id="s1130" /><section><a id="s1135" />
<p class="b14hd" id="st0995">History</p>
<p id="p4255" class="b1textfl">A 36-year-old female with history of pelvic radiation presents with left-sided flank pain.<a id="l0850" /></p>
<div><?mpslid S673?>
<p class="b1numlista" id="o3370"><a id="Case141-1" href="#Case0141-1">1</a>.&#160;<a id="p4260" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l0855" /></p><?mpslid S674?>
<p class="b1numlist1a" id="o3375">A.&#160;<a id="p4265" />Retroperitoneal fibrosis</p><?mpslid E674?><?mpslid S675?>
<p class="b1numlist1a" id="o3380">B.&#160;<a id="p4270" />Malignant ureteric obstruction</p><?mpslid E675?><?mpslid S676?>
<p class="b1numlist1a" id="o3385">C.&#160;<a id="p4275" />Obstructing calculus</p><?mpslid E676?><?mpslid S677?>
<p class="b1numlist1a" id="o3390">D.&#160;<a id="p4280" />Benign ureteric stricture</p><?mpslid E677?><?mpslid E673?><?mpslid S678?>
<p class="b1numlista" id="o3395"><a id="Case141-2" href="#Case0141-2">2</a>.&#160;<a id="p4285" />Which factor will have the most impact upon the likelihood of long-term success in treating a ureteral stricture?<a id="l0860" /></p><?mpslid S679?>
<p class="b1numlist1a" id="o3400">A.&#160;<a id="p4290" />Side of stricture</p><?mpslid E679?><?mpslid S680?>
<p class="b1numlist1a" id="o3405">B.&#160;<a id="p4295" />Grade of hydronephrosis</p><?mpslid E680?><?mpslid S681?>
<p class="b1numlist1a" id="o3410">C.&#160;<a id="p4300" />Length of stricture</p><?mpslid E681?><?mpslid S682?>
<p class="b1numlist1a" id="o3415">D.&#160;<a id="p4305" />Disappearance of stricture &#8220;waist&#8221; on post-procedure imaging</p><?mpslid E682?><?mpslid E678?><?mpslid S683?>
<p class="b1numlista" id="o3420"><a id="Case141-3" href="#Case0141-3">3</a>.&#160;<a id="p4310" />What is an indication for placement of an in situ nephrostomy catheter following ureteric balloon dilation and stenting?<a id="l0865" /></p><?mpslid S684?>
<p class="b1numlist1a" id="o3425">A.&#160;<a id="p4315" />Hemorrhage with clot in the collecting system</p><?mpslid E684?><?mpslid S685?>
<p class="b1numlist1a" id="o3430">B.&#160;<a id="p4320" />Post-procedure nephrostomy catheters need not be placed as the nephroureteral stent provides internal drainage</p><?mpslid E685?><?mpslid S686?>
<p class="b1numlist1a" id="o3435">C.&#160;<a id="p4325" />Nephrostomy catheters should be placed after all ureteral dilation/stenting procedures involving strictures shorter than 2&#160;cm</p><?mpslid E686?><?mpslid S687?>
<p class="b1numlist1a" id="o3440">D.&#160;<a id="p4330" />Severe pre-procedure hydronephrosis</p><?mpslid E687?><?mpslid E683?><?mpslid S688?>
<p class="b1numlista" id="o3445"><a id="Case141-4" href="#Case0141-4">4</a>.&#160;<a id="p4335" />All of these are options for an interventional radiologist to dilate a ureteral stricture <em>EXCEPT</em>:<a id="l0870" /></p><?mpslid S689?>
<p class="b1numlist1a" id="o3450">A.&#160;<a id="p4340" />Cryoplasty</p><?mpslid E689?><?mpslid S690?>
<p class="b1numlist1a" id="o3455">B.&#160;<a id="p4345" />Noncutting balloon dilation</p><?mpslid E690?><?mpslid S691?>
<p class="b1numlist1a" id="o3460">C.&#160;<a id="p4350" />Cutting balloon dilation</p><?mpslid E691?><?mpslid S692?>
<p class="b1numlist1a" id="o3465">D.&#160;<a id="p4355" />Endoureterotomy<a epub:type="noteref" href="#fn0155" id="Cfn0155">*</a></p><?mpslid E692?><?mpslid E688?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0155">
<a href="#Cfn0155"><sup>*</sup></a><a id="np0155" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0710tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P288" epub:type="pagebreak" title="288" />
<div class="boxg1" id="b0295">
<p class="b1title">Answers</p>
<p class="b1subt">Case 141</p>
<section><a id="s1140" />
<p class="b11hd" id="st1000">Benign Ureteral Stricture</p>
<a id="p4360" />
<a id="l0875" />
<div><?mpslid S693?>
<p class="b1numlista" id="o3470"><a id="Case0141-1" href="#Case141-1">1</a>.&#160;<a id="p4365" /><strong>B and D</strong>. The provided case presents a column of contrast within a dilated right ureter. There is smooth tapering of contrast distally. The second image was taken after successful balloon dilation and placement of a nephroureteral stent. Differential for this appearance includes both benign malignant ureteral strictures. An obstructing calculus would produce a filling defect outlining the stone&#8217;s position. Retroperitoneal fibrosis would not likely demonstrate such smooth tapering at the site of stricture.</p><?mpslid E693?><?mpslid S694?>
<p class="b1numlista" id="o3475"><a id="Case0141-2" href="#Case141-2">2</a>.&#160;<a id="p4370" /><strong>C</strong>. The length of stricture has been found to have a large impact upon successful dilatation. Studies have found a significant difference between short (&#60;&#160;2&#160;cm) and long (&#62;&#160;2&#160;cm) segment strictures as well as a significant difference between benign and malignant strictures. Other factors including size of stricture, grade of hydronephrosis, and disappearance of &#8220;waist&#8221; of stricture have not been found to have a significant influence upon long-term outcomes.</p><?mpslid E694?><?mpslid S695?>
<p class="b1numlista" id="o3480"><a id="Case0141-3" href="#Case141-3">3</a>.&#160;<a id="p4375" /><strong>A</strong>. A nephrostomy catheter should be placed if there was enough trauma to cause hemorrhage with clot in the collecting system. This can be left for a short period to allow for urinary drainage. The nephrostomy catheter can then safely be removed. If the procedure was relatively atraumatic, a nephrostomy catheter is not required. Pre-procedure severe hydronephrosis may make the procedure more technically difficult but should not mandate a nephrostomy catheter.</p><?mpslid E695?><?mpslid S696?>
<p class="b1numlista" id="o3485"><a id="Case0141-4" href="#Case141-4">4</a>.&#160;<a id="p4380" /><strong>D</strong>. Endoureterotomy is an open or laparoscopic surgical technique requiring an incision within the ureter. Balloon catheter dilation with both noncutting and cutting balloons has been performed. Cryoplasty is a technique in which the stricture will undergo supercooling and rewarming during dilation. This has been hypothesized to induce apoptosis rather than necrosis.</p><?mpslid E696?>
</div>
<section><a id="s1145" />
<p class="b12hd" id="st1005">Comment</p>
<section><a id="s1150" />
<p class="b13hd" id="st1010">Imaging Interpretation</p>
<p id="p4385" class="b1textfl">These images demonstrate a tight stricture of the left ureter at the ureterovesical junction, with consequent hydroureteronephrosis (<a href="chp004_a.xhtml#f2815">Figures S141-1</a> and <a href="chp004_a.xhtml#f2820">S141-2</a>). In this patient, the stricture was due to prior radiation therapy. The benign nature of this stricture is favored by its focal, smooth appearance without evidence of mass effect. That said, the radiographic appearance is fairly nonspecific, and malignancy cannot be excluded on this basis alone. The stricture was successfully crossed, and a nephroureteral stent was placed (<a href="chp004_a.xhtml#f2820">Figure S141-2</a>).</p>
</section>
<section><a id="s1155" />
<p class="b13hd" id="st1015">Percutaneous Treatment</p>
<p id="p4390" class="b1textfl">Balloon dilation of the ureter can be effective in treating benign strictures but is associated with high recurrence rates. Cutting balloons may also be used for difficult lesions, ones resistant to standard balloon angioplasty, and may be performed via ureteroscopic or percutaneous approach. Following intervention, a stent is typically left across the stenosis to provide a scaffold for healing while preventing collapse to an unacceptable diameter.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0155" />
<h3 class="ref2hd" id="st1020">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0465">1. Adamo R, Saad WE, Brown D. Percutaneous ureteral interventions. <em>Tech Vasc Interv Radiol</em>. 2009;12:205&#8211;215.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0470">2. Heran MK, Bergen DC, MacNeily AE. The use of cryoplasty in a benign ureteric stricture. <em>Pediatr Radiol</em>. 2010;40:1806&#8211;1809.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0475">3. Lang EK, Glorioso 3rd LW. Antegrade transluminal dilatation of benign ureteral strictures: long-term results. <em>AJR Am J Roentgenol</em>. 1988;150:131&#8211;134.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0115" />
<h3 class="ref2hd" id="st1025">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0480">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 499&#8211;506.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0155" />
<span id="P289" epub:type="pagebreak" title="289" />
<h2 class="h1hd" id="sc0155tit">Case 142</h2>
<a id="p4395" />
<div class="boxg1" id="b0300"><a id="p4400" />
<div class="pageavoid" id="f0300"><figure class="fig"><img src="../images/F000039b03-59-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 142-1</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0305"><figure class="fig"><img src="../images/F000039b03-60-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 142-2</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<section><a id="s1160" /><section><a id="s1165" /><section><a id="s1170" /><section><a id="s1175" />
<p class="b14hd" id="st1030">History</p>
<p id="p4405" class="b1textfl">A 67-year-old female presents with severe bilateral lower-extremity swelling.<a id="l0880" /></p>
<div><?mpslid S697?>
<p class="b1numlista" id="o3490"><a id="Case142-1" href="#Case0142-1">1</a>.&#160;<a id="p4410" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l0885" /></p><?mpslid S698?>
<p class="b1numlist1a" id="o3495">A.&#160;<a id="p4415" />Leiomyosarcoma</p><?mpslid E698?><?mpslid S699?>
<p class="b1numlist1a" id="o3500">B.&#160;<a id="p4420" />Compression of inferior vena cava (IVC)</p><?mpslid E699?><?mpslid S700?>
<p class="b1numlist1a" id="o3505">C.&#160;<a id="p4425" />Congenital anomaly of IVC</p><?mpslid E700?><?mpslid S701?>
<p class="b1numlist1a" id="o3510">D.&#160;<a id="p4430" />Extension of tumor into IVC</p><?mpslid E701?><?mpslid E697?><?mpslid S702?>
<p class="b1numlista" id="o3515"><a id="Case142-2" href="#Case0142-2">2</a>.&#160;<a id="p4435" />What is the most common malignant primary IVC tumor?<a id="l0890" /></p><?mpslid S703?>
<p class="b1numlist1a" id="o3520">A.&#160;<a id="p4440" />Sarcoma</p><?mpslid E703?><?mpslid S704?>
<p class="b1numlist1a" id="o3525">B.&#160;<a id="p4445" />Melanoma</p><?mpslid E704?><?mpslid S705?>
<p class="b1numlist1a" id="o3530">C.&#160;<a id="p4450" />Leiomyosarcoma</p><?mpslid E705?><?mpslid S706?>
<p class="b1numlist1a" id="o3535">D.&#160;<a id="p4455" />Hamartoma</p><?mpslid E706?><?mpslid E702?><?mpslid S707?>
<p class="b1numlista" id="o3540"><a id="Case142-3" href="#Case0142-3">3</a>.&#160;<a id="p4460" />Which of the following would <em>MOST</em> suggest acute onset of disease?<a id="l0895" /></p><?mpslid S708?>
<p class="b1numlist1a" id="o3545">A.&#160;<a id="p4465" />Venous stasis ulcers</p><?mpslid E708?><?mpslid S709?>
<p class="b1numlist1a" id="o3550">B.&#160;<a id="p4470" />Venous collaterals on imaging</p><?mpslid E709?><?mpslid S710?>
<p class="b1numlist1a" id="o3555">C.&#160;<a id="p4475" />Cellulitis</p><?mpslid E710?><?mpslid S711?>
<p class="b1numlist1a" id="o3560">D.&#160;<a id="p4480" /><em>Phlegmasia cerulea dolens</em></p><?mpslid E711?><?mpslid E707?><?mpslid S712?>
<p class="b1numlista" id="o3565"><a id="Case142-4" href="#Case0142-4">4</a>.&#160;<a id="p4485" />Which of the following is <em>NOT</em> a common presentation for leiomyosarcoma?<a id="l0900" /></p><?mpslid S713?>
<p class="b1numlist1a" id="o3570">A.&#160;<a id="p4490" />Abdominal pain</p><?mpslid E713?><?mpslid S714?>
<p class="b1numlist1a" id="o3575">B.&#160;<a id="p4495" />Arterial compromise</p><?mpslid E714?><?mpslid S715?>
<p class="b1numlist1a" id="o3580">C.&#160;<a id="p4500" />Budd-Chiari syndrome</p><?mpslid E715?><?mpslid S716?>
<p class="b1numlist1a" id="o3585">D.&#160;<a id="p4505" />Deep venous thrombosis (DVT)<a epub:type="noteref" href="#fn0160" id="Cfn0160">*</a></p><?mpslid E716?><?mpslid E712?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0160">
<a href="#Cfn0160"><sup>*</sup></a><a id="np0160" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0715tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P290" epub:type="pagebreak" title="290" />
<div class="boxg1" id="b0305">
<p class="b1title">Answers</p>
<p class="b1subt">Case 142</p>
<section><a id="s1180" />
<p class="b11hd" id="st1035">Infiltrating Inferior Vena Cava Tumor and Biopsy</p>
<a id="p4510" />
<a id="l0905" />
<div><?mpslid S717?>
<p class="b1numlista" id="o3590"><a id="Case0142-1" href="#Case142-1">1</a>.&#160;<a id="p4515" /><strong>A, B, and D.</strong> The images demonstrate a mass in the IVC. No extension to the kidneys is seen on these limited images. The differential diagnosis of an IVC mass includes leiomyosarcoma, sarcoma, thrombus, or extension of tumor into the IVC. Leiomyosarcoma and other sarcomas will enhance on post-contrast images, while bland thrombus will not enhance.</p><?mpslid E717?><?mpslid S718?>
<p class="b1numlista" id="o3595"><a id="Case0142-2" href="#Case142-2">2</a>.&#160;<a id="p4520" /><strong>C.</strong> Leiomyosarcoma is the most common primary malignant tumor of the IVC, most frequently affecting women in the fifth and sixth decades of life.</p><?mpslid E718?><?mpslid S719?>
<p class="b1numlista" id="o3600"><a id="Case0142-3" href="#Case142-3">3</a>.&#160;<a id="p4525" /><strong>D.</strong> <em>Phlegmasia cerulea dolens</em> (painful blue edema) is a very severe form of DVT as a result of extensive thrombosis of the deep veins and collaterals and resultant arterial compromise from swelling. Although it may not be a totally acute process, symptoms commonly surface acutely when collaterals also thrombose. These patients have painful and cyanotic lower extremities with lower-extremity edema. The other answer choices are descriptive of a chronic DVT.</p><?mpslid E719?><?mpslid S720?>
<p class="b1numlista" id="o3605"><a id="Case0142-4" href="#Case142-4">4</a>.&#160;<a id="p4530" /><strong>B.</strong> The common presenting symptoms for leiomyosarcoma are abdominal pain, distention, Budd-Chiari syndrome, and DVT.</p><?mpslid E720?>
</div>
<section><a id="s1185" />
<p class="b12hd" id="st1040">Comment</p>
<section><a id="s1190" />
<p class="b13hd" id="st1045">Main Teaching Point</p>
<p id="p4535" class="b1textfl">Leiomyosarcoma is the most common primary tumor of the IVC. It usually occurs in women in the fifth to sixth decades of life and more commonly arises in the middle segment of the IVC. Patients affected by leiomyosarcoma usually have painful and edematous lower extremities from occlusion of the IVC. Other symptoms are reflective of level caval occlusion. Biopsy of the tumor may be performed by imaging guidance with ultrasound or computed tomography (CT) or endovascularly with forceps (<a href="chp004_a.xhtml#f2835">Figures S142-3</a> through <a href="chp004_a.xhtml#f2845">S142-5</a>). The prognosis for leiomyosarcoma is poor, with only a 33% 5-year survival even with surgery and adjunctive and/or neoadjunctive chemoradiation.</p>
</section>
<section><a id="s1195" />
<p class="b13hd" id="st1050">Imaging Interpretation</p>
<p id="p4540" class="b1textfl">On CT, leiomyosarcomas appear as low-attenuating infiltrating masses directly in the region of the IVC, usually with thrombus, internal hemorrhage, and internal necrosis. On magnetic resonance imaging, leiomyosarcomas commonly appear hypointense or isointense on T1-weighted images and hyperintense on T2-weighted images (<a href="chp004_a.xhtml#f2825">Figure S142-1</a>). Leiomyosarcoma commonly enhances after contrast administration, distinguishing it from bland thrombus (<a href="chp004_a.xhtml#f2830">Figure S142-2</a>). Either modality may show associated hepatic, intra-atrial, or pulmonary metastases.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0160" />
<h3 class="ref2hd" id="st1055">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0485">1. Ganeshalingam S, Rajesawaran G, Jones RL, et al. Leiomyosarcomas of the inferior vena cava: diagnostic features on cross-section imaging. <em>Clin Radiol</em>. 2011;66:50&#8211;56.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0490">2. Kandpal H, Sharma R, Gamangatti S, et al. Imaging of the inferior vena cava: a road less traveled. <em>Radiographics</em>. 2008;28:669&#8211;690.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr8030" />
<h3 class="ref2hd" id="st8030">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb8030">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 301&#8211;303.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0160" />
<span id="P291" epub:type="pagebreak" title="291" />
<h2 class="h1hd" id="sc0160tit">Case 143</h2>
<a id="p4545" />
<div class="boxg1" id="b0310"><a id="p4550" />
<div class="pageavoid" id="f0310"><figure class="fig"><img src="../images/F000039b03-61-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 143-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0315"><figure class="fig"><img src="../images/F000039b03-62-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 143-2</span></figcaption></figure></div>
<section><a id="s1200" /><section><a id="s1205" /><section><a id="s1210" /><section><a id="s1215" />
<p class="b14hd" id="st1060">History</p>
<p id="p4555" class="b1textfl">A 65-year-old man with hypertension presents with new-onset left buttock and leg pain following attempted angioplasty of a vascular stenosis.<a id="l0910" /></p>
<div><?mpslid S721?>
<p class="b1numlista" id="o3610"><a id="Case143-1" href="#Case0143-1">1</a>.&#160;<a id="p4560" />Which of the following is the most likely diagnosis based on the imaging findings in the first image?<a id="l0915" /></p><?mpslid S722?>
<p class="b1numlist1a" id="o3615">A.&#160;<a id="p4565" />Pseudoaneurysm</p><?mpslid E722?><?mpslid S723?>
<p class="b1numlist1a" id="o3620">B.&#160;<a id="p4570" />Embolism</p><?mpslid E723?><?mpslid S724?>
<p class="b1numlist1a" id="o3625">C.&#160;<a id="p4575" />Atherosclerotic stenosis</p><?mpslid E724?><?mpslid S725?>
<p class="b1numlist1a" id="o3630">D.&#160;<a id="p4580" />Dissection</p><?mpslid E725?><?mpslid E721?><?mpslid S726?>
<p class="b1numlista" id="o3635"><a id="Case143-2" href="#Case0143-2">2</a>.&#160;<a id="p4585" />Which vessel is affected?<a id="l0920" /></p><?mpslid S727?>
<p class="b1numlist1a" id="o3640">A.&#160;<a id="p4590" />Common iliac artery</p><?mpslid E727?><?mpslid S728?>
<p class="b1numlist1a" id="o3645">B.&#160;<a id="p4595" />External iliac artery</p><?mpslid E728?><?mpslid S729?>
<p class="b1numlist1a" id="o3650">C.&#160;<a id="p4600" />Common iliac vein</p><?mpslid E729?><?mpslid S730?>
<p class="b1numlist1a" id="o3655">D.&#160;<a id="p4605" />Internal iliac vein</p><?mpslid E730?><?mpslid E726?><?mpslid S731?>
<p class="b1numlista" id="o3660"><a id="Case143-3" href="#Case0143-3">3</a>.&#160;<a id="p4610" />What is the most likely first-line treatment?<a id="l0925" /></p><?mpslid S732?>
<p class="b1numlist1a" id="o3665">A.&#160;<a id="p4615" />Angioplasty alone</p><?mpslid E732?><?mpslid S733?>
<p class="b1numlist1a" id="o3670">B.&#160;<a id="p4620" />Placement of a metallic stent</p><?mpslid E733?><?mpslid S734?>
<p class="b1numlist1a" id="o3675">C.&#160;<a id="p4625" />Placement of a stent graft</p><?mpslid E734?><?mpslid S735?>
<p class="b1numlist1a" id="o3680">D.&#160;<a id="p4630" />Surgical repair</p><?mpslid E735?><?mpslid E731?><?mpslid S736?>
<p class="b1numlista" id="o3685"><a id="Case143-4" href="#Case0143-4">4</a>.&#160;<a id="p4635" />In which situation is a self-expanding stent preferable to a balloon-expandable stent?<a id="l0930" /></p><?mpslid S737?>
<p class="b1numlist1a" id="o3690">A.&#160;<a id="p4640" />When extremely precise deployment is necessary (i.e., near a critical branch point)</p><?mpslid E737?><?mpslid S738?>
<p class="b1numlist1a" id="o3695">B.&#160;<a id="p4645" />Across a lesion that requires extremely high radial force to dilate</p><?mpslid E738?><?mpslid S739?>
<p class="b1numlist1a" id="o3700">C.&#160;<a id="p4650" />Within a vessel that will undergo frequent motion (i.e., near a joint)</p><?mpslid E739?><?mpslid S740?>
<p class="b1numlist1a" id="o3705">D.&#160;<a id="p4655" />When planning to over-dilate (i.e., larger than the adjacent vessel diameter)<a epub:type="noteref" href="#fn0165" id="Cfn0165">*</a></p><?mpslid E740?><?mpslid E736?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0165">
<a href="#Cfn0165"><sup>*</sup></a><a id="np0165" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0720tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P292" epub:type="pagebreak" title="292" />
<div class="boxg1" id="b0315">
<p class="b1title">Answers</p>
<p class="b1subt">Case 143</p>
<section><a id="s1220" />
<p class="b11hd" id="st1065">Stenting of Iliac Artery Dissection</p>
<a id="p4660" />
<a id="l0935" />
<div><?mpslid S741?>
<p class="b1numlista" id="o3710"><a id="Case0143-1" href="#Case143-1">1</a>.&#160;<a id="p4665" /><strong>D.</strong> The first image demonstrates a linear defect within the left common iliac artery with differential contrast enhancement on either side of it, compatible with a dissection. There is likely in situ thrombus as well.</p><?mpslid E741?><?mpslid S742?>
<p class="b1numlista" id="o3715"><a id="Case0143-2" href="#Case143-2">2</a>.&#160;<a id="p4670" /><strong>A.</strong> Particularly on the second image, notice the smooth contours of the vessels with lack of visible valves, indicating these are arteries, not veins. As the abnormality occurs cephalad to the internal iliac, the affected vessel must be the common iliac artery.</p><?mpslid E742?><?mpslid S743?>
<p class="b1numlista" id="o3720"><a id="Case0143-3" href="#Case143-3">3</a>.&#160;<a id="p4675" /><strong>A.</strong> Dissections often require the placement of a stent to hold the dissection flap against the vessel wall (otherwise the dissection will recur). However, low-pressure balloon angioplasty with a prolonged inflation is commonly the first-line treatment attempted. If this fails, most operators would place a stent. Stent grafts in this location would be reserved for the treatment of an aneurysm, pseudoaneurysm, or extravasation (conditions where the flow must stay within the stent to treat the abnormality).</p><?mpslid E743?><?mpslid S744?>
<p class="b1numlista" id="o3725"><a id="Case0143-4" href="#Case143-4">4</a>.&#160;<a id="p4680" /><strong>C.</strong> Self-expanding stents have a predefined diameter that the stent attempts to assume and therefore can be compressed or twisted and are less likely to become permanently crushed or broken in the process.</p><?mpslid E744?>
</div>
<section><a id="s1225" />
<p class="b12hd" id="st1070">Comment</p>
<section><a id="s1230" />
<p class="b13hd" id="st1075">Main Teaching Point</p>
<p id="p4685" class="b1textfl">Stent placement has become an accepted method of treating a variety of arterial vascular abnormalities, including flow-limiting dissections, short-segment arterial occlusions, arterial stenoses refractory to angioplasty, arterial stenoses that recur following successful angioplasty, and eccentric or extremely calcified atherosclerotic lesions (<a href="chp004_a.xhtml#f2850">Figures S143-1</a> and <a href="chp004_a.xhtml#f2855">S143-2</a>). Currently available vascular stents fall into two main categories.</p>
</section>
<section><a id="s1235" />
<p class="b13hd" id="st1080">Balloon-Expandable Stents</p>
<p id="p4690" class="b1textfl"><em>Balloon-expandable stents</em> (prototype: Palmaz stent) are generally less than 4&#160;cm long, although longer stents are available and are pre-mounted on an angioplasty balloon. Their primary advantage is the pinpoint accuracy with which they can be positioned, because the deployment step simply involves inflating the carrier balloon. Their primary disadvantages are the inability to treat longer lesions with a single stent and the possibility of the stent&#8217;s slipping off the balloon during introduction. The latter problem has been largely remedied by stents that are securely mounted upon their carrier balloons by the manufacturer and careful deployment once the sheath has been retracted.</p>
</section>
<section><a id="s1240" />
<p class="b13hd" id="st1085">Self-Expandable Stents</p>
<p id="p4695" class="b1textfl"><em>Self-expandable stents</em> (prototype: Wallstent) are available in longer lengths, possess greater longitudinal flexibility, and do not require balloon mounting. However, because deployment requires a carefully controlled unsheathing of the restrained stent, allowing it to expand, these stents are slightly more prone to malpositioning during deployment. However, many newer stents have easier deployment mechanisms to minimize maldeployment.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0165" />
<h3 class="ref2hd" id="st1090">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0495">1. Funovics MA, Lackner B, Cejna M, et al. Predictors of long-term results after treatment of iliac artery obliteration by transluminal angioplasty and stent deployment. <em>Cardiovasc Intervent Radiol</em>. 2002;25:397&#8211;402.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0500">2. Tsetis D. Endovascular treatment of complications of femoral arterial access. <em>Cardiovasc Intervent Radiol</em>. 2010;33:457&#8211;468.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0120" />
<h3 class="ref2hd" id="st1095">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0505">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 214&#8211;217.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0165" />
<span id="P293" epub:type="pagebreak" title="293" />
<h2 class="h1hd" id="sc0165tit">Case 144</h2>
<a id="p4700" />
<div class="boxg1" id="b0320"><a id="p4705" />
<div class="pageavoid" id="f0320"><figure class="fig"><img src="../images/F000039b03-63-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 144-1</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0325"><figure class="fig"><img src="../images/F000039b03-64-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 144-2</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<section><a id="s1245" /><section><a id="s1250" /><section><a id="s1255" /><section><a id="s1260" />
<p class="b14hd" id="st1100">History</p>
<p id="p4710" class="b1textfl">A 54-year-old male with recent diagnosis of essential thrombocythemia presents with hematemesis and melena for 1 day.<a id="l0940" /></p>
<div><?mpslid S745?>
<p class="b1numlista" id="o3730"><a id="Case144-1" href="#Case0144-1">1</a>.&#160;<a id="p4715" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l0945" /></p><?mpslid S746?>
<p class="b1numlist1a" id="o3735">A.&#160;<a id="p4720" />Hepatoportal arteriovenous fistula</p><?mpslid E746?><?mpslid S747?>
<p class="b1numlist1a" id="o3740">B.&#160;<a id="p4725" />Hepatocellular carcinoma (HCC)</p><?mpslid E747?><?mpslid S748?>
<p class="b1numlist1a" id="o3745">C.&#160;<a id="p4730" />Caroli&#8217;s disease</p><?mpslid E748?><?mpslid S749?>
<p class="b1numlist1a" id="o3750">D.&#160;<a id="p4735" />Cavernous transformation of the portal vein (CTPV)</p><?mpslid E749?><?mpslid E745?><?mpslid S750?>
<p class="b1numlista" id="o3755"><a id="Case144-2" href="#Case0144-2">2</a>.&#160;<a id="p4740" />Which of the following is <em>NOT</em> a known underlying cause of portal vein thrombosis (PVT) that could potentially lead to the correct diagnosis in Question 1?<a id="l0950" /></p><?mpslid S751?>
<p class="b1numlist1a" id="o3760">A.&#160;<a id="p4745" />Umbilical catheterization in children</p><?mpslid E751?><?mpslid S752?>
<p class="b1numlist1a" id="o3765">B.&#160;<a id="p4750" />Prothrombin gene G20210A mutation</p><?mpslid E752?><?mpslid S753?>
<p class="b1numlist1a" id="o3770">C.&#160;<a id="p4755" />Portal venous gas</p><?mpslid E753?><?mpslid S754?>
<p class="b1numlist1a" id="o3775">D.&#160;<a id="p4760" />Pancreatitis</p><?mpslid E754?><?mpslid E750?><?mpslid S755?>
<p class="b1numlista" id="o3780"><a id="Case144-3" href="#Case0144-3">3</a>.&#160;<a id="p4765" />Which of the following is true regarding CTPV?<a id="l0955" /></p><?mpslid S756?>
<p class="b1numlist1a" id="o3785">A.&#160;<a id="p4770" />CTPV becomes evident on imaging several months after the initial thrombotic event.</p><?mpslid E756?><?mpslid S757?>
<p class="b1numlist1a" id="o3790">B.&#160;<a id="p4775" />Cirrhosis is the main risk factor for developing CTPV.</p><?mpslid E757?><?mpslid S758?>
<p class="b1numlist1a" id="o3795">C.&#160;<a id="p4780" />CTPV often extends beyond the main portal vein and into the intrahepatic circulation.</p><?mpslid E758?><?mpslid S759?>
<p class="b1numlist1a" id="o3800">D.&#160;<a id="p4785" />CTPV is an extensive hemodynamic adaptation that can effectively offset the development of portal hypertension.</p><?mpslid E759?><?mpslid E755?><?mpslid S760?>
<p class="b1numlista" id="o3805"><a id="Case144-4" href="#Case0144-4">4</a>.&#160;<a id="p4790" />Which of the following treatments is <em>MOST</em> likely contraindicated in this patient, at this time?<a id="l0960" /></p><?mpslid S761?>
<p class="b1numlist1a" id="o3810">A.&#160;<a id="p4795" />Transjugular intrahepatic portal systemic shunt (TIPS)</p><?mpslid E761?><?mpslid S762?>
<p class="b1numlist1a" id="o3815">B.&#160;<a id="p4800" />Liver transplant</p><?mpslid E762?><?mpslid S763?>
<p class="b1numlist1a" id="o3820">C.&#160;<a id="p4805" />Anticoagulation</p><?mpslid E763?><?mpslid S764?>
<p class="b1numlist1a" id="o3825">D.&#160;<a id="p4810" />Distal splenorenal shunt<a epub:type="noteref" href="#fn0170" id="Cfn0170">*</a></p><?mpslid E764?><?mpslid E760?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0170">
<a href="#Cfn0170"><sup>*</sup></a><a id="np0170" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0725tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P294" epub:type="pagebreak" title="294" />
<div class="boxg1" id="b0325">
<p class="b1title">Answers</p>
<p class="b1subt">Case 144</p>
<section><a id="s1265" />
<p class="b11hd" id="st1105">Cavernous Transformation of the Portal Vein</p>
<a id="p4815" />
<a id="l0965" />
<div><?mpslid S765?>
<p class="b1numlista" id="o3830"><a id="Case0144-1" href="#Case144-1">1</a>.&#160;<a id="p4820" /><strong>D.</strong> The patient has CTPV, radiographically represented as a network of intertwined periportal collateral vessels. Severe dilatation of the portovenous system secondary to portal hypertension is also seen. With the patient&#8217;s history of essential thrombocythemia, which has a predilection for thrombotic complications in large abdominal vessels, he may have incurred PVT leading to CTPV. Hepatoportal arteriovenous fistula in adults most commonly occurs secondary to trauma or malignancy and will appear as a dilated hepatic artery and portal vein with early filling of the fistula and opacification of the portal venous system during the arterial phase.</p><?mpslid E765?><?mpslid S766?>
<p class="b1numlista" id="o3835"><a id="Case0144-2" href="#Case144-2">2</a>.&#160;<a id="p4825" /><strong>C.</strong> Portal venous gas is a radiographic sign often associated with underlying abdominal disease and is not associated with development of PVT and subsequent CTPV. PVT in adults is often caused by congenital or acquired hypercoagulable states, abdominal malignancies, local inflammatory disease, cirrhosis, iatrogenic injury to the portal vein, and trauma, among other causes. PVT in children can be a sequela from sepsis or umbilical vein catheterization. CTPV does not occur in all PVT cases and may result from congenital malformation or development of hemangioma of the portal vein without a thrombotic event.</p><?mpslid E766?><?mpslid S767?>
<p class="b1numlista" id="o3840"><a id="Case0144-3" href="#Case144-3">3</a>.&#160;<a id="p4830" /><strong>C.</strong> CTPV often occurs around the intrahepatic portal veins, well beyond the bifurcation of the portal vein. CTPV can occur only 1 to 2 weeks after the initial thrombotic event, even if the thrombosed portal vein becomes partially recanalized. Although cirrhosis may contribute to the development of PVT due to increased resistance to portal inflow, it does not have a strong predilection for developing CTPV. CTPV most commonly occurs in patients with noncirrhotic and nontumoral PVT.</p><?mpslid E767?><?mpslid S768?>
<p class="b1numlista" id="o3845"><a id="Case0144-4" href="#Case144-4">4</a>.&#160;<a id="p4835" /><strong>C.</strong> CTPV is a relative contraindication for liver transplant and TIPS given the difficult anatomy. Other surgical options for diverting the portal blood include mesocaval, portacaval, proximal and distal splenorenal shunts. Studies suggest that early anticoagulation therapy for those with hypercoagulable state with CTPV may result in recanalization and prevention of thrombus propagation. However, in a patient with active variceal bleeding, band ligation or sclerotherapy is indicated prior to initiating anticoagulation therapy.</p><?mpslid E768?>
</div>
<section><a id="s1270" />
<p class="b12hd" id="st1110">Comment</p>
<section><a id="s1275" />
<p class="b13hd" id="st1115">Etiology</p>
<p id="p4840" class="b1textfl">CTPV is a relatively uncommon finding and is classically described as venous collateralization in response to thrombotic insult to the portal vein. Only a few days after the initial thrombotic event, collateral venous channels form in and around the intrahepatic and extrahepatic biliary channels to bypass the thrombus. Most patients with CTPV have healthy livers, and the underlying cause of PVT remains undetermined. When identifiable, the most common causes of PVT include HCC, cirrhosis, periportal inflammatory processes (e.g., pancreatitis, ascending cholangitis), and sepsis (the most common cause in children). Less common causes include hypercoagulable states and trauma.</p>
</section>
<section><a id="s1280" />
<p class="b13hd" id="st1120">Clinical Presentation</p>
<p id="p4845" class="b1textfl">Many patients are asymptomatic from PVT and CTPV and present with symptoms of the underlying disease that caused the thrombosis. In symptomatic patients, upper gastrointestinal tract bleeding is the most common presentation. In advanced stages of CTPV, patients may present with decreased liver function from loss of liver mass and strictures/displacements of the biliary and main bile ducts.</p>
</section>
<section><a id="s1285" />
<p class="b13hd" id="st1125">Imaging Evaluation</p>
<p id="p4850" class="b1textfl">Cross-sectional imaging modalities such as duplex ultrasound, helical computed tomography, and magnetic resonance imaging are fairly accurate in depicting PVT and CTPV. In questionable cases, definitive diagnosis of acute or partial portal vein occlusion may be identified by observing a focal filling defect within the portal vein during the venous phase of a celiac or superior mesenteric arteriogram or direct portography via transhepatic or TIPS access. CTPV is identified as enhancing serpiginous collateral veins in the porta hepatis with nonvisualization of the normal expected portal venous branching pattern (<a href="chp004_a.xhtml#f2860">Figures S144-1</a> through <a href="chp004_a.xhtml#f2875">S144-4</a>). Patients often develop varicosities secondary to portal hypertension.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0170" />
<h3 class="ref2hd" id="st1130">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0510">1. De Gaetano AM, Lafortune M, Patriquin H, et al. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. <em>AJR Am J Roentgenol.</em> 1995;165:1151&#8211;1155.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0515">2. Gallego C, Velasco M, Marcuello P, et al. Congenital and acquired anomalies of the portal venous system. <em>Radiographics.</em> 2002;22:141&#8211;159.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0520">3. Walser EM, Soloway R, Raza SA, et al. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein. <em>J Vasc Interv Radiol</em>. 2006;17:373&#8211;378.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0125" />
<h3 class="ref2hd" id="st1135">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0525">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 329.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0170" />
<span id="P295" epub:type="pagebreak" title="295" />
<h2 class="h1hd" id="sc0170tit">Case 145</h2>
<a id="p4855" />
<div class="boxg1" id="b0330"><a id="p4860" />
<div class="pageavoid" id="f0330"><figure class="fig"><img src="../images/F000039b03-65-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 145-1</span> <span class="figcredit">Courtesy of Dr. Ranjith Vellody.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0335"><figure class="fig"><img src="../images/F000039b03-66-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 145-2</span> <span class="figcredit">Courtesy of Dr. Ranjith Vellody.</span>
</figcaption>
</figure>
</div>
<section><a id="s1290" /><section><a id="s1295" /><section><a id="s1300" /><section><a id="s1305" />
<p class="b14hd" id="st1140">History</p>
<p id="p4865" class="b1textfl">A 12-year-old female presents with confusion and right upper quadrant pain.<a id="l0970" /></p>
<div><?mpslid S769?>
<p class="b1numlista" id="o3850"><a id="Case145-1" href="#Case0145-1">1</a>.&#160;<a id="p4870" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l0975" /></p><?mpslid S770?>
<p class="b1numlist1a" id="o3855">A.&#160;<a id="p4875" />Normal anatomy</p><?mpslid E770?><?mpslid S771?>
<p class="b1numlist1a" id="o3860">B.&#160;<a id="p4880" />Gastroesophageal varix</p><?mpslid E771?><?mpslid S772?>
<p class="b1numlist1a" id="o3865">C.&#160;<a id="p4885" />Congenital absence of the portal vein (Abernethy malformation)</p><?mpslid E772?><?mpslid S773?>
<p class="b1numlist1a" id="o3870">D.&#160;<a id="p4890" />Hypertrophied azygous vein</p><?mpslid E773?><?mpslid E769?><?mpslid S774?>
<p class="b1numlista" id="o3875"><a id="Case145-2" href="#Case0145-2">2</a>.&#160;<a id="p4895" />Which of the following is an associated finding in patients with the diagnosis above?<a id="l0980" /></p><?mpslid S775?>
<p class="b1numlist1a" id="o3880">A.&#160;<a id="p4900" />Splenic cysts</p><?mpslid E775?><?mpslid S776?>
<p class="b1numlist1a" id="o3885">B.&#160;<a id="p4905" />Pulmonary fibrosis</p><?mpslid E776?><?mpslid S777?>
<p class="b1numlist1a" id="o3890">C.&#160;<a id="p4910" />Cardiac myxomas</p><?mpslid E777?><?mpslid S778?>
<p class="b1numlist1a" id="o3895">D.&#160;<a id="p4915" />Hepatic tumors</p><?mpslid E778?><?mpslid E774?><?mpslid S779?>
<p class="b1numlista" id="o3900"><a id="Case145-3" href="#Case0145-3">3</a>.&#160;<a id="p4920" />Of the following lab abnormalities, which is the most likely cause of confusion?<a id="l0985" /></p><?mpslid S780?>
<p class="b1numlist1a" id="o3905">A.&#160;<a id="p4925" />Low platelet count</p><?mpslid E780?><?mpslid S781?>
<p class="b1numlist1a" id="o3910">B.&#160;<a id="p4930" />Hypokalemia</p><?mpslid E781?><?mpslid S782?>
<p class="b1numlist1a" id="o3915">C.&#160;<a id="p4935" />Hyperammonemia</p><?mpslid E782?><?mpslid S783?>
<p class="b1numlist1a" id="o3920">D.&#160;<a id="p4940" />Hypoammonemia</p><?mpslid E783?><?mpslid E779?><?mpslid S784?>
<p class="b1numlista" id="o3925"><a id="Case145-4" href="#Case0145-4">4</a>.&#160;<a id="p4945" />Which of the following subtypes of this process is surgically correctable?<a id="l0990" /></p><?mpslid S785?>
<p class="b1numlist1a" id="o3930">A.&#160;<a id="p4950" />Type A</p><?mpslid E785?><?mpslid S786?>
<p class="b1numlist1a" id="o3935">B.&#160;<a id="p4955" />Type I</p><?mpslid E786?><?mpslid S787?>
<p class="b1numlist1a" id="o3940">C.&#160;<a id="p4960" />Type B</p><?mpslid E787?><?mpslid S788?>
<p class="b1numlist1a" id="o3945">D.&#160;<a id="p4965" />Type II<a epub:type="noteref" href="#fn0175" id="Cfn0175">*</a></p><?mpslid E788?><?mpslid E784?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0175">
<a href="#Cfn0175"><sup>*</sup></a><a id="np0175" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0730tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P296" epub:type="pagebreak" title="296" />
<div class="boxg1" id="b0335">
<p class="b1title">Answers</p>
<p class="b1subt">Case 145</p>
<section><a id="s1310" />
<p class="b11hd" id="st1145">Abernethy Malformation</p>
<a id="p4970" />
<a id="l0995" />
<div><?mpslid S789?>
<p class="b1numlista" id="o3950"><a id="Case0145-1" href="#Case145-1">1</a>.&#160;<a id="p4975" /><strong>C.</strong> The images demonstrate injection of the splenic and superior mesenteric veins (SMVs) with flow of blood directly to the inferior vena cava and right atrium, without flow through the liver. A gastroesophageal varix may have the appearance of the venous anatomy seen with the splenic injection; however, there should be flow through the portal vein on SMV and splenic injection.</p><?mpslid E789?><?mpslid S790?>
<p class="b1numlista" id="o3955"><a id="Case0145-2" href="#Case145-2">2</a>.&#160;<a id="p4980" /><strong>D.</strong> Hepatic tumors including adenoma, focal nodular hyperplasia, and hepatocellular carcinoma are thought to be associated with Abernethy malformation.</p><?mpslid E790?><?mpslid S791?>
<p class="b1numlista" id="o3960"><a id="Case0145-3" href="#Case145-3">3</a>.&#160;<a id="p4985" /><strong>C.</strong> Hyperammonemia, which is more commonly seen in patients with cirrhosis and portal hypertension, is a result of the portosystemic shunting.</p><?mpslid E791?><?mpslid S792?>
<p class="b1numlista" id="o3965"><a id="Case0145-4" href="#Case145-4">4</a>.&#160;<a id="p4990" /><strong>D.</strong> Two types of Abernethy malformations have been described; type I and II. Type I shunts occur when the portal vein is absent and the portal blood is shunted into the systemic veins. Type II shunts are described as a hypoplastic portal vein with the majority of blood diverted into the vena cava via a side-to-side connection, which may be surgically corrected.</p><?mpslid E792?>
</div>
<section><a id="s1315" />
<p class="b12hd" id="st1150">Comment</p>
<section><a id="s1320" />
<p class="b13hd" id="st1155">Main Teaching Point</p>
<p id="p4995" class="b1textfl">Abernethy malformation is a congenital shunt in which the intestinal and splenic veins bypass the liver and drain directly into the systemic veins (<a href="chp004_a.xhtml#f2880">Figures S145-1</a> through <a href="chp004_a.xhtml#f2890">S145-3</a>). Two types have been described; type 1 occurring only in females and type II mostly in males. Type I shunts occur when the portal vein is absent and the portal blood is shunted into the systemic veins. Type I malformations are even further divided depending on whether the splenic and SMVs drain separately or as a common trunk into the systemic veins. Type II shunting is described as a hypoplastic portal vein with the majority of blood diverted into the vena cava via a side-to-side communication.</p>
</section>
<section><a id="s1325" />
<p class="b13hd" id="st1160">Patient Presentation</p>
<p id="p5000" class="b1textfl">Abernethy malformation can present with a variety of clinical manifestations. These can range from remaining completely asymptomatic to having mild liver dysfunction to more serious conditions such as multiple primary hepatic tumors, pulmonary arteriovenous fistulas, and hepatic encephalopathy (<a href="chp004_a.xhtml#f2895">Figure S145-4</a>). These malformations can be recognized on imaging studies by only two tubular structures noted at the hepatic hilum (hepatic artery and common bile duct). Computed tomography and magnetic resonance imaging are better than ultrasound at identifying the portal vein anomaly and mapping out the portosystemic shunt. Type II shunts may be surgically corrected, whereas type 1 shunts may not.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0175" />
<h3 class="ref2hd" id="st1165">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0530">1. Gallego C, Miralles M, Marin C, et al. Congenital hepatic shunts. <em>Radiographics</em>. 2004;24:755&#8211;772.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0535">2. Lisovsky M, Konstas AA, Misdraji J. Congenital extrahepatic portosystemic shunts (Abernathy malformation): a histopathologic evaluation. <em>Am J Surg Pathol</em>. 2011;35:1381&#8211;1390.</p>
</section>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0175" />
<span id="P297" epub:type="pagebreak" title="297" />
<h2 class="h1hd" id="sc0175tit">Case 146</h2>
<a id="p5005" />
<div class="boxg1" id="b0340"><a id="p5010" />
<div class="pageavoid" id="f0340"><figure class="fig"><img src="../images/F000039b03-67-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 146-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0345"><figure class="fig"><img src="../images/F000039b03-68-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 146-2</span></figcaption></figure></div>
<section><a id="s1330" /><section><a id="s1335" /><section><a id="s1340" /><section><a id="s1345" />
<p class="b14hd" id="st1170">History</p>
<p id="p5015" class="b1textfl">A 63-year-old male, status post Whipple procedure, presents with jaundice and right upper quadrant discomfort.<a id="l1000" /></p>
<div><?mpslid S793?>
<p class="b1numlista" id="o3970"><a id="Case146-1" href="#Case0146-1">1</a>.&#160;<a id="p5020" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1005" /></p><?mpslid S794?>
<p class="b1numlist1a" id="o3975">A.&#160;<a id="p5025" />Bile leak</p><?mpslid E794?><?mpslid S795?>
<p class="b1numlist1a" id="o3980">B.&#160;<a id="p5030" />Primary sclerosing cholangitis</p><?mpslid E795?><?mpslid S796?>
<p class="b1numlist1a" id="o3985">C.&#160;<a id="p5035" />Anastomotic biliary ductal stricture</p><?mpslid E796?><?mpslid S797?>
<p class="b1numlist1a" id="o3990">D.&#160;<a id="p5040" />Ischemic bile duct injury</p><?mpslid E797?><?mpslid E793?><?mpslid S798?>
<p class="b1numlista" id="o3995"><a id="Case146-2" href="#Case0146-2">2</a>.&#160;<a id="p5045" />Deferral of biliary intervention should be considered in which of the following clinical scenarios?<a id="l1010" /></p><?mpslid S799?>
<p class="b1numlist1a" id="o4000">A.&#160;<a id="p5050" />Portal hypertension</p><?mpslid E799?><?mpslid S800?>
<p class="b1numlist1a" id="o4005">B.&#160;<a id="p5055" />Small bowel obstruction</p><?mpslid E800?><?mpslid S801?>
<p class="b1numlist1a" id="o4010">C.&#160;<a id="p5060" />Cholangitis</p><?mpslid E801?><?mpslid S802?>
<p class="b1numlist1a" id="o4015">D.&#160;<a id="p5065" />Localized cancer recurrence</p><?mpslid E802?><?mpslid E798?><?mpslid S803?>
<p class="b1numlista" id="o4020"><a id="Case146-3" href="#Case0146-3">3</a>.&#160;<a id="p5070" />Which of the following imaging modalities is most sensitive for detecting biliary ductal stricture?<a id="l1015" /></p><?mpslid S804?>
<p class="b1numlist1a" id="o4025">A.&#160;<a id="p5075" />Magnetic resonance cholangiopancreatography (MRCP)</p><?mpslid E804?><?mpslid S805?>
<p class="b1numlist1a" id="o4030">B.&#160;<a id="p5080" />Ultrasound</p><?mpslid E805?><?mpslid S806?>
<p class="b1numlist1a" id="o4035">C.&#160;<a id="p5085" />Hepatobiliary scintigraphy</p><?mpslid E806?><?mpslid S807?>
<p class="b1numlist1a" id="o4040">D.&#160;<a id="p5090" />Endoscopic retrograde cholangiopancreatography (ERCP)</p><?mpslid E807?><?mpslid E803?><?mpslid S808?>
<p class="b1numlista" id="o4045"><a id="Case146-4" href="#Case0146-4">4</a>.&#160;<a id="p5095" />If left untreated, biliary anastomotic strictures can result in which of the following? (Choose all that apply.)<a id="l1020" /></p><?mpslid S809?>
<p class="b1numlist1a" id="o4050">A.&#160;<a id="p5100" />Hepatic cirrhosis</p><?mpslid E809?><?mpslid S810?>
<p class="b1numlist1a" id="o4055">B.&#160;<a id="p5105" />Cholangitis</p><?mpslid E810?><?mpslid S811?>
<p class="b1numlist1a" id="o4060">C.&#160;<a id="p5110" />Intrahepatic bile duct stones</p><?mpslid E811?><?mpslid S812?>
<p class="b1numlist1a" id="o4065">D.&#160;<a id="p5115" />Biliary fistula<a epub:type="noteref" href="#fn0180" id="Cfn0180">*</a></p><?mpslid E812?><?mpslid E808?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0180">
<a href="#Cfn0180"><sup>*</sup></a><a id="np0180" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0735tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P298" epub:type="pagebreak" title="298" />
<div class="boxg1" id="b0345">
<p class="b1title">Answers</p>
<p class="b1subt">Case 146</p>
<section><a id="s1350" />
<p class="b11hd" id="st1175">Biliary-Enteric Anastomotic Stricture</p>
<a id="p5120" />
<a id="l1025" />
<div><?mpslid S813?>
<p class="b1numlista" id="o4070"><a id="Case0146-1" href="#Case146-1">1</a>.&#160;<a id="p5125" /><strong>B, C, and D.</strong> In this patient status post hepaticojejunostomy, MRCP and percutaneous cholangiography demonstrate moderate diffuse intrahepatic biliary dilatation to the level of the biliary-enteric anastomosis with abrupt termination at this location, compatible with biliary-enteric anastomotic stricture. Differential consideration includes ischemic bile duct injury and primary sclerosing cholangitis. Of note, primary sclerosing cholangitis will characteristically demonstrate irregular beading of intrahepatic and extrahepatic bile ducts with multifocal strictures. No contrast extravasation is observed on cholangiography to indicate a bile leak.</p><?mpslid E813?><?mpslid S814?>
<p class="b1numlista" id="o4075"><a id="Case0146-2" href="#Case146-2">2</a>.&#160;<a id="p5130" /><strong>C.</strong> In a patient presenting clinically with cholangitis, temporary deferral of percutaneous biliary intervention may be considered until a course of antibiotics treats the infection. This can potentially avoid undesirable postintervention outcomes, including liver abscess and sepsis. However, in many cases, biliary drainage with the concurrent administration of antibiotics is the treatment necessary to decompress the system.</p><?mpslid E814?><?mpslid S815?>
<p class="b1numlista" id="o4080"><a id="Case0146-3" href="#Case146-3">3</a>.&#160;<a id="p5135" /><strong>C.</strong> Of the modalities listed, hepatobiliary scintigraphy is the most sensitive test to detect absent biliary flow distally. Ultrasound, MRCP, and ERCP can be useful in initial evaluation of biliary dilation, though bowel contents and postoperative changes may obfuscate areas of concern. Cholangiography and ERCP are the most specific methods of confirming diagnosis but are invasive.</p><?mpslid E815?><?mpslid S816?>
<p class="b1numlista" id="o4085"><a id="Case0146-4" href="#Case146-4">4</a>.&#160;<a id="p5140" /><strong>A, B, C, and D.</strong> Prompt intervention for biliary-enteric anastomotic strictures is mandated. Secondary biliary cirrhosis, cholangitis, intrahepatic bile duct stones, and biliary fistulas are well-documented complications of untreated biliary stricture, resulting in considerably increased morbidity. Early percutaneous intervention may circumvent these complications and avoid surgical anastomotic revision. However, surgical revision may be necessary in cases that are resistant to balloon dilation.</p><?mpslid E816?>
</div>
<section><a id="s1355" />
<p class="b12hd" id="st1180">Comment</p>
<section><a id="s1360" />
<p class="b13hd" id="st1185">Main Teaching Point</p>
<p id="p5145" class="b1textfl">A primary late complication of biliary surgery may be the development of a stricture at the biliary-enteric anastomosis. This may be diagnosed by cross-sectional imaging, cholangiography, or ERCP (<a href="chp004_a.xhtml#f2900">Figures S146-1</a> and <a href="chp004_a.xhtml#f2905">S146-2</a>). Although surgical therapy can provide a durable treatment for this problem, the difficulty of performing repeat biliary surgery in the same operative bed is considerable.</p>
</section>
<section><a id="s1365" />
<p class="b13hd" id="st1190">Percutaneous Management</p>
<p id="p5150" class="b1textfl">For this reason, percutaneous biliary drainage is usually performed initially. Balloon dilation of the anastomotic stricture can then be performed (<a href="chp004_a.xhtml#f2910">Figures S146-3</a> through <a href="chp004_a.xhtml#f2920">S146-5</a>). An internal-external drainage catheter can be left behind for several months to serve as a scaffold of good caliber around which the anastomosis can heal. Depending upon the results of balloon dilation, definitive surgical anastomotic revision might or might not be required.</p>
</section>
<section><a id="s1370" />
<p class="b13hd" id="st1195">Clinical Considerations</p>
<p id="p5155" class="b1textfl">Like other biliary interventions, antibiotic prophylaxis is recommended for biliary balloon dilation procedures. If the patient presents with cholangitis, then the balloon dilation procedure should be deferred to a future date when the patient is no longer infected. In this situation, at the initial sitting placement of a biliary drainage catheter should suffice.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0180" />
<h3 class="ref2hd" id="st1200">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0540">1. Janssen JJ, van Delden OM, van Lienden KP, et al. Percutaneous balloon dilatation and long-term drainage as treatment of anastomotic and nonanastomotic benign biliary strictures. <em>Cardiovasc Intervent Radiol</em>. 2014;37:1559&#8211;1567.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0545">2. Laasch HU, Martin DF. Management of benign biliary strictures. <em>Cardiovasc Intervent Radiol</em>. 2002;25:457&#8211;466.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0130" />
<h3 class="ref2hd" id="st1205">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0550">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 469&#8211;471.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0180" />
<span id="P299" epub:type="pagebreak" title="299" />
<h2 class="h1hd" id="sc0180tit">Case 147</h2>
<a id="p5160" />
<div class="boxg1" id="b0350"><a id="p5165" />
<div class="pageavoid" id="f0350"><figure class="fig"><img src="../images/F000039b03-69-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 147-1</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0355"><figure class="fig"><img src="../images/F000039b03-70-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 147-2</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<section><a id="s1375" /><section><a id="s1380" /><section><a id="s1385" /><section><a id="s1390" />
<p class="b14hd" id="st1210">History</p>
<p id="p5170" class="b1textfl">A 43-year-old male with facial swelling and dizziness presents for computed tomography (CT) evaluation of disease.<a id="l1030" /></p>
<div><?mpslid S817?>
<p class="b1numlista" id="o4090"><a id="Case147-1" href="#Case0147-1">1</a>.&#160;<a id="p5175" />Which of the following is the most likely diagnosis for the imaging and clinical findings presented?<a id="l1035" /></p><?mpslid S818?>
<p class="b1numlist1a" id="o4095">A.&#160;<a id="p5180" />Budd-Chiari syndrome</p><?mpslid E818?><?mpslid S819?>
<p class="b1numlist1a" id="o4100">B.&#160;<a id="p5185" />Caval obstruction</p><?mpslid E819?><?mpslid S820?>
<p class="b1numlist1a" id="o4105">C.&#160;<a id="p5190" />Klatskin tumor</p><?mpslid E820?><?mpslid S821?>
<p class="b1numlist1a" id="o4110">D.&#160;<a id="p5195" />Arteriovenous malformation</p><?mpslid E821?><?mpslid E817?><?mpslid S822?>
<p class="b1numlista" id="o4115"><a id="Case147-2" href="#Case0147-2">2</a>.&#160;<a id="p5200" />Which of the following collateral pathways carries venous blood from the upper body through the liver in the setting of superior vena cava (SVC) obstruction?<a id="l1040" /></p><?mpslid S823?>
<p class="b1numlist1a" id="o4120">A.&#160;<a id="p5205" />Caval-superficial-recanalized paraumbilical-portal</p><?mpslid E823?><?mpslid S824?>
<p class="b1numlist1a" id="o4125">B.&#160;<a id="p5210" />Caval-mesenteric-portal</p><?mpslid E824?><?mpslid S825?>
<p class="b1numlist1a" id="o4130">C.&#160;<a id="p5215" />Caval-hemiazygous-azygous</p><?mpslid E825?><?mpslid S826?>
<p class="b1numlist1a" id="o4135">D.&#160;<a id="p5220" />Caval-retroperitoneal-portal</p><?mpslid E826?><?mpslid E822?><?mpslid S827?>
<p class="b1numlista" id="o4140"><a id="Case147-3" href="#Case0147-3">3</a>.&#160;<a id="p5225" />Which of the following is the <em>LEAST</em> likely etiology of SVC syndrome?<a id="l1045" /></p><?mpslid S828?>
<p class="b1numlist1a" id="o4145">A.&#160;<a id="p5230" />Thrombosis secondary to central venous catheter</p><?mpslid E828?><?mpslid S829?>
<p class="b1numlist1a" id="o4150">B.&#160;<a id="p5235" />Infection</p><?mpslid E829?><?mpslid S830?>
<p class="b1numlist1a" id="o4155">C.&#160;<a id="p5240" />Extrinsic compression due to malignancy</p><?mpslid E830?><?mpslid S831?>
<p class="b1numlist1a" id="o4160">D.&#160;<a id="p5245" />Pulmonary hypertension</p><?mpslid E831?><?mpslid E827?><?mpslid S832?>
<p class="b1numlista" id="o4165"><a id="Case147-4" href="#Case0147-4">4</a>.&#160;<a id="p5250" />Which of the following treatments in <em>NOT</em> commonly employed in SVC syndrome?<a id="l1050" /></p><?mpslid S833?>
<p class="b1numlist1a" id="o4170">A.&#160;<a id="p5255" />Balloon angioplasty with or without stenting</p><?mpslid E833?><?mpslid S834?>
<p class="b1numlist1a" id="o4175">B.&#160;<a id="p5260" />Surgical resection of the obstructed portion of the SVC</p><?mpslid E834?><?mpslid S835?>
<p class="b1numlist1a" id="o4180">C.&#160;<a id="p5265" />Catheter thrombolysis</p><?mpslid E835?><?mpslid S836?>
<p class="b1numlist1a" id="o4185">D.&#160;<a id="p5270" />Surgical bypass grafting<a epub:type="noteref" href="#fn0185" id="Cfn0185">*</a></p><?mpslid E836?><?mpslid E832?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0185">
<a href="#Cfn0185"><sup>*</sup></a><a id="np0185" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0740tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P300" epub:type="pagebreak" title="300" />
<div class="boxg1" id="b0355">
<p class="b1title">Answers</p>
<p class="b1subt">Case 147</p>
<section><a id="s1395" />
<p class="b11hd" id="st1215">Caval Obstruction with Collateralization: Bright Liver Sign</p>
<a id="p5275" />
<a id="l1055" />
<div><?mpslid S837?>
<p class="b1numlista" id="o4190"><a id="Case0147-1" href="#Case147-1">1</a>.&#160;<a id="p5280" /><strong>B.</strong> Focal hepatic enhancement involving the left lobe of the liver has been demonstrated in cases of caval obstruction and is due to development of cavoportal collateral pathways. In Budd-Chiari syndrome, hepatic venous outflow obstruction may lead to hypertrophy and hyperenhancement of the caudate lobe. Klatskin tumors cause intrahepatic biliary ductal dilatation and are not hyperenhancing. Arteriovenous malformations typically appear as a tangle of enhancing vessels.</p><?mpslid E837?><?mpslid S838?>
<p class="b1numlista" id="o4195"><a id="Case0147-2" href="#Case147-2">2</a>.&#160;<a id="p5285" /><strong>A.</strong> Cavoportal collateral pathways carry blood to the liver in the setting of SVC obstruction including the caval-superficial-umbilical-portal pathway, which results in focal enhancement of Couinaud segment IV, and the caval-mammary-phrenic-hepatic capsule-portal pathway, which results in focal enhancement of the anterosuperior liver near the bare area. The other collateral pathways may be seen in inferior vena cava (IVC) obstruction.</p><?mpslid E838?><?mpslid S839?>
<p class="b1numlista" id="o4200"><a id="Case0147-3" href="#Case147-3">3</a>.&#160;<a id="p5290" /><strong>D.</strong> Prior to the modern antibiotic era, infections such as tuberculosis and syphilis were the most common cause of SVC syndrome. SVC obstruction due to malignancy, whether via extrinsic compression or intrinsic involvement, is currently the most common cause, and thrombotic obstruction secondary to use of intravascular devices including central venous catheters and transvenous pacemakers is rapidly increasing. Pulmonary hypertension is not a recognized cause of SVC syndrome.</p><?mpslid E839?><?mpslid S840?>
<p class="b1numlista" id="o4205"><a id="Case0147-4" href="#Case147-4">4</a>.&#160;<a id="p5295" /><strong>B.</strong> Endovascular procedures including balloon angioplasty with or without stenting are among the safest and most effective treatments available to relieve symptoms of SVC syndrome. Other therapies include surgical bypass grafting, catheter thrombolysis in the setting of acute thrombosis, and chemotherapy and radiotherapy in the setting of malignancy.</p><?mpslid E840?>
</div>
<section><a id="s1400" />
<p class="b12hd" id="st1220">Comment</p>
<section><a id="s1405" />
<p class="b13hd" id="st1225">Etiology</p>
<p id="p5300" class="b1textfl">Acquired caval occlusion may occur secondary to malignancy, either via direct involvement of the cava by tumor or external compression due to adjacent mass or nodal disease. Infection, though this is uncommon since the advent of antibiotics, and iatrogenic causes including central venous catheters and transvenous pacemakers, and benign conditions such as fibrosing mediastinitis are other common causes of SVC syndrome. With chronic occlusion, collateral pathways develop to facilitate venous drainage. Some are well described, including the azygous-hemiazygous, vertebral, mammary, and lateral thoracic pathways, whereas others such as the cavoportal pathways are less common.</p>
</section>
<section><a id="s1410" />
<p class="b13hd" id="st1230">Anatomy</p>
<p id="p5305" class="b1textfl">The cavoportal collateral pathways include the caval-superficial-recanalized paraumbilical-portal and caval-mammary-phrenic-hepatic capsule-portal pathways, which may be seen with SVC obstruction, and the caval-renal-portal, caval-retroperitoneal-portal, and caval-mesenteric-portal pathways, which may be seen with IVC obstruction. Those seen with SVC obstruction may cause focal hepatic enhancement on CT following intravenous contrast injection into an upper extremity vein (<a href="chp004_a.xhtml#f2925">Figures S147-1</a> through <a href="chp004_a.xhtml#f2935">S147-3</a>). The caval-superficial-paraumbilical-portal pathway is associated with hyperenhancement of Couinaud segment IV while the caval-mammary-phrenic-hepatic capsule-portal pathway is associated with hyperenhancement of an anterosuperior region near the bare area. While caval occlusion is often known or suspected in such cases, correct interpretation of these unusual hepatic enhancement patterns occasionally results in a diagnosis of previously occult obstruction.</p>
</section>
<section><a id="s1415" />
<p class="b13hd" id="st1235">Treatment Methods</p>
<p id="p5310" class="b1textfl">Treatment options include chemotherapy and radiotherapy for malignant etiologies; catheter thrombolysis in the setting of soft thrombus, which should be suspected with acute symptom onset, thrombosis secondary to an intravascular catheter, or when the occlusion is easily traversed with a wire; surgical bypass grafting; and endovascular procedures including balloon angioplasty and stenting. Endovascular procedures have the advantage of low morbidity and fast onset of symptom relief and do not damage tissues in a way that would preclude subsequent sampling for pathological conditions. The occlusion is traversed with a wire and luminal patency achieved via balloon angioplasty. Stenting is commonly performed when occlusion is secondary to malignancy but is avoided if possible in patients with benign occlusion and relatively longer life expectancy due to the risk of stent occlusion.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0185" />
<h3 class="ref2hd" id="st1240">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0555">1. Kapur S, Paik E, Rezaei A, et al. Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction. <em>Radiographics</em>. 2010;30:67&#8211;78.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0560">2. Siegel Y, Schallert E. Prevalence and etiology of focal liver opacification in patients with superior vena cava obstruction. <em>J Comput Assist Tomogr</em>. 2013;37:805&#8211;808.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr8035" />
<h3 class="ref2hd" id="st8035">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb8035">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 144&#8211;145.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0185" />
<span id="P301" epub:type="pagebreak" title="301" />
<h2 class="h1hd" id="sc0185tit">Case 148</h2>
<a id="p5315" />
<div class="boxg1" id="b0360"><a id="p5320" />
<div class="pageavoid" id="f0360"><figure class="fig"><img src="../images/F000039b03-71-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 148-1</span> <span class="figcredit">Courtesy of Dr. Ranjith Vellody.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0365"><figure class="fig"><img src="../images/F000039b03-72-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 148-2</span> <span class="figcredit">Courtesy of Dr. Ranjith Vellody.</span>
</figcaption>
</figure>
</div>
<section><a id="s1420" /><section><a id="s1425" /><section><a id="s1430" /><section><a id="s1435" />
<p class="b14hd" id="st1245">History</p>
<p id="p5325" class="b1textfl">A 15-year-old male with lower-extremity pain of 2 months, worse at night, presents for treatment.<a id="l1060" /></p>
<div><?mpslid S841?>
<p class="b1numlista" id="o4210"><a id="Case148-1" href="#Case0148-1">1</a>.&#160;<a id="p5330" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1065" /></p><?mpslid S842?>
<p class="b1numlist1a" id="o4215">A.&#160;<a id="p5335" />Osteomyelitis</p><?mpslid E842?><?mpslid S843?>
<p class="b1numlist1a" id="o4220">B.&#160;<a id="p5340" />Stress fracture</p><?mpslid E843?><?mpslid S844?>
<p class="b1numlist1a" id="o4225">C.&#160;<a id="p5345" />Osteoid osteoma</p><?mpslid E844?><?mpslid S845?>
<p class="b1numlist1a" id="o4230">D.&#160;<a id="p5350" />Cortical desmoid</p><?mpslid E845?><?mpslid E841?><?mpslid S846?>
<p class="b1numlista" id="o4235"><a id="Case148-2" href="#Case0148-2">2</a>.&#160;<a id="p5355" />What is the most common region for the occurrence of this lesion?<a id="l1070" /></p><?mpslid S847?>
<p class="b1numlist1a" id="o4240">A.&#160;<a id="p5360" />Skull</p><?mpslid E847?><?mpslid S848?>
<p class="b1numlist1a" id="o4245">B.&#160;<a id="p5365" />Long bones of the limbs</p><?mpslid E848?><?mpslid S849?>
<p class="b1numlist1a" id="o4250">C.&#160;<a id="p5370" />Pelvis</p><?mpslid E849?><?mpslid S850?>
<p class="b1numlist1a" id="o4255">D.&#160;<a id="p5375" />Spine</p><?mpslid E850?><?mpslid E846?><?mpslid S851?>
<p class="b1numlista" id="o4260"><a id="Case148-3" href="#Case0148-3">3</a>.&#160;<a id="p5380" />Which of the following percutaneous procedures is most commonly performed for treatment of this lesion?<a id="l1075" /></p><?mpslid S852?>
<p class="b1numlist1a" id="o4265">A.&#160;<a id="p5385" />Percutaneous aspiration</p><?mpslid E852?><?mpslid S853?>
<p class="b1numlist1a" id="o4270">B.&#160;<a id="p5390" />Percutaneous embolization</p><?mpslid E853?><?mpslid S854?>
<p class="b1numlist1a" id="o4275">C.&#160;<a id="p5395" />Percutaneous packing</p><?mpslid E854?><?mpslid S855?>
<p class="b1numlist1a" id="o4280">D.&#160;<a id="p5400" />Percutaneous ablation</p><?mpslid E855?><?mpslid E851?><?mpslid S856?>
<p class="b1numlista" id="o4285"><a id="Case148-4" href="#Case0148-4">4</a>.&#160;<a id="p5405" />While this procedure is relatively low risk, which of the following is a known complication?<a id="l1080" /></p><?mpslid S857?>
<p class="b1numlist1a" id="o4290">A.&#160;<a id="p5410" />Metastatic spread</p><?mpslid E857?><?mpslid S858?>
<p class="b1numlist1a" id="o4295">B.&#160;<a id="p5415" />Growth retardation</p><?mpslid E858?><?mpslid S859?>
<p class="b1numlist1a" id="o4300">C.&#160;<a id="p5420" />Mental retardation</p><?mpslid E859?><?mpslid S860?>
<p class="b1numlist1a" id="o4305">D.&#160;<a id="p5425" />Superficial skin burn<a epub:type="noteref" href="#fn0190" id="Cfn0190">*</a></p><?mpslid E860?><?mpslid E856?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0190">
<a href="#Cfn0190"><sup>*</sup></a><a id="np0190" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0745tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P302" epub:type="pagebreak" title="302" />
<div class="boxg1" id="b0365">
<p class="b1title">Answers</p>
<p class="b1subt">Case 148</p>
<section><a id="s1440" />
<p class="b11hd" id="st1250">Osteoid Osteoma</p>
<a id="p5430" />
<a id="l1085" />
<div><?mpslid S861?>
<p class="b1numlista" id="o4310"><a id="Case0148-1" href="#Case148-1">1</a>.&#160;<a id="p5435" /><strong>C</strong>. The images show asymmetric cortical thickening with periosteal reaction and a nidus of low attenuation. Given the characterization of pain and young age, this most likely represents an osteoid osteoma; a benign bone tumor.</p><?mpslid E861?><?mpslid S862?>
<p class="b1numlista" id="o4315"><a id="Case0148-2" href="#Case148-2">2</a>.&#160;<a id="p5440" /><strong>B.</strong> The most common locations for osteoid osteoma are in the metaphysis and diaphysis of the long bones, specifically the femur and the tibia. In the femur, the most common sites are the femoral neck and the intertrochanteric region.</p><?mpslid E862?><?mpslid S863?>
<p class="b1numlista" id="o4320"><a id="Case0148-3" href="#Case148-3">3</a>.&#160;<a id="p5445" /><strong>D.</strong> The procedure being performed in Figures 148-1 and S148-2, as well as in Figures S148-3 and S148-4, is percutaneous radiofrequency ablation (RFA). The ablation techniques have shown to be equivalent to surgical resection in terms of treatment efficacy. Under computed tomography (CT) guidance, the nidus of the tumor is accessed with an RFA probe. The lesion then undergoes ablation for several minutes.</p><?mpslid E863?><?mpslid S864?>
<p class="b1numlista" id="o4325"><a id="Case0148-4" href="#Case148-4">4</a>.&#160;<a id="p5450" /><strong>D.</strong> Complications related to percutaneous RFA are rare, but include superficial skin burns, cellulitis, fracture, or damage to the adjacent nerves. Case reports of fractures have been reported as well.</p><?mpslid E864?>
</div>
<section><a id="s1445" />
<p class="b12hd" id="st1255">Comment</p>
<section><a id="s1450" />
<p class="b13hd" id="st1260">Main Teaching Point</p>
<p id="p5455" class="b1textfl">Osteoid osteoma is a benign tumor of the bone most commonly found within the long bones of adolescents. It classically presents with pain and swelling, worst at night. These lesions are commonly found in the cortex of long bones of the limbs but may be found elsewhere including the phalanges and the spine. The osteoid osteoma lesion is comprised of a lucent nidus, fibrovascular rim, and adjacent reactive sclerosis (<a href="chp004_a.xhtml#f2940">Figures S148-1</a> through <a href="chp004_a.xhtml#f2950">S148-3</a>). Diagnosis of osteoid osteoma is usually made with plain radiographs or CT. Magnetic resonance imaging or bone scintigraphy may also help in making the diagnosis.</p>
</section>
<section><a id="s1455" />
<p class="b13hd" id="st1265">Treatment Methods</p>
<p id="p5460" class="b1textfl">Osteoid osteoma lesions are benign but may cause significant pain. The pain usually responds to nonsteroidal anti-inflammatory medications. However, if pain from the lesion limits the patient&#8217;s activities, it can result in leg-length discrepancies, scoliosis, or disuse osteopenia. In these situations, surgical resection or curettage may be performed. Additionally, the lesions can be treated with RFA or cryoablation, which are percutaneous and avoid the potential complications of a surgical repair (<a href="chp004_a.xhtml#f2955">Figure S148-4</a>). The complications related to percutaneous options remain incompletely evaluated but include superficial skin burns, cellulitis, fracture, or damage to the adjacent nerves.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0190" />
<h3 class="ref2hd" id="st1270">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0565">1. Boscainos PJ, Cousins GR, Kulshreshtha R, et al. Osteoid osteoma. <em>Orthopedics</em>. 2013;36:792&#8211;800.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0570">2. Earhart J, Wellman D, Donaldson J, et al. Radiofrequency ablation in the treatment of osteoid osteoma: results and complications. <em>Pediatr Radiol</em>. 2013;43:814&#8211;819.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr8040" />
<h3 class="ref2hd" id="st8040">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb8040">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 543&#8211;544.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0190" />
<span id="P303" epub:type="pagebreak" title="303" />
<h2 class="h1hd" id="sc0190tit">Case 149</h2>
<a id="p5465" />
<div class="boxg1" id="b0370"><a id="p5470" />
<div class="pageavoid" id="f0370"><figure class="fig"><img src="../images/F000039b03-73-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 149-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0375"><figure class="fig"><img src="../images/F000039b03-74-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 149-2</span></figcaption></figure></div>
<section><a id="s1460" /><section><a id="s1465" /><section><a id="s1470" /><section><a id="s1475" />
<p class="b14hd" id="st1275">History</p>
<p id="p5475" class="b1textfl">A 42-year-old female presents to her primary care physician with pain and paresthesias involving her hands.<a id="l1090" /></p>
<div><?mpslid S865?>
<p class="b1numlista" id="o4330"><a id="Case149-1" href="#Case0149-1">1</a>.&#160;<a id="p5480" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1095" /></p><?mpslid S866?>
<p class="b1numlist1a" id="o4335">A.&#160;<a id="p5485" />Traumatic injury to the radial artery</p><?mpslid E866?><?mpslid S867?>
<p class="b1numlist1a" id="o4340">B.&#160;<a id="p5490" />Vascular manifestations of rheumatoid arthritis</p><?mpslid E867?><?mpslid S868?>
<p class="b1numlist1a" id="o4345">C.&#160;<a id="p5495" />Systemic sclerosis</p><?mpslid E868?><?mpslid S869?>
<p class="b1numlist1a" id="o4350">D.&#160;<a id="p5500" />Buerger&#8217;s disease</p><?mpslid E869?><?mpslid E865?><?mpslid S870?>
<p class="b1numlista" id="o4355"><a id="Case149-2" href="#Case0149-2">2</a>.&#160;<a id="p5505" />Prior to any arterial interventions in this case, what is best test to ensure adequate collateral perfusion of the hand?<a id="l1100" /></p><?mpslid S871?>
<p class="b1numlist1a" id="o4360">A.&#160;<a id="p5510" />Skin exam to screen for cyanosis</p><?mpslid E871?><?mpslid S872?>
<p class="b1numlist1a" id="o4365">B.&#160;<a id="p5515" />Plain film of the hand to observe for osteonecrosis</p><?mpslid E872?><?mpslid S873?>
<p class="b1numlist1a" id="o4370">C.&#160;<a id="p5520" />Allen&#8217;s test</p><?mpslid E873?><?mpslid S874?>
<p class="b1numlist1a" id="o4375">D.&#160;<a id="p5525" />Doppler ultrasound</p><?mpslid E874?><?mpslid E870?><?mpslid S875?>
<p class="b1numlista" id="o4380"><a id="Case149-3" href="#Case0149-3">3</a>.&#160;<a id="p5530" />What radiographic finding in these images allows for a confident diagnosis of the disease process?<a id="l1105" /></p><?mpslid S876?>
<p class="b1numlist1a" id="o4385">A.&#160;<a id="p5535" />Multiple, diffuse occluded and stenotic arterial lesions</p><?mpslid E876?><?mpslid S877?>
<p class="b1numlist1a" id="o4390">B.&#160;<a id="p5540" />The formation of pseudoaneurysms</p><?mpslid E877?><?mpslid S878?>
<p class="b1numlist1a" id="o4395">C.&#160;<a id="p5545" />The localization of the lesions to the digits</p><?mpslid E878?><?mpslid S879?>
<p class="b1numlist1a" id="o4400">D.&#160;<a id="p5550" />The evidence of acro-osteolysis</p><?mpslid E879?><?mpslid E875?><?mpslid S880?>
<p class="b1numlista" id="o4405"><a id="Case149-4" href="#Case0149-4">4</a>.&#160;<a id="p5555" />How can one best determine if there is a significant vasospastic component present?<a id="l1110" /></p><?mpslid S881?>
<p class="b1numlist1a" id="o4410">A.&#160;<a id="p5560" />Injection of epinephrine</p><?mpslid E881?><?mpslid S882?>
<p class="b1numlist1a" id="o4415">B.&#160;<a id="p5565" />Exposure of the digits to a cold environment</p><?mpslid E882?><?mpslid S883?>
<p class="b1numlist1a" id="o4420">C.&#160;<a id="p5570" />Exposure of the digits to a warm environment</p><?mpslid E883?><?mpslid S884?>
<p class="b1numlist1a" id="o4425">D.&#160;<a id="p5575" />Injection of nitroglycerin<a epub:type="noteref" href="#fn0195" id="Cfn0195">*</a></p><?mpslid E884?><?mpslid E880?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0195">
<a href="#Cfn0195"><sup>*</sup></a><a id="np0195" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0750tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P304" epub:type="pagebreak" title="304" />
<div class="boxg1" id="b0375">
<p class="b1title">Answers</p>
<p class="b1subt">Case 149</p>
<section><a id="s1480" />
<p class="b11hd" id="st1280">Scleroderma</p>
<a id="p5580" />
<a id="l1115" />
<div><?mpslid S885?>
<p class="b1numlista" id="o4430"><a id="Case0149-1" href="#Case149-1">1</a>.&#160;<a id="p5585" /><strong>C.</strong> The most likely diagnosis for the images presented in this case is systemic sclerosis or scleroderma. The images show multiple areas of occlusion and stenoses within the hand, which are characteristic of scleroderma. The differential should still include embolic phenomena, vasculitides, traumatic lesions, and vasospasm, but the identification of acro-osteolysis allows for a confident diagnosis of scleroderma.</p><?mpslid E885?><?mpslid S886?>
<p class="b1numlista" id="o4435"><a id="Case0149-2" href="#Case149-2">2</a>.&#160;<a id="p5590" /><strong>C.</strong> The Allen&#8217;s test is the best and most practical exam finding to ensure that there is adequate collateral perfusion of the hand. Both the ulnar and the radial artery participate in blood flow to the hand. The exam is performed by manually occluding both the radial and the ulnar artery and having the patient make a fist. While still applying pressure, have the patient open the hand and the palm should appear pallored. Release pressure on one of the arteries and color should return to the hand. Before any arterial interventions are undertaken in one of the arteries, the Allen&#8217;s test should be performed to ensure that there is adequate flow from the other artery.</p><?mpslid E886?><?mpslid S887?>
<p class="b1numlista" id="o4440"><a id="Case0149-3" href="#Case149-3">3</a>.&#160;<a id="p5595" /><strong>D.</strong> The evidence of acro-osteolysis in these images allows for a confident diagnosis of scleroderma. Acro-osteolysis is a radiographic finding that refers to terminal bony erosions due to resorption of the distal phalanges. This is a common radiographic finding in patients with vascular involvement of scleroderma. There are multiple stenotic and occluded lesions in these images, but this is not specific for scleroderma as there are many other disease processes that can present like this (embolic, vasculitis, or trauma). There is no localization to the digits in these images nor is there evidence of pseudoaneurysmal formation.</p><?mpslid E887?><?mpslid S888?>
<p class="b1numlista" id="o4445"><a id="Case0149-4" href="#Case149-4">4</a>.&#160;<a id="p5600" /><strong>D.</strong> The injection of a vasodilator, such as nitroglycerin, would allow for the identification of a vasospastic component in this case. If the arterial lesions improve with the administration of a vasodilator, then this indicates that a sympathectomy may be beneficial for the patient (such as a patient with Raynaud&#8217;s phenomenon). A vasoconstrictor, such as epinephrine, would only worsen these lesions. Exposure of the hand to warm and cold environments may elicit a response such as cyanosis of the digits, but it is not as specific as vasodilator administration.</p><?mpslid E888?>
</div>
<section><a id="s1485" />
<p class="b12hd" id="st1285">Comment</p>
<section><a id="s1490" />
<p class="b13hd" id="st1290">Main Teaching Point</p>
<p id="p5605" class="b1textfl">Small artery occlusions and stenoses in the palmar and digital arteries can produce severe pain, paresthesias, Raynaud&#8217;s phenomenon, fingertip necrosis, and gangrene (<a href="chp004_a.xhtml#f2960">Figures S149-1</a> through <a href="chp004_a.xhtml#f2975">S149-4</a>). The pathophysiology of vascular lesions in these patients often includes embolic, traumatic, vasoreactive, and inflammatory components. Diagnostic evaluation should focus upon identifying contributing factors that are treatable by medical or surgical interventions.</p>
</section>
<section><a id="s1495" />
<p class="b13hd" id="st1295">Endovascular Evaluation</p>
<p id="p5610" class="b1textfl">First, the angiogram should be carefully scrutinized for any evidence of emboli. Potential sources of digital emboli include the heart (diagnosed by echocardiography and treated with anticoagulation), atherosclerotic plaques in the subclavian artery (treated with anticoagulation and/or surgical removal of the source lesion), sports-related injury to the axillary artery (subject to surgical repair), and occupational vascular injuries such as hypothenar hammer syndrome (also subject to surgical repair). Second, the presence of a significant vasospastic component to the arterial lesions should be sought during the angiographic evaluation. If the stenotic lesions improve significantly following administration of a vasodilator (such as tolazoline or nitroglycerin), then a sympathectomy may be more likely to provide some degree of symptom relief.</p>
</section>
<section><a id="s1500" />
<p class="b13hd" id="st1300">Disease Progression</p>
<p id="p5615" class="b1textfl">Unfortunately, this patient has irreversible small-vessel occlusions due to scleroderma. The vascular findings mimic those seen with other small-vessel diseases. However, the diagnosis of scleroderma can confidently be made in this patient due to the clear radiographic evidence of acro-osteolysis (<a href="chp004_a.xhtml#f2965">Figures S149-2</a> and <a href="chp004_a.xhtml#f2970">S149-3</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0195" />
<h3 class="ref2hd" id="st1305">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0575">1. Stucker M, Quinna S, Memmel U, et al. Macroangiopathy of the upper extremities in progressive systemic sclerosis. <em>Eur J Med Res</em>. 2000;5:295&#8211;302.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0580">2. Taylor MH, McFadden JA, Bolster MB, et al. Ulnar artery involvement in systemic sclerosis (scleroderma). <em>J Rheumatol</em>. 2002;29:102&#8211;106.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0135" />
<h3 class="ref2hd" id="st1310">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0585">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 130.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0195" />
<span id="P305" epub:type="pagebreak" title="305" />
<h2 class="h1hd" id="sc0195tit">Case 150</h2>
<a id="p5620" />
<div class="boxg1" id="b0380"><a id="p5625" />
<div class="pageavoid" id="f0380"><figure class="fig"><img src="../images/F000039b03-75-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 150-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0385"><figure class="fig"><img src="../images/F000039b03-76-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 150-2</span></figcaption></figure></div>
<section><a id="s1505" /><section><a id="s1510" /><section><a id="s1515" /><section><a id="s1520" />
<p class="b14hd" id="st1315">History</p>
<p id="p5630" class="b1textfl">A 68-year-old male with abdominal aortic aneurysm presents for preoperative computed tomography angiography (CTA).<a id="l1120" /></p>
<div><?mpslid S889?>
<p class="b1numlista" id="o4450"><a id="Case150-1" href="#Case0150-1">1</a>.&#160;<a id="p5635" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1125" /></p><?mpslid S890?>
<p class="b1numlist1a" id="o4455">A.&#160;<a id="p5640" />Right internal iliac artery aneurysm</p><?mpslid E890?><?mpslid S891?>
<p class="b1numlist1a" id="o4460">B.&#160;<a id="p5645" />Right common iliac artery aneurysm</p><?mpslid E891?><?mpslid S892?>
<p class="b1numlist1a" id="o4465">C.&#160;<a id="p5650" />Right external iliac artery pseudoaneurysm</p><?mpslid E892?><?mpslid S893?>
<p class="b1numlist1a" id="o4470">D.&#160;<a id="p5655" />Right internal iliac artery dissection</p><?mpslid E893?><?mpslid E889?><?mpslid S894?>
<p class="b1numlista" id="o4475"><a id="Case150-2" href="#Case0150-2">2</a>.&#160;<a id="p5660" />For asymptomatic lesions, which diameter necessitates intervention?<a id="l1130" /></p><?mpslid S895?>
<p class="b1numlist1a" id="o4480">A.&#160;<a id="p5665" />1.0 to 1.5&#160;cm</p><?mpslid E895?><?mpslid S896?>
<p class="b1numlist1a" id="o4485">B.&#160;<a id="p5670" />2.0 to 2.5&#160;cm</p><?mpslid E896?><?mpslid S897?>
<p class="b1numlist1a" id="o4490">C.&#160;<a id="p5675" />3.0 to 3.5&#160;cm</p><?mpslid E897?><?mpslid S898?>
<p class="b1numlist1a" id="o4495">D.&#160;<a id="p5680" />4.0 to 4.5&#160;cm</p><?mpslid E898?><?mpslid E894?><?mpslid S899?>
<p class="b1numlista" id="o4500"><a id="Case150-3" href="#Case0150-3">3</a>.&#160;<a id="p5685" />Endovascular repair is elected. Before occluding the inflow to this lesion, what step should be performed?<a id="l1135" /></p><?mpslid S900?>
<p class="b1numlist1a" id="o4505">A.&#160;<a id="p5690" />Embolization of distal arteries arising from lesion</p><?mpslid E900?><?mpslid S901?>
<p class="b1numlist1a" id="o4510">B.&#160;<a id="p5695" />Stent-graft placement in external iliac artery</p><?mpslid E901?><?mpslid S902?>
<p class="b1numlist1a" id="o4515">C.&#160;<a id="p5700" />Contralateral common iliac arteriogram</p><?mpslid E902?><?mpslid S903?>
<p class="b1numlist1a" id="o4520">D.&#160;<a id="p5705" />Thrombin injection into lesion</p><?mpslid E903?><?mpslid E899?><?mpslid S904?>
<p class="b1numlista" id="o4525"><a id="Case150-4" href="#Case0150-4">4</a>.&#160;<a id="p5710" />Which of the following is the most common complication of endovascular repair of this lesion?<a id="l1140" /></p><?mpslid S905?>
<p class="b1numlist1a" id="o4530">A.&#160;<a id="p5715" />Endoleak from stent graft</p><?mpslid E905?><?mpslid S906?>
<p class="b1numlist1a" id="o4535">B.&#160;<a id="p5720" />Buttock claudication</p><?mpslid E906?><?mpslid S907?>
<p class="b1numlist1a" id="o4540">C.&#160;<a id="p5725" />Distal atheroembolization</p><?mpslid E907?><?mpslid S908?>
<p class="b1numlist1a" id="o4545">D.&#160;<a id="p5730" />Colonic ischemia<a epub:type="noteref" href="#fn0200" id="Cfn0200">*</a></p><?mpslid E908?><?mpslid E904?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0200">
<a href="#Cfn0200"><sup>*</sup></a><a id="np0200" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0755tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P306" epub:type="pagebreak" title="306" />
<div class="boxg1" id="b0385">
<p class="b1title">Answers</p>
<p class="b1subt">Case 150</p>
<section><a id="s1525" />
<p class="b11hd" id="st1320">Internal Iliac Artery Aneurysm</p>
<a id="p5735" />
<a id="l1145" />
<div><?mpslid S909?>
<p class="b1numlista" id="o4550"><a id="Case0150-1" href="#Case150-1">1</a>.&#160;<a id="p5740" /><strong>A and B.</strong> Fusiform dilation is seen in the right common and internal iliac arteries. There is mild dilation of the left common iliac artery as well.</p><?mpslid E909?><?mpslid S910?>
<p class="b1numlista" id="o4555"><a id="Case0150-2" href="#Case150-2">2</a>.&#160;<a id="p5745" /><strong>C.</strong> The risk of aneurysmal rupture increases dramatically with a diameter above 3&#160;cm. Therefore asymptomatic aneurysms above 3.0 to 3.5&#160;cm in diameter should be electively repaired.</p><?mpslid E910?><?mpslid S911?>
<p class="b1numlista" id="o4560"><a id="Case0150-3" href="#Case150-3">3</a>.&#160;<a id="p5750" /><strong>A.</strong> In order to prevent retrograde filling of the aneurysm sac, the outflow vessels should be occluded with coils.</p><?mpslid E911?><?mpslid S912?>
<p class="b1numlista" id="o4565"><a id="Case0150-4" href="#Case150-4">4</a>.&#160;<a id="p5755" /><strong>B.</strong> Buttock claudication occurs with a mean incidence of 21.8% in patients after endovascular repair but is usually mild and transient. Endoleak, distal arterial atheroembolization, colonic ischemia, and graft occlusion are other, less frequent complications.</p><?mpslid E912?>
</div>
<section><a id="s1530" />
<p class="b12hd" id="st1325">Comment</p>
<section><a id="s1535" />
<p class="b13hd" id="st1330">Main Teaching Point</p>
<p id="p5760" class="b1textfl">Isolated iliac artery aneurysms can rupture, embolize, or produce local compression symptoms. These may be found incidentally or as part of evaluation for other aneurysmal disease (<a href="chp004_a.xhtml#f2980">Figures S150-1</a> and <a href="chp004_a.xhtml#f2985">S150-2</a>). The rate of rupture increases significantly between 3 and 4&#160;cm, and therefore most surgeons recommend elective operative repair for iliac aneurysms larger than 3.0 to 3.5&#160;cm in diameter. Because retroperitoneal dissection can be difficult when the aneurysm morphology is complex, endovascular methods to repair iliac aneurysms have gained favor. So far, the primary patencies of stent grafts for iliac artery aneurysms have been excellent (81% to 97% at 2 to 5 years), and the incidence of endoleaks has been very low.</p>
</section>
<section><a id="s1540" />
<p class="b13hd" id="st1335">Treatment Methods</p>
<p id="p5765" class="b1textfl">Because of the late potential for cross-pelvic collaterals to reconstitute the aneurysm sac, it is very important to gain control of all distal vessels arising from the aneurysm, either by surgical ligation or by coil embolization (<a href="chp004_a.xhtml#f2990">Figures S150-3</a> through <a href="chp004_a.xhtml#f3000">S150-5</a>). Once these outflow vessels are successfully occluded, the inflow to the aneurysm may be occluded by placing a stent graft across the origin of the internal iliac artery. Follow-up after endovascular repair commonly includes CTA before discharge and at 6-month intervals for the next 12 months. An increase in size greater than or equal to 5&#160;mm requires further intervention or closer surveillance.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0200" />
<h3 class="ref2hd" id="st1340">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0590">1. Razavi MK, Dake MD, Semba CP, et al. Percutaneous endoluminal placement of stent-grafts for the treatment of isolated iliac artery aneurysms. <em>Radiology</em>. 1995;197:801&#8211;804.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0595">2. Sanchez LA, Patel AV, Ohki T, et al. Midterm experience with the endovascular treatment of isolated iliac aneurysms. <em>J Vasc Surg</em>. 1999;30:907&#8211;914.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0600">3. Uberoi R, Tsetis D, Shrivastava V, et al. Standard of practice for the interventional management of isolated iliac artery aneurysms. <em>Cardiovasc Intervent Radiol</em>. 2011;34:3&#8211;13.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0140" />
<h3 class="ref2hd" id="st1345">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0605">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 203&#8211;209.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0200" />
<span id="P307" epub:type="pagebreak" title="307" />
<h2 class="h1hd" id="sc0200tit">Case 151</h2>
<a id="p5770" />
<div class="boxg1" id="b0390"><a id="p5775" />
<div class="pageavoid" id="f0390"><figure class="fig"><img src="../images/F000039b03-77-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 151-1</span> <span class="figcredit">Courtesy of Dr. David Hovsepian.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0395"><figure class="fig"><img src="../images/F000039b03-78-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 151-2</span> <span class="figcredit">Courtesy of Dr. David Hovsepian.</span>
</figcaption>
</figure>
</div>
<section><a id="s1545" /><section><a id="s1550" /><section><a id="s1555" /><section><a id="s1560" />
<p class="b14hd" id="st1350">History</p>
<p id="p5780" class="b1textfl">A 37-year-old female presents for evaluation; remaining history is withheld.<a id="l1150" /></p>
<div><?mpslid S913?>
<p class="b1numlista" id="o4570"><a id="Case151-1" href="#Case0151-1">1</a>.&#160;<a id="p5785" />What is the most common cause of the findings depicted in image 151-1?<a id="l1155" /></p><?mpslid S914?>
<p class="b1numlist1a" id="o4575">A.&#160;<a id="p5790" />Congenital anomaly</p><?mpslid E914?><?mpslid S915?>
<p class="b1numlist1a" id="o4580">B.&#160;<a id="p5795" />Ectopic pregnancy</p><?mpslid E915?><?mpslid S916?>
<p class="b1numlist1a" id="o4585">C.&#160;<a id="p5800" />Pelvic inflammatory disease</p><?mpslid E916?><?mpslid S917?>
<p class="b1numlist1a" id="o4590">D.&#160;<a id="p5805" />Endometriosis</p><?mpslid E917?><?mpslid E913?><?mpslid S918?>
<p class="b1numlista" id="o4595"><a id="Case151-2" href="#Case0151-2">2</a>.&#160;<a id="p5810" />For what condition would the procedure depicted in the images be performed?<a id="l1160" /></p><?mpslid S919?>
<p class="b1numlist1a" id="o4600">A.&#160;<a id="p5815" />Pelvic congestion syndrome</p><?mpslid E919?><?mpslid S920?>
<p class="b1numlist1a" id="o4605">B.&#160;<a id="p5820" />Infertility</p><?mpslid E920?><?mpslid S921?>
<p class="b1numlist1a" id="o4610">C.&#160;<a id="p5825" />Ovarian torsion</p><?mpslid E921?><?mpslid S922?>
<p class="b1numlist1a" id="o4615">D.&#160;<a id="p5830" />Uterine arteriovenous malformation</p><?mpslid E922?><?mpslid E918?><?mpslid S923?>
<p class="b1numlista" id="o4620"><a id="Case151-3" href="#Case0151-3">3</a>.&#160;<a id="p5835" />During which phase of the menstrual cycle is it best to perform this procedure?<a id="l1165" /></p><?mpslid S924?>
<p class="b1numlist1a" id="o4625">A.&#160;<a id="p5840" />Follicular</p><?mpslid E924?><?mpslid S925?>
<p class="b1numlist1a" id="o4630">B.&#160;<a id="p5845" />Ovulatory</p><?mpslid E925?><?mpslid S926?>
<p class="b1numlist1a" id="o4635">C.&#160;<a id="p5850" />Luteal</p><?mpslid E926?><?mpslid S927?>
<p class="b1numlist1a" id="o4640">D.&#160;<a id="p5855" />Secretory</p><?mpslid E927?><?mpslid E923?><?mpslid S928?>
<p class="b1numlista" id="o4645"><a id="Case151-4" href="#Case0151-4">4</a>.&#160;<a id="p5860" />Which of the following is a contraindication to performing this procedure?<a id="l1170" /></p><?mpslid S929?>
<p class="b1numlist1a" id="o4650">A.&#160;<a id="p5865" />Fibroids</p><?mpslid E929?><?mpslid S930?>
<p class="b1numlist1a" id="o4655">B.&#160;<a id="p5870" />Endometriosis</p><?mpslid E930?><?mpslid S931?>
<p class="b1numlist1a" id="o4660">C.&#160;<a id="p5875" />Adenomyosis</p><?mpslid E931?><?mpslid S932?>
<p class="b1numlist1a" id="o4665">D.&#160;<a id="p5880" />Pelvic infection<a epub:type="noteref" href="#fn0205" id="Cfn0205">*</a></p><?mpslid E932?><?mpslid E928?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0205">
<a href="#Cfn0205"><sup>*</sup></a><a id="np0205" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0760tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P308" epub:type="pagebreak" title="308" />
<div class="boxg1" id="b0395">
<p class="b1title">Answers</p>
<p class="b1subt">Case 151</p>
<section><a id="s1565" />
<p class="b11hd" id="st1355">Fallopian Tube Recanalization</p>
<a id="p5885" />
<a id="l1175" />
<div><?mpslid S933?>
<p class="b1numlista" id="o4670"><a id="Case0151-1" href="#Case151-1">1</a>.&#160;<a id="p5890" /><strong>C.</strong> The image demonstrates bilateral proximal fallopian tubal occlusions, for which of those listed, pelvic inflammatory disease is the most common cause.</p><?mpslid E933?><?mpslid S934?>
<p class="b1numlista" id="o4675"><a id="Case0151-2" href="#Case151-2">2</a>.&#160;<a id="p5895" /><strong>B.</strong> Tubal disease is estimated to cause up to one-third of subfertility issues in women, with approximately 10% to 25% consisting of proximal tubal occlusions.</p><?mpslid E934?><?mpslid S935?>
<p class="b1numlista" id="o4680"><a id="Case0151-3" href="#Case151-3">3</a>.&#160;<a id="p5900" /><strong>A.</strong> The follicular phase is the best time to perform this procedure, typically between days 6 and 11 of the menstrual cycle.</p><?mpslid E935?><?mpslid S936?>
<p class="b1numlista" id="o4685"><a id="Case0151-4" href="#Case151-4">4</a>.&#160;<a id="p5905" /><strong>D.</strong> Active pelvic infection is a contraindication to this procedure and could result in peritonitis or bacteremia, if attempted. However, prior resolved episodes of pelvic infection are not a contraindication.</p><?mpslid E936?>
</div>
<section><a id="s1570" />
<p class="b12hd" id="st1360">Comment</p>
<section><a id="s1575" />
<p class="b13hd" id="st1365">Etiology</p>
<p id="p5910" class="b1textfl">The fallopian tube extends from the cornu of the uterine cavity to the ovary. The ovarian end is fimbriated, open to the peritoneal cavity, and adjacent to the ovary; thus allowing the ovulated egg to travel into the fallopian tube for fertilization. Approximately one-third of female infertility issues are due to tubal disease, with 10% to 20% resulting from proximal tubal occlusion. The most common cause is pelvic inflammatory disease. Hysterosalpingogram (HSG) is used to evaluate for potential causes of infertility, including uterine anatomical abnormalities and fallopian tube patency.</p>
</section>
<section><a id="s1580" />
<p class="b13hd" id="st1370">Procedural Technique</p>
<p id="p5915" class="b1textfl">When HSG demonstrates proximal tubal occlusion (<a href="chp004_a.xhtml#f3005">Figure S151-1</a>), a selective salpingogram is performed with a small catheter through the orifice of the fallopian tube (<a href="chp004_a.xhtml#f3010">Figure S151-2</a>). If tubal occlusion is confirmed, a guidewire may be gently advanced in an attempt to traverse the occlusion and dislodge a mucous plug (<a href="chp004_a.xhtml#f3015">Figure S151-3</a>), as in this case. Repeat salpingogram then demonstrates spill of contrast into the peritoneal cavity, consistent with a patent (recanalized) fallopian tube (<a href="chp004_a.xhtml#f3020">Figure S151-4</a>).</p>
</section>
<section><a id="s1585" />
<p class="b13hd" id="st1375">Clinical Considerations</p>
<p id="p5920" class="b1textfl">The procedure is typically performed during the follicular stage of the menstrual cycle between days 6 and 11. Active pelvic infection is an absolute contraindication. Technical success rates of the procedure are high, with reports ranging from 71% to 92%. Successful fallopian tube recanalization allows for unlimited natural attempts at conception and is less invasive and costly than other infertility treatments. The average rate of pregnancy after a successful procedure is reported as high as 60%, when the underlying tubes are normal. A few causes of failure to recanalize may be due to complete occlusions from prior infection, surgery, or endometriosis. Re-occlusion of the fallopian tubes can occur, and recanalization may be attempted. Potential complications include mild cramping, vaginal bleeding, tubal perforation (&#60;&#160;4%), adnexal infection, and ectopic pregnancy (3%).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0205" />
<h3 class="ref2hd" id="st1380">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0610">1. Lopera J, Suri R, Kroma GM, et al. Role of interventional procedures in obstetrics/gynecology. <em>Radiol Clin North Am</em>. 2013;51:1049&#8211;1066.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0615">2. Pinto AB, Hovsepian DM, Wattanakumtornkul S, et al. Pregnancy outcomes after fallopian tube recanalization: oil-based versus water-soluble contrast agents. <em>J Vasc Interv Radiol</em>. 2003;14:69&#8211;74.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0620">3. Thurmond AS. Fallopian tube catheterization. <em>Semin Intervent Radiol</em>. 2013;30:381&#8211;387.</p>
</section>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0205" />
<span id="P309" epub:type="pagebreak" title="309" />
<h2 class="h1hd" id="sc0205tit">Case 152</h2>
<a id="p5925" />
<div class="boxg1" id="b0400"><a id="p5930" />
<div class="pageavoid" id="f0400"><figure class="fig"><img src="../images/F000039b03-79-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 152-1</span> <span class="figcredit">Courtesy of Dr. Alan H. Matsumoto.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0405"><figure class="fig"><img src="../images/F000039b03-80-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 152-2</span> <span class="figcredit">Courtesy of Dr. Alan H. Matsumoto.</span>
</figcaption>
</figure>
</div>
<section><a id="s1590" /><section><a id="s1595" /><section><a id="s1600" /><section><a id="s1605" />
<p class="b14hd" id="st1390">History</p>
<p id="p5935" class="b1textfl">A 54-year-old woman presents to her primary care physician. The remaining history is withheld.<a id="l1180" /></p>
<div><?mpslid S937?>
<p class="b1numlista" id="o4690"><a id="Case152-1" href="#Case0152-1">1</a>.&#160;<a id="p5940" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1185" /></p><?mpslid S938?>
<p class="b1numlist1a" id="o4695">A.&#160;<a id="p5945" />Chronic distal aortoiliac occlusive disease</p><?mpslid E938?><?mpslid S939?>
<p class="b1numlist1a" id="o4700">B.&#160;<a id="p5950" />Infrarenal aortic dissection</p><?mpslid E939?><?mpslid S940?>
<p class="b1numlist1a" id="o4705">C.&#160;<a id="p5955" />Occluded aortoiliac bypass graft</p><?mpslid E940?><?mpslid S941?>
<p class="b1numlist1a" id="o4710">D.&#160;<a id="p5960" />Aortoenteric fistula</p><?mpslid E941?><?mpslid E937?><?mpslid S942?>
<p class="b1numlista" id="o4715"><a id="Case152-2" href="#Case0152-2">2</a>.&#160;<a id="p5965" />With what symptoms do these patients usually present?<a id="l1190" /></p><?mpslid S943?>
<p class="b1numlist1a" id="o4720">A.&#160;<a id="p5970" />Acute-onset lower-extremity pain</p><?mpslid E943?><?mpslid S944?>
<p class="b1numlist1a" id="o4725">B.&#160;<a id="p5975" />Lower-extremity myalgias and paresthesias</p><?mpslid E944?><?mpslid S945?>
<p class="b1numlist1a" id="o4730">C.&#160;<a id="p5980" />Intermittent lower-extremity claudication</p><?mpslid E945?><?mpslid S946?>
<p class="b1numlist1a" id="o4735">D.&#160;<a id="p5985" />Hematochezia</p><?mpslid E946?><?mpslid E942?><?mpslid S947?>
<p class="b1numlista" id="o4740"><a id="Case152-3" href="#Case0152-3">3</a>.&#160;<a id="p5990" />Which of the following procedures has been performed?<a id="l1195" /></p><?mpslid S948?>
<p class="b1numlist1a" id="o4745">A.&#160;<a id="p5995" />Aorto-bifemoral bypass graft placement</p><?mpslid E948?><?mpslid S949?>
<p class="b1numlist1a" id="o4750">B.&#160;<a id="p6000" />Endograft placement</p><?mpslid E949?><?mpslid S950?>
<p class="b1numlist1a" id="o4755">C.&#160;<a id="p6005" />Percutaneous aortoiliac reconstruction</p><?mpslid E950?><?mpslid S951?>
<p class="b1numlist1a" id="o4760">D.&#160;<a id="p6010" />Aortoiliac bypass graft placement</p><?mpslid E951?><?mpslid E947?><?mpslid S952?>
<p class="b1numlista" id="o4765"><a id="Case152-4" href="#Case0152-4">4</a>.&#160;<a id="p6015" />Which of the following is a complication of the intervention above?<a id="l1200" /></p><?mpslid S953?>
<p class="b1numlist1a" id="o4770">A.&#160;<a id="p6020" />Lower-extremity microembolization</p><?mpslid E953?><?mpslid S954?>
<p class="b1numlist1a" id="o4775">B.&#160;<a id="p6025" />Stroke</p><?mpslid E954?><?mpslid S955?>
<p class="b1numlist1a" id="o4780">C.&#160;<a id="p6030" />Renal artery coverage</p><?mpslid E955?><?mpslid S956?>
<p class="b1numlist1a" id="o4785">D.&#160;<a id="p6035" />Hematuria<a epub:type="noteref" href="#fn0210" id="Cfn0210">*</a></p><?mpslid E956?><?mpslid E952?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0210">
<a href="#Cfn0210"><sup>*</sup></a><a id="np0210" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0765tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P310" epub:type="pagebreak" title="310" />
<div class="boxg1" id="b0405">
<p class="b1title">Answers</p>
<p class="b1subt">Case 152</p>
<section><a id="s1610" />
<p class="b11hd" id="st1395">Percutaneous Aortoiliac Reconstruction</p>
<a id="p6040" />
<a id="l1205" />
<div><?mpslid S957?>
<p class="b1numlista" id="o4790"><a id="Case0152-1" href="#Case152-1">1</a>.&#160;<a id="p6045" /><strong>A.</strong> The first image demonstrates aortoiliac occlusive disease. No dissection, graft, or fistula is seen.</p><?mpslid E957?><?mpslid S958?>
<p class="b1numlista" id="o4795"><a id="Case0152-2" href="#Case152-2">2</a>.&#160;<a id="p6050" /><strong>C.</strong> These patients commonly present with bilateral lower extremity and buttock claudication.</p><?mpslid E958?><?mpslid S959?>
<p class="b1numlista" id="o4800"><a id="Case0152-3" href="#Case152-3">3</a>.&#160;<a id="p6055" /><strong>C.</strong> The image demonstrates percutaneous stenting of the aorta and iliac arteries. An endograft, however, was not placed nor was a bypass graft.</p><?mpslid E959?><?mpslid S960?>
<p class="b1numlista" id="o4805"><a id="Case0152-4" href="#Case152-4">4</a>.&#160;<a id="p6060" /><strong>A.</strong> Unlike abdominal aortic aneurysm repair where the endograft is commonly advanced to the renal arteries, percutaneous stenting of the aortic bifurcation for aortoiliac occlusive disease does not require sealing of an aneurysm neck.</p><?mpslid E960?>
</div>
<section><a id="s1615" />
<p class="b12hd" id="st1400">Comment</p>
<section><a id="s1620" />
<p class="b13hd" id="st1405">Main Teaching Point</p>
<p id="p6065" class="b1textfl">Distal aortoiliac occlusive disease was historically treated with aortoiliac or aortofemoral bypass grafts. However, with the recent improvement in the endovascular technologies, a percutaneous approach is possible, in selected patients. The images demonstrate placement of aortoiliac stents with significant immediate improvement in the flow following stenting (<a href="chp004_a.xhtml#f3025">Figures S152-1</a> through <a href="chp004_a.xhtml#f3040">S152-4</a>). Endograft placement was not possible in this case due to the small sizes of the iliac vessels and aorta.</p>
</section>
<section><a id="s1625" />
<p class="b13hd" id="st1410">Endovascular Management</p>
<p id="p6070" class="b1textfl">Studies have shown that the percutaneous approach with stenting of the chronic infrarenal aortoiliac occlusive disease leads to shorter hospital stay and less morbidity. There may be slightly decreased patency rates; however, this remains controversial. With stenting, bypass can also be performed at a later date if needed. Either covered or bare stents can be used for this type of aortoiliac reconstruction. Covered stents may exclude endothelium and atheromatous plaques, hypothetically reducing the rate of re-stenosis. Because of this reason, covered stents may be more advantageous in advanced peripheral arterial disease.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0210" />
<h3 class="ref2hd" id="st1415">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0630">1. Lun Y, Zhang J, Wu X, et al. Comparison of midterm outcomes between surgical treatment and endovascular reconstruction for chronic infrarenal aortoiliac occlusion. <em>J Vasc Interv Radiol</em>. 2015;26:196&#8211;204.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0635">2. Sharafuddin MJ, Hoballah JJ, Kresowik TF, et al. Kissing stent reconstruction of the aortoiliac bifurcation. <em>Perspect Vasc Surg Endovasc Ther</em>. 2008;20:50&#8211;60.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr8000" />
<h3 class="ref2hd" id="st8000">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb8000">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 209&#8211;214.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0210" />
<span id="P311" epub:type="pagebreak" title="311" />
<h2 class="h1hd" id="sc0210tit">Case 153</h2>
<a id="p6075" />
<div class="boxg1" id="b0410"><a id="p6080" />
<div class="pageavoid" id="f0410"><figure class="fig"><img src="../images/F000039b03-81-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 153-1</span> <span class="figcredit">Courtesy of Dr. Kyung J. Cho.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0415"><figure class="fig"><img src="../images/F000039b03-82-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 153-2</span> <span class="figcredit">Courtesy of Dr. Kyung J. Cho.</span>
</figcaption>
</figure>
</div>
<section><a id="s1630" /><section><a id="s1635" /><section><a id="s1640" /><section><a id="s1645" />
<p class="b14hd" id="st1420">History</p>
<p id="p6085" class="b1textfl">A 62-year-old female presents with a history of hyperaldosteronism.<a id="l1210" /></p>
<div><?mpslid S961?>
<p class="b1numlista" id="o4810"><a id="Case153-1" href="#Case0153-1">1</a>.&#160;<a id="p6090" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1215" /></p><?mpslid S962?>
<p class="b1numlist1a" id="o4815">A.&#160;<a id="p6095" />Normal adrenal glands</p><?mpslid E962?><?mpslid S963?>
<p class="b1numlist1a" id="o4820">B.&#160;<a id="p6100" />Adrenal metastasis</p><?mpslid E963?><?mpslid S964?>
<p class="b1numlist1a" id="o4825">C.&#160;<a id="p6105" />Adrenal adenoma</p><?mpslid E964?><?mpslid S965?>
<p class="b1numlist1a" id="o4830">D.&#160;<a id="p6110" />Pheochromocytoma</p><?mpslid E965?><?mpslid E961?><?mpslid S966?>
<p class="b1numlista" id="o4835"><a id="Case153-2" href="#Case0153-2">2</a>.&#160;<a id="p6115" />What is the most common indication for adrenal venous sampling?<a id="l1220" /></p><?mpslid S967?>
<p class="b1numlist1a" id="o4840">A.&#160;<a id="p6120" />To identify the location of a biochemically proven pheochromocytoma without a visible source</p><?mpslid E967?><?mpslid S968?>
<p class="b1numlist1a" id="o4845">B.&#160;<a id="p6125" />To determine whether autonomous hormone production is unilateral or bilateral</p><?mpslid E968?><?mpslid S969?>
<p class="b1numlist1a" id="o4850">C.&#160;<a id="p6130" />To diagnose syndromes of androgen excess</p><?mpslid E969?><?mpslid S970?>
<p class="b1numlist1a" id="o4855">D.&#160;<a id="p6135" />To diagnose adrenal Cushing&#8217;s disease</p><?mpslid E970?><?mpslid E966?><?mpslid S971?>
<p class="b1numlista" id="o4860"><a id="Case153-3" href="#Case0153-3">3</a>.&#160;<a id="p6140" />How is the quality of an adrenal venous sample assessed?<a id="l1225" /></p><?mpslid S972?>
<p class="b1numlist1a" id="o4865">A.&#160;<a id="p6145" />The cortisol levels of the adrenal venous sample are compared to the contralateral adrenal venous sample and should be similar.</p><?mpslid E972?><?mpslid S973?>
<p class="b1numlist1a" id="o4870">B.&#160;<a id="p6150" />The aldosterone-cortisol ratio of the adrenal venous sample is compared to the contralateral adrenal venous sample and should be similar.</p><?mpslid E973?><?mpslid S974?>
<p class="b1numlist1a" id="o4875">C.&#160;<a id="p6155" />The cortisol levels of the adrenal venous sample are compared to those of a peripheral blood sample and should be 2 to 3 times greater.</p><?mpslid E974?><?mpslid S975?>
<p class="b1numlist1a" id="o4880">D.&#160;<a id="p6160" />The aldosterone-cortisol ratio of the adrenal venous sample is compared to that of a peripheral blood sample and should be 2 to 3 times greater.</p><?mpslid E975?><?mpslid E971?><?mpslid S976?>
<p class="b1numlista" id="o4885"><a id="Case153-4" href="#Case0153-4">4</a>.&#160;<a id="p6165" />In a unilateral adrenal adenoma, what is the contralateral normal adrenal gland aldosterone-cortisol ratio compared to a peripheral sample?<a id="l1230" /></p><?mpslid S977?>
<p class="b1numlist1a" id="o4890">A.&#160;<a id="p6170" />Lower</p><?mpslid E977?><?mpslid S978?>
<p class="b1numlist1a" id="o4895">B.&#160;<a id="p6175" />Equal</p><?mpslid E978?><?mpslid S979?>
<p class="b1numlist1a" id="o4900">C.&#160;<a id="p6180" />Elevated</p><?mpslid E979?><?mpslid S980?>
<p class="b1numlist1a" id="o4905">D.&#160;<a id="p6185" />Unpredictable<a epub:type="noteref" href="#fn0215" id="Cfn0215">*</a></p><?mpslid E980?><?mpslid E976?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0215">
<a href="#Cfn0215"><sup>*</sup></a><a id="np0215" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0770tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P312" epub:type="pagebreak" title="312" />
<div class="boxg1" id="b0415">
<p class="b1title">Answers</p>
<p class="b1subt">Case 153</p>
<section><a id="s1650" />
<p class="b11hd" id="st1425">Selective Adrenal Venous Sampling</p>
<a id="p6190" />
<a id="l1235" />
<div><?mpslid S981?>
<p class="b1numlista" id="o4910"><a id="Case0153-1" href="#Case153-1">1</a>.&#160;<a id="p6195" /><strong>B, C, and D.</strong> The imaging findings demonstrate a vascular mass in the region of the right adrenal gland that could represent an adrenal adenoma, metastasis, or pheochromocytoma. Based on the history, this case is most likely a right adrenal adenoma producing excess aldosterone. The left adrenal gland appears normal, but the right clearly is not.</p><?mpslid E981?><?mpslid S982?>
<p class="b1numlista" id="o4915"><a id="Case0153-2" href="#Case153-2">2</a>.&#160;<a id="p6200" /><strong>B.</strong> The most common indication for adrenal venous sampling is to determine whether autonomous hormone production in primary hyperaldosteronism is unilateral or bilateral, as unilateral disease can be corrected surgically. Other less common indications are to diagnose syndromes of androgen excess or adrenal Cushing disease or to identify the location of a biochemically proven pheochromocytoma without a visible source.</p><?mpslid E982?><?mpslid S983?>
<p class="b1numlista" id="o4920"><a id="Case0153-3" href="#Case153-3">3</a>.&#160;<a id="p6205" /><strong>C.</strong> Determining the quality of the adrenal venous sample involves comparing the cortisol levels of the adrenal venous sample to a peripheral blood sample. The cortisol levels in the adrenal venous sample should be 2 to 3 times greater than that in the peripheral blood.</p><?mpslid E983?><?mpslid S984?>
<p class="b1numlista" id="o4925"><a id="Case0153-4" href="#Case153-4">4</a>.&#160;<a id="p6210" /><strong>A.</strong> Adrenal adenomas that produce excess aldosterone show an aldosterone-cortisol ratio higher than the peripheral value. To compensate for this excess production, the contralateral normal adrenal gland shows decreased aldosterone production.</p><?mpslid E984?>
</div>
<section><a id="s1655" />
<p class="b12hd" id="st1430">Comment</p>
<section><a id="s1660" />
<p class="b13hd" id="st1435">Main Teaching Point</p>
<p id="p6215" class="b1textfl">Primary hyperaldosteronism is important to identify within the hypertensive population, because most patients with a unilateral source of excess aldosterone production are amenable to surgical cure. Typically, postural hormonal testing is first performed by an endocrinologist. The diagnosis is then confirmed by selective adrenal venous sampling with measurement of aldosterone concentrations (expressed as aldosterone-to-cortisol ratio) in each adrenal vein. Selective adrenal venous sampling has been shown to be more sensitive and specific than cross-sectional imaging or scintigraphy, and endocrine surgeons are often guided by the results of the sampling study (<a href="chp004_a.xhtml#f3045">Figures S153-1</a> and <a href="chp004_a.xhtml#f3055">S153-3</a>). Patients with unilateral disease are ideally treated by laparoscopic adrenalectomy. Patients in whom localization is not achieved usually have bilateral adrenal hyperplasia and are treated medically.</p>
</section>
<section><a id="s1665" />
<p class="b13hd" id="st1440">Endovascular Management</p>
<p id="p6220" class="b1textfl">The intervention itself requires concurrent catheterization of the left and right adrenal veins with careful, controlled aspiration of blood for sampling (<a href="chp004_a.xhtml#f3050">Figures S153-2</a> and <a href="chp004_a.xhtml#f3060">S153-4</a>). It is important to place additional side holes in the catheters to ensure appropriate sampling. The left adrenal vein is usually easier to select, given its origin from the left renal vein. The right renal vein is more difficult and may be the cause of technical failure. Once the veins are catheterized, adrenocorticotropic hormone is commonly given to stimulate cortisol and aldosterone production. Samples are obtained from the left and right adrenal veins as well as a peripheral sample, commonly from the inferior vena cava, and sent to the lab for evaluation. Once the results are available, they should be carefully analyzed for a localizing discrepancy.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0215" />
<h3 class="ref2hd" id="st1445">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0640">1. Cho KJ. Current role of angiography in the evaluation of adrenal disease causing hypertension. <em>Urol Radiol</em>. 1981-1982;3:249&#8211;255.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0645">2. Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. <em>Radiographics</em>. 2005;25:S143&#8211;S158.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0650">3. Kahn SL, Angle JF. Adrenal vein sampling. <em>Tech Vasc Interv Radiol</em>. 2010;13:110&#8211;125.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0150" />
<h3 class="ref2hd" id="st1450">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0655">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 306&#8211;307.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0215" />
<span id="P313" epub:type="pagebreak" title="313" />
<h2 class="h1hd" id="sc0215tit">Case 154</h2>
<a id="p6225" />
<div class="boxg1" id="b0420"><a id="p6230" />
<div class="pageavoid" id="f0420"><figure class="fig"><img src="../images/F000039b03-83-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 154-1</span> <span class="figcredit">Courtesy of Dr. David M. Williams.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0425"><figure class="fig"><img src="../images/F000039b03-84-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 154-2</span> <span class="figcredit">Courtesy of Dr. David M. Williams.</span>
</figcaption>
</figure>
</div>
<section><a id="s1670" /><section><a id="s1675" /><section><a id="s1680" /><section><a id="s1685" />
<p class="b14hd" id="st1455">History</p>
<p id="p6235" class="b1textfl">A 50-year-old female presents to the emergency department with severe chest and back pain.<a id="l1240" /></p>
<div><?mpslid S985?>
<p class="b1numlista" id="o4930"><a id="Case154-1" href="#Case0154-1">1</a>.&#160;<a id="p6240" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1245" /></p><?mpslid S986?>
<p class="b1numlist1a" id="o4935">A.&#160;<a id="p6245" />Pseudoaneurysm</p><?mpslid E986?><?mpslid S987?>
<p class="b1numlist1a" id="o4940">B.&#160;<a id="p6250" />Thoracic aortic aneurysm</p><?mpslid E987?><?mpslid S988?>
<p class="b1numlist1a" id="o4945">C.&#160;<a id="p6255" />Aortic dissection with rupture</p><?mpslid E988?><?mpslid S989?>
<p class="b1numlist1a" id="o4950">D.&#160;<a id="p6260" />Penetrating atherosclerotic ulcer</p><?mpslid E989?><?mpslid E985?><?mpslid S990?>
<p class="b1numlista" id="o4955"><a id="Case154-2" href="#Case0154-2">2</a>.&#160;<a id="p6265" />What is the key imaging finding of intramural hematoma on a noncontrast computed tomography (CT)?<a id="l1250" /></p><?mpslid S991?>
<p class="b1numlist1a" id="o4960">A.&#160;<a id="p6270" />Circumferential hypodensity surrounding the aorta</p><?mpslid E991?><?mpslid S992?>
<p class="b1numlist1a" id="o4965">B.&#160;<a id="p6275" />Hypoattenuating saccular projection with direct connection to the true lumen</p><?mpslid E992?><?mpslid S993?>
<p class="b1numlist1a" id="o4970">C.&#160;<a id="p6280" />Focal areas of hyperattenuation extending beyond the expected contour of the aortic wall</p><?mpslid E993?><?mpslid S994?>
<p class="b1numlist1a" id="o4975">D.&#160;<a id="p6285" />Faint peripheral hyperattenuating crescent within the aortic wall</p><?mpslid E994?><?mpslid E990?><?mpslid S995?>
<p class="b1numlista" id="o4980"><a id="Case154-3" href="#Case0154-3">3</a>.&#160;<a id="p6290" />What is the initial management of patients with suspected thoracic aortic dissection?<a id="l1255" /></p><?mpslid S996?>
<p class="b1numlist1a" id="o4985">A.&#160;<a id="p6295" />Pain control and blood pressure management</p><?mpslid E996?><?mpslid S997?>
<p class="b1numlist1a" id="o4990">B.&#160;<a id="p6300" />Aortogram with fenestration of the intimal flap</p><?mpslid E997?><?mpslid S998?>
<p class="b1numlist1a" id="o4995">C.&#160;<a id="p6305" />Surgical composite graft replacement of aortic valve, aortic root, and ascending aorta with reimplantation of coronary arteries (Bentall procedure)</p><?mpslid E998?><?mpslid S999?>
<p class="b1numlist1a" id="o5000">D.&#160;<a id="p6310" />Endovascular stent-graft placement</p><?mpslid E999?><?mpslid E995?><?mpslid S1000?>
<p class="b1numlista" id="o5005"><a id="Case154-4" href="#Case0154-4">4</a>.&#160;<a id="p6315" />What role does angiography currently have in the management of this disorder?<a id="l1260" /></p><?mpslid S1001?>
<p class="b1numlist1a" id="o5010">A.&#160;<a id="p6320" />Defining branch vessel anatomy and lumen of origin</p><?mpslid E1001?><?mpslid S1002?>
<p class="b1numlist1a" id="o5015">B.&#160;<a id="p6325" />Confirming diagnosis of suspected acute aortic rupture in a hemodynamically unstable patient</p><?mpslid E1002?><?mpslid S1003?>
<p class="b1numlist1a" id="o5020">C.&#160;<a id="p6330" />Embolization of the aortic rupture site</p><?mpslid E1003?><?mpslid S1004?>
<p class="b1numlist1a" id="o5025">D.&#160;<a id="p6335" />Maintaining branch vessel patency<a epub:type="noteref" href="#fn0220" id="Cfn0220">*</a></p><?mpslid E1004?><?mpslid E1000?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0220">
<a href="#Cfn0220"><sup>*</sup></a><a id="np0220" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0775tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P314" epub:type="pagebreak" title="314" />
<div class="boxg1" id="b0425">
<p class="b1title">Answers</p>
<p class="b1subt">Case 154</p>
<section><a id="s1690" />
<p class="b11hd" id="st1460">Aortic Dissection with Rupture</p>
<a id="p6340" />
<a id="l1265" />
<div><?mpslid S1005?>
<p class="b1numlista" id="o5030"><a id="Case0154-1" href="#Case154-1">1</a>.&#160;<a id="p6345" /><strong>C.</strong> The most likely diagnosis is aortic dissection with rupture. Both computed tomographic angiography (CTA) images presented here show a well-demarcated dissection flap, which starts in the descending thoracic aorta and continues distally into the abdominal aorta. Left-sided hemothorax and mediastinal hematoma are also noted. Pseudoaneurysm and aneurysm commonly present as definable dilations of the aorta, although both may be associated with dissection. Penetrating atherosclerotic ulceration tends to be a focal extension beyond the expected contour of the aortic lumen without longitudinal spread.</p><?mpslid E1005?><?mpslid S1006?>
<p class="b1numlista" id="o5035"><a id="Case0154-2" href="#Case154-2">2</a>.&#160;<a id="p6350" /><strong>D.</strong> The key imaging finding of intramural hematoma (IMH) is a faint peripheral hyperattenuating crescent within the aortic wall (~&#160;40 to 50) Hounsfield units seen on noncontrast CT. IMH is thought to be due to rupture of vasa vasorum supplying the aortic wall. Within the differential one must consider an aneurysm, pseudoaneurysm, and penetrating atherosclerotic ulcer, among others.</p><?mpslid E1006?><?mpslid S1007?>
<p class="b1numlista" id="o5040"><a id="Case0154-3" href="#Case154-3">3</a>.&#160;<a id="p6355" /><strong>A.</strong> Patients with suspected thoracic aortic dissection should be promptly treated with antihypertensive medications to reduce systolic blood pressure to 100 to 120&#160;mm&#160;Hg. Surgical and endovascular treatments should only be used in confirmed cases of complicated type B aortic dissection and all cases of type A dissection. Endovascular management includes fenestration to improve visceral or lower-extremity perfusion or endograft placement across the entry tear, if visible and if anatomy allows.</p><?mpslid E1007?><?mpslid S1008?>
<p class="b1numlista" id="o5045"><a id="Case0154-4" href="#Case154-4">4</a>.&#160;<a id="p6360" /><strong>A and D.</strong> Angiography may be employed to define branch vessel anatomy, patency, and lumen of origin in patients undergoing surgery or endovascular therapy, although CTA is utilized far more frequently. In patients with visceral or lower-extremity malperfusion, fenestration and stenting may be performed to maintain branch vessel patency.</p><?mpslid E1008?>
</div>
<section><a id="s1695" />
<p class="b12hd" id="st1465">Comment</p>
<section><a id="s1700" />
<p class="b13hd" id="st1470">Main Teaching Point</p>
<p id="p6365" class="b1textfl">Aortic rupture is a dreaded complication of aortic dissection. Stanford type A dissections carry a moderate risk of ascending aortic rupture into the pericardial sac, producing pericardial tamponade; to prevent this, these patients are treated with immediate aortic repair. Stanford type B dissections typically are managed medically, initially with pain control and an intravenous beta-blocker unless there are signs of end-organ ischemia or continued hemorrhage into the pleural or retroperitoneal spaces. Occasionally, Stanford type B dissections progress to aortic rupture. Clinical signs that can indicate impending or completed aortic rupture are persistent or increasing chest pain, uncontrolled hypertension, development of a left-sided pleural effusion on chest radiography or CT, and/or hemodynamic instability. In the cases shown here, aortic rupture with hemothorax is clearly depicted on CT (<a href="chp004_a.xhtml#f3065">Figures S154-1</a> through <a href="chp004_a.xhtml#f3080">S154-4</a>).</p>
</section>
<section><a id="s1705" />
<p class="b13hd" id="st1475">Imaging Interpretation</p>
<p id="p6370" class="b1textfl">The majority of aortic dissections are seen in older, hypertensive patients. Connective tissue disorders including Marfan syndrome and Ehlers-Danlos syndrome are also risk factors. Modalities that assist in diagnosis include CTA, magnetic resonance imaging (MRI), and transesophageal echocardiography (TEE). The classic intimal flap is seen in approximately 70% of cases of aortic dissection. TEE has high sensitivity and specificity, but due to its invasive nature it has been largely replaced by CTA. Contrast-enhanced CT is most commonly used due to widespread availability, short acquisition time, and its noninvasive nature. For diagnosis of aortic dissection, CTA is best performed using echocardiographic gating or multidetector scanning. MRI is less commonly utilized for initial diagnosis but is very specific. Use of MRI is limited in unstable patients due to the length of study and in patients with implanted electronic devices.</p>
</section>
<section><a id="s1710" />
<p class="b13hd" id="st1480">Treatment Methods</p>
<p id="p6375" class="b1textfl">The standard of care for the treatment of aortic rupture was immediate surgical aortic replacement until a relatively recent paradigm shift toward endovascular stent-graft repair. The main potential advantage of this approach is the ability to avoid thoracotomy and aortic clamping in this subset of patients who tend to have multiple comorbidities. Studies have shown improved morbidity, mortality, and length of hospitalization with similar long-term durability.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0220" />
<h3 class="ref2hd" id="st1485">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0660">1. Braverman A. Aortic dissection: prompt diagnosis and emergency treatment are critical. <em>Cleve Clin J Med</em>. 2011;78:685&#8211;696.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0665">2. McMahon M, Squirrell C. Multidetector CT of aortic dissection: a pictorial review. <em>Radiographics</em>. 2010;30:445&#8211;460.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0670">3. Patel HJ, Williams DM, Upchurch Jr GR, et al. A comparative analysis of open and endovascular repair for the ruptured descending thoracic aorta. <em>J Vasc Surg</em>. 2009;50:1265&#8211;1270.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0155" />
<h3 class="ref2hd" id="st1490">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0675">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 188&#8211;193.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0220" />
<span id="P315" epub:type="pagebreak" title="315" />
<h2 class="h1hd" id="sc0220tit">Case 155</h2>
<a id="p6380" />
<div class="boxg1" id="b0430"><a id="p6385" />
<div class="pageavoid" id="f0430"><figure class="fig"><img src="../images/F000039b03-85-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 155-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0435"><figure class="fig"><img src="../images/F000039b03-86-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 155-2</span></figcaption></figure></div>
<section><a id="s1715" /><section><a id="s1720" /><section><a id="s1725" /><section><a id="s1730" />
<p class="b14hd" id="st1495">History</p>
<p id="p6390" class="b1textfl">An 87-year-old male who had undergone a Whipple resection (pancreaticoduodenectomy) 9 months previously for pancreatic adenocarcinoma presents to the emergency department with a 10-hour history of severe epigastric pain, fever, and vomiting.<a id="l1270" /></p>
<div><?mpslid S1009?>
<p class="b1numlista" id="o5050"><a id="Case155-1" href="#Case0155-1">1</a>.&#160;<a id="p6395" />Which of the following is the most likely diagnosis for the clinical presentation and the imaging findings presented?<a id="l1275" /></p><?mpslid S1010?>
<p class="b1numlist1a" id="o5055">A.&#160;<a id="p6400" />Delayed gastric emptying</p><?mpslid E1010?><?mpslid S1011?>
<p class="b1numlist1a" id="o5060">B.&#160;<a id="p6405" />Afferent loop syndrome (ALS)</p><?mpslid E1011?><?mpslid S1012?>
<p class="b1numlist1a" id="o5065">C.&#160;<a id="p6410" />Choledocholithiasis with cholangitis</p><?mpslid E1012?><?mpslid S1013?>
<p class="b1numlist1a" id="o5070">D.&#160;<a id="p6415" />Pancreatic fistula</p><?mpslid E1013?><?mpslid E1009?><?mpslid S1014?>
<p class="b1numlista" id="o5075"><a id="Case155-2" href="#Case0155-2">2</a>.&#160;<a id="p6420" />Which of the following surgical techniques utilized in pancreaticoduodenectomies may have predisposed this patient to his current clinical presentation?<a id="l1280" /></p><?mpslid S1015?>
<p class="b1numlist1a" id="o5080">A.&#160;<a id="p6425" />Gastrojejunostomy placed in an antecolic position instead of a retrocolic position</p><?mpslid E1015?><?mpslid S1016?>
<p class="b1numlist1a" id="o5085">B.&#160;<a id="p6430" />Jejunal portion of the afferent loop that measures less than 20&#160;cm</p><?mpslid E1016?><?mpslid S1017?>
<p class="b1numlist1a" id="o5090">C.&#160;<a id="p6435" />Pylorus preserving pancreaticoduodenectomy</p><?mpslid E1017?><?mpslid S1018?>
<p class="b1numlist1a" id="o5095">D.&#160;<a id="p6440" />Laparoscopic Whipple procedure</p><?mpslid E1018?><?mpslid E1014?><?mpslid S1019?>
<p class="b1numlista" id="o5100"><a id="Case155-3" href="#Case0155-3">3</a>.&#160;<a id="p6445" />Which portion of the gastrointestinal tract is most involved in the development of this syndrome?<a id="l1285" /></p><?mpslid S1020?>
<p class="b1numlist1a" id="o5105">A.&#160;<a id="p6450" />Jejunal portion proximal to the gastrojejunostomy</p><?mpslid E1020?><?mpslid S1021?>
<p class="b1numlist1a" id="o5110">B.&#160;<a id="p6455" />Duodenal stump</p><?mpslid E1021?><?mpslid S1022?>
<p class="b1numlist1a" id="o5115">C.&#160;<a id="p6460" />Remaining portion of the duodenum</p><?mpslid E1022?><?mpslid S1023?>
<p class="b1numlist1a" id="o5120">D.&#160;<a id="p6465" />Common hepatic duct</p><?mpslid E1023?><?mpslid E1019?><?mpslid S1024?>
<p class="b1numlista" id="o5125"><a id="Case155-4" href="#Case0155-4">4</a>.&#160;<a id="p6470" />Which of the following interventions can serve as a definitive treatment for this syndrome? (Choose all that apply.)<a id="l1290" /></p><?mpslid S1025?>
<p class="b1numlist1a" id="o5130">A.&#160;<a id="p6475" />Decompression with nasogastric tube and bowel rest</p><?mpslid E1025?><?mpslid S1026?>
<p class="b1numlist1a" id="o5135">B.&#160;<a id="p6480" />Administration of high-dose octreotide</p><?mpslid E1026?><?mpslid S1027?>
<p class="b1numlist1a" id="o5140">C.&#160;<a id="p6485" />Deconstruction of patient&#8217;s previous Whipple and restoring gastrointestinal continuity with another reconstruction technique</p><?mpslid E1027?><?mpslid S1028?>
<p class="b1numlist1a" id="o5145">D.&#160;<a id="p6490" />Placement of dual stents at the site of stenosis<a epub:type="noteref" href="#fn0225" id="Cfn0225">*</a></p><?mpslid E1028?><?mpslid E1024?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0225">
<a href="#Cfn0225"><sup>*</sup></a><a id="np0225" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0780tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P316" epub:type="pagebreak" title="316" />
<div class="boxg1" id="b0435">
<p class="b1title">Answers</p>
<p class="b1subt">Case 155</p>
<section><a id="s1735" />
<p class="b11hd" id="st1500">Afferent Loop Syndrome</p>
<a id="p6495" />
<a id="l1295" />
<div><?mpslid S1029?>
<p class="b1numlista" id="o5150"><a id="Case0155-1" href="#Case155-1">1</a>.&#160;<a id="p6500" /><strong>B.</strong> Although delayed gastric emptying and pancreatic fistula have been reported in post pancreaticoduodenectomy patients and may present similarly, the image findings of bilateral biliary ductal dilation and pattern of small bowel dilatation make ALS the most likely diagnosis. Whipple procedure involves the removal of the gallbladder and the common bile duct, making choledocholithiasis with cholangitis unlikely.</p><?mpslid E1029?><?mpslid S1030?>
<p class="b1numlista" id="o5155"><a id="Case0155-2" href="#Case155-2">2</a>.&#160;<a id="p6505" /><strong>A.</strong> ALS has been associated with antecolic gastrojejunostomy, redundant afferent loop partial omentectomy, and poor positioning of the gastrojejunostomy along the greater curvature of the stomach. Pylorus-preserving pancreaticoduodenectomy or a laparoscopic approach does not increase the risk of developing ALS.</p><?mpslid E1030?><?mpslid S1031?>
<p class="b1numlista" id="o5160"><a id="Case0155-3" href="#Case155-3">3</a>.&#160;<a id="p6510" /><strong>A.</strong> A jejunal portion of the afferent loop more than 30&#160;cm in length has been implicated in the development of internal small bowel herniation, kinking from redundancy, loop volvulus, and intussusception. The common hepatic duct, remaining duodenal length, and duodenal stump has less of an impact on development of ALS. Duodenal stump perforation or leakage from a rapidly progressing ALS is a surgical emergency.</p><?mpslid E1031?><?mpslid S1032?>
<p class="b1numlista" id="o5165"><a id="Case0155-4" href="#Case155-4">4</a>.&#160;<a id="p6515" /><strong>C and D.</strong> Surgical intervention for ALS depends on the etiology of the obstruction. When the obstruction is caused by recurrent or unresectable malignancy, or immediate decompression is warranted prior to a more invasive surgical procedure, interventional radiology can provide urgent decompression via placement of a drainage catheter (<a href="chp004_a.xhtml#f3090">Figure S155-2</a>). This can be followed by placement of dual stents at the site of stenosis via a percutaneous transhepatic biliary drainage tract or a perioral route. For a candidate with surgically amenable disease, deconstruction of the previous Whipple and restoration of the gastrointestinal continuity with either Billroth I or Roux-en-Y is another option. Although high-dose octreotide has been shown to reduce and attenuate severe acute pancreatitis and nasogastric tube decompression with bowel rest may provide temporary relief, neither intervention can alleviate the underlying obstruction.</p><?mpslid E1032?>
</div>
<section><a id="s1740" />
<p class="b12hd" id="st1505">Comment</p>
<section><a id="s1745" />
<p class="b13hd" id="st1510">Etiology</p>
<p id="p6520" class="b1textfl">ALS is a rare postoperative complication in 0.3% to 1% of patients who undergo gastrojejunal reconstructions such as Whipple procedure and Billroth II. Most of the cases are due to mechanical obstructions from adhesions, internal hernia, intussusception, volvulus, kinking of the loop, or stenosis from cancer recurrence or radiation injury. Uncommonly, preferential gastric emptying into the afferent loop or reflux of gastric content into the afferent loop due to efferent loop obstruction has been reported.</p>
</section>
<section><a id="s1750" />
<p class="b13hd" id="st1515">Clinical Presentation</p>
<p id="p6525" class="b1textfl">Patients have brisk onset of symptoms and can present anywhere from a few weeks to years after their reconstructive surgery. Patients with complete obstruction will oftentimes present earlier (within a few weeks postoperatively) with severe epigastric pain, nonbilious nausea and vomiting, postprandial fullness, and rarely with obstructive jaundice. Patients with partial obstruction, considered the chronic form of ALS, will often present several months to years later. These patients will often present with projectile bilious vomiting when the distended afferent loop forcefully decompresses, pushing its content into the stomach.</p>
</section>
<section><a id="s1755" />
<p class="b13hd" id="st1520">Treatment Methods</p>
<p id="p6530" class="b1textfl">Computed tomography is useful in establishing the diagnosis of ALS and will often show a severely dilated transversely oriented small bowel anterior to the spine in the mid abdomen. The first image demonstrates bilateral biliary dilation and severe dilation of a loop of bowel that courses into the hepatic hilum (<a href="chp004_a.xhtml#f3085">Figure S155-1</a>). Decompression of the afferent loop can be accomplished with radical reconstructive surgery (usually reserved for patients in whom the reconstructive surgery was performed for benign disease) or via percutaneous placement of a drainage catheter within the dilated loop (<a href="chp004_a.xhtml#f3090">Figure S155-2</a>). Once initial decompression has occurred, if a stenosis at the bowel-bowel anastomosis is detected and the patient has short life expectancy, then dual stent may be placed within the stenosis via a percutaneous transhepatic biliary drainage tract or a perioral route to relieve the obstruction in carefully selected patients.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0225" />
<h3 class="ref2hd" id="st1525">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0680">1. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. <em>Surg Clin North Am</em>. 1992;72:445&#8211;465.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0685">2. Gayer G, Barsuk D, Hertz M, et al. CT diagnosis of afferent loop syndrome. <em>Clin Radiol</em>. 2002;57:835&#8211;839.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0690">3. Kim YH, Han JK, Lee KH, et al. Palliative percutaneous tube enterostomy in afferent-loop syndrome presenting as jaundice: clinical effectiveness. <em>J Vasc Interv Radiol</em>. 2002;13:845&#8211;849.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0695">4. Kim DJ, Lee JH, Kim W. Afferent loop obstruction following laparoscopic distal gastrectomy with Billroth-II gastrojejunostomy. <em>J Korean Surg Soc</em>. 2013;84:281&#8211;286.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0160" />
<h3 class="ref2hd" id="st1530">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0700">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 437&#8211;441.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0225" />
<span id="P317" epub:type="pagebreak" title="317" />
<h2 class="h1hd" id="sc0225tit">Case 156</h2>
<a id="p6535" />
<div class="boxg1" id="b0440"><a id="p6540" />
<div class="pageavoid" id="f0440"><figure class="fig"><img src="../images/F000039b03-87-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 156-1</span> <span class="figcredit">Courtesy of Dr. Bill S. Majdalany.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0445"><figure class="fig"><img src="../images/F000039b03-88-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 156-2</span> <span class="figcredit">Courtesy of Dr. Bill S. Majdalany.</span>
</figcaption>
</figure>
</div>
<section><a id="s1760" /><section><a id="s1765" /><section><a id="s1770" /><section><a id="s1775" />
<p class="b14hd" id="st1535">History</p>
<p id="p6545" class="b1textfl">A 54-year-old male with history of lung cancer status post resection presents with worsening shortness of breath post-operatively.<a id="l1300" /></p>
<div><?mpslid S1033?>
<p class="b1numlista" id="o5170"><a id="Case156-1" href="#Case0156-1">1</a>.&#160;<a id="p6550" />Which of the following is the most likely diagnosis given the history and imaging findings presented?<a id="l1305" /></p><?mpslid S1034?>
<p class="b1numlist1a" id="o5175">A.&#160;<a id="p6555" />Myocardial infarction</p><?mpslid E1034?><?mpslid S1035?>
<p class="b1numlist1a" id="o5180">B.&#160;<a id="p6560" />Malignant pleural effusion</p><?mpslid E1035?><?mpslid S1036?>
<p class="b1numlist1a" id="o5185">C.&#160;<a id="p6565" />Chylous effusion</p><?mpslid E1036?><?mpslid S1037?>
<p class="b1numlist1a" id="o5190">D.&#160;<a id="p6570" />Progressive malignancy</p><?mpslid E1037?><?mpslid E1033?><?mpslid S1038?>
<p class="b1numlista" id="o5195"><a id="Case156-2" href="#Case0156-2">2</a>.&#160;<a id="p6575" />This patient&#8217;s postoperative course was most likely complicated by which of the following?<a id="l1310" /></p><?mpslid S1039?>
<p class="b1numlist1a" id="o5200">A.&#160;<a id="p6580" />Malpositioned thoracostomy tubes</p><?mpslid E1039?><?mpslid S1040?>
<p class="b1numlist1a" id="o5205">B.&#160;<a id="p6585" />Pneumothorax</p><?mpslid E1040?><?mpslid S1041?>
<p class="b1numlist1a" id="o5210">C.&#160;<a id="p6590" />Elevated chest tube output</p><?mpslid E1041?><?mpslid S1042?>
<p class="b1numlist1a" id="o5215">D.&#160;<a id="p6595" />Pneumonia</p><?mpslid E1042?><?mpslid E1038?><?mpslid S1043?>
<p class="b1numlista" id="o5220"><a id="Case156-3" href="#Case0156-3">3</a>.&#160;<a id="p6600" />What is the most common cause of this entity?<a id="l1315" /></p><?mpslid S1044?>
<p class="b1numlist1a" id="o5225">A.&#160;<a id="p6605" />Lung resection</p><?mpslid E1044?><?mpslid S1045?>
<p class="b1numlist1a" id="o5230">B.&#160;<a id="p6610" />Esophagectomy</p><?mpslid E1045?><?mpslid S1046?>
<p class="b1numlist1a" id="o5235">C.&#160;<a id="p6615" />Superior vena cava thrombosis</p><?mpslid E1046?><?mpslid S1047?>
<p class="b1numlist1a" id="o5240">D.&#160;<a id="p6620" />Proximal descending thoracic aortic aneurysm</p><?mpslid E1047?><?mpslid E1043?><?mpslid S1048?>
<p class="b1numlista" id="o5245"><a id="Case156-4" href="#Case0156-4">4</a>.&#160;<a id="p6625" />Once access to the thoracic duct is obtained, which procedure will be performed?<a id="l1320" /></p><?mpslid S1049?>
<p class="b1numlist1a" id="o5250">A.&#160;<a id="p6630" />Pleurodesis</p><?mpslid E1049?><?mpslid S1050?>
<p class="b1numlist1a" id="o5255">B.&#160;<a id="p6635" />Surgical ligation of the thoracic duct (TD)</p><?mpslid E1050?><?mpslid S1051?>
<p class="b1numlist1a" id="o5260">C.&#160;<a id="p6640" />Type I thoracic duct embolization (TDE)</p><?mpslid E1051?><?mpslid S1052?>
<p class="b1numlist1a" id="o5265">D.&#160;<a id="p6645" />Type II TDE<a epub:type="noteref" href="#fn0230" id="Cfn0230">*</a></p><?mpslid E1052?><?mpslid E1048?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0230">
<a href="#Cfn0230"><sup>*</sup></a><a id="np0230" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0785tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P318" epub:type="pagebreak" title="318" />
<div class="boxg1" id="b0445">
<p class="b1title">Answers</p>
<p class="b1subt">Case 156</p>
<section><a id="s1780" />
<p class="b11hd" id="st1540">Chylothorax-Thoracic Duct Embolization</p>
<a id="p6650" />
<a id="l1325" />
<div><?mpslid S1053?>
<p class="b1numlista" id="o5270"><a id="Case0156-1" href="#Case156-1">1</a>.&#160;<a id="p6655" /><strong>C.</strong> The lymphangiogram depicts active extravasation of Lipiodol from the TD, confirming the diagnosis of chylothorax. The lymphangiogram was performed to aid TDE.</p><?mpslid E1053?><?mpslid S1054?>
<p class="b1numlista" id="o5275"><a id="Case0156-2" href="#Case156-2">2</a>.&#160;<a id="p6660" /><strong>C.</strong> Figure 156-2 depicts active extravasation of Lipiodol from the TD with free spilling into the left pleural space, consistent with chylothorax. Typically, in the postoperative setting, chylothorax manifests with increased thoracotomy tube output. The pleural fluid is classically described as milky in appearance but is an unreliable feature of chylothorax and can also be seen in pseudochylothorax.</p><?mpslid E1054?><?mpslid S1055?>
<p class="b1numlista" id="o5280"><a id="Case0156-3" href="#Case156-3">3</a>.&#160;<a id="p6665" /><strong>B.</strong> As explained further below, iatrogenic trauma is the most common cause of injury to the TD and chylothorax, with esophagectomy as the leading operation.</p><?mpslid E1055?><?mpslid S1056?>
<p class="b1numlista" id="o5285"><a id="Case0156-4" href="#Case156-4">4</a>.&#160;<a id="p6670" /><strong>C.</strong> <a href="chp004_a.xhtml#f3110">Figures S156-4</a> and <a href="chp004_a.xhtml#f3120">S156-6</a> demonstrate coils within the TD, which is considered a type I TDE. Type II TDE describes the mechanical interruption of the lymphatic channels in the abdomen that coalesce into the TD (typically the cisterna chyli when identified), by repeatedly stabbing these channels with a needle. In addition the contrast agent used for lymphangiography, Lipiodol, is a viscous oil that has been shown to occlude the flow of lymph through the TD and thereby successfully treat chylous effusions.</p><?mpslid E1056?>
</div>
<section><a id="s1785" />
<p class="b12hd" id="st1545">Comment</p>
<section><a id="s1790" />
<p class="b13hd" id="st1550">Etiology</p>
<p id="p6675" class="b1textfl">Chylous pleural effusion (chylothorax) is generically defined as the presence of chyle within the pleural space and typically occurs secondary to damage to the TD or its main branches. Chyle is composed of essential proteins, lipids, and lymphocytes from the liver, intestines, abdominal wall, and lower extremities. Thus chylous effusions can lead to immunosuppression, respiratory compromise, dehydration, cachexia, and even death. The etiologies of chylous effusions are generally grouped into traumatic and nontraumatic causes. Traumatic etiologies are by far the most common, and multiple reports suggest that intraoperative iatrogenic trauma is now the leading cause of chylothorax. This is thought to be secondary to the increasing number of oncologic thoracic procedures now being performed. Esophagectomies account for the most cases of posttraumatic chylothorax with pneumonectomies a distant second (<a href="chp004_a.xhtml#f3095">Figure S156-1</a>). Nontraumatic etiologies include those that obstruct lymphatic outflow (lymphoma, sarcoidosis, central venous thrombosis, Beh&#231;et's disease), diseases of the lymphatic pathways (lymphangiomyomatosis, Gorham-Stout syndrome, Noonan syndrome), increased lymph production (portal hypertension, cirrhosis), and idiopathic.</p>
</section>
<section><a id="s1795" />
<p class="b13hd" id="st1555">Clinical Presentation</p>
<p id="p6680" class="b1textfl">The most common clinical symptoms of chylothorax include fatigue and dyspnea. Less commonly, patients with a chylothorax may present with pleuritic chest pain and fever. The fluid itself typically has a milky appearance, is odorless, alkaline, and typically sterile. However, the hallmark of chylous effusion is the presence of a high concentration of triglycerides within the pleural fluid (&#62;&#160;110&#160;mg/dL).</p>
</section>
<section><a id="s1800" />
<p class="b13hd" id="st1560">Treatment Methods</p>
<p id="p6685" class="b1textfl">Conservative measures, including placing the patient on a nil per os diet with aggressive electrolyte and nutrient replacement, typically via total parenteral nutrition regimens with medium-chain triglycerides, are considered first-line therapy as this has been shown to significantly reduce the flow through the TD by inhibiting fat absorption into the lymphatic system. However, if conservative management fails, or is likely to fail (outputs greater than 1000&#160;mL/day), invasive treatment options should be considered. While surgical ligation of the TD has been used in the past, the associated morbidity and mortality of reoperation have rendered percutaneous TDE a safe and effective alternative, with clinical success rates ranging from 70% to greater than 90% in the literature.</p>
</section>
<section><a id="s1805" />
<p class="b13hd" id="st1565">Endovascular Management</p>
<p id="p6690" class="b1textfl">TDE is a minimally invasive percutaneous procedure that should be employed in the setting of chylothorax when conservative management has failed or is likely to fail (output &#62;&#160;100&#160;mL/day). Technical and clinical success rates of TDE are reported between 70% and 90% with a favorable safety profile when compared to open ligation of the TD. Two types of TDEs have been described: type 1, coil embolization of the TDs (<a href="chp004_a.xhtml#f3100">Figures S156-2</a> through <a href="chp004_a.xhtml#f3120">S156-6</a>), and type 2, disruption of the cisterna chyli by mechanical (maceration with a needle) or chemical means (occlusion with Lipiodol).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0230" />
<h3 class="ref2hd" id="st1570">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0705">1. Chen E, Itkin M. Thoracic duct embolization for chylous leaks. <em>Semin Intervent Radiol</em>. 2011;28:63&#8211;74.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0710">2. Itkin M, Kucharczuk JC, Kwak A, et al. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. <em>J Thorac Cardiovasc Surg</em>. 2010;139:584&#8211;589.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0715">3. Pamarthi V, Stecker MS, Schenker MP, et al. Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients. <em>J Vasc Interv Radiol</em>. 2014;25:1398&#8211;1404.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0165" />
<h3 class="ref2hd" id="st1575">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0720">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 196&#8211;197.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0230" />
<span id="P319" epub:type="pagebreak" title="319" />
<h2 class="h1hd" id="sc0230tit">Case 157</h2>
<a id="p6695" />
<div class="boxg1" id="b0450"><a id="p6700" />
<div class="pageavoid" id="f0450"><figure class="fig"><img src="../images/F000039b03-89-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 157-1</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0455"><figure class="fig"><img src="../images/F000039b03-90-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 157-2</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<section><a id="s1810" /><section><a id="s1815" /><section><a id="s1820" /><section><a id="s1825" />
<p class="b14hd" id="st1580">History</p>
<p id="p6705" class="b1textfl">An 8-year-old male with a history of coarctation/hypoplasia of the aortic arch status post repair presents with severe hypertension.<a id="l1330" /></p>
<div><?mpslid S1057?>
<p class="b1numlista" id="o5290"><a id="Case157-1" href="#Case0157-1">1</a>.&#160;<a id="p6710" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1335" /></p><?mpslid S1058?>
<p class="b1numlist1a" id="o5295">A.&#160;<a id="p6715" />Abdominal aortic aneurysm</p><?mpslid E1058?><?mpslid S1059?>
<p class="b1numlist1a" id="o5300">B.&#160;<a id="p6720" />Takayasu arteritis</p><?mpslid E1059?><?mpslid S1060?>
<p class="b1numlist1a" id="o5305">C.&#160;<a id="p6725" />Polyarteritis nodosa</p><?mpslid E1060?><?mpslid S1061?>
<p class="b1numlist1a" id="o5310">D.&#160;<a id="p6730" />Middle aortic syndrome (MAS)</p><?mpslid E1061?><?mpslid E1057?><?mpslid S1062?>
<p class="b1numlista" id="o5315"><a id="Case157-2" href="#Case0157-2">2</a>.&#160;<a id="p6735" />What is the first step in management of this patient?<a id="l1340" /></p><?mpslid S1063?>
<p class="b1numlist1a" id="o5320">A.&#160;<a id="p6740" />Balloon angioplasty</p><?mpslid E1063?><?mpslid S1064?>
<p class="b1numlist1a" id="o5325">B.&#160;<a id="p6745" />Pharmacologic management of hypertension</p><?mpslid E1064?><?mpslid S1065?>
<p class="b1numlist1a" id="o5330">C.&#160;<a id="p6750" />Surgical bypass</p><?mpslid E1065?><?mpslid S1066?>
<p class="b1numlist1a" id="o5335">D.&#160;<a id="p6755" />Observation</p><?mpslid E1066?><?mpslid E1062?><?mpslid S1067?>
<p class="b1numlista" id="o5340"><a id="Case157-3" href="#Case0157-3">3</a>.&#160;<a id="p6760" />What is the most likely etiology of hypertension in this patient?<a id="l1345" /></p><?mpslid S1068?>
<p class="b1numlist1a" id="o5345">A.&#160;<a id="p6765" />Mass effect on the kidneys</p><?mpslid E1068?><?mpslid S1069?>
<p class="b1numlist1a" id="o5350">B.&#160;<a id="p6770" />Renal vasculitis</p><?mpslid E1069?><?mpslid S1070?>
<p class="b1numlist1a" id="o5355">C.&#160;<a id="p6775" />Pressure gradient across the renal arteries</p><?mpslid E1070?><?mpslid S1071?>
<p class="b1numlist1a" id="o5360">D.&#160;<a id="p6780" />Primary hyperaldosteronism</p><?mpslid E1071?><?mpslid E1067?><?mpslid S1072?>
<p class="b1numlista" id="o5365"><a id="Case157-4" href="#Case0157-4">4</a>.&#160;<a id="p6785" />Which of the following diseases is <em>NOT</em> associated with acquired MAS?<a id="l1350" /></p><?mpslid S1073?>
<p class="b1numlist1a" id="o5370">A.&#160;<a id="p6790" />Trisomy 21</p><?mpslid E1073?><?mpslid S1074?>
<p class="b1numlist1a" id="o5375">B.&#160;<a id="p6795" />Takayasu arteritis</p><?mpslid E1074?><?mpslid S1075?>
<p class="b1numlist1a" id="o5380">C.&#160;<a id="p6800" />Williams syndrome</p><?mpslid E1075?><?mpslid S1076?>
<p class="b1numlist1a" id="o5385">D.&#160;<a id="p6805" />Neurofibromatosis<a epub:type="noteref" href="#fn0235" id="Cfn0235">*</a></p><?mpslid E1076?><?mpslid E1072?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0235">
<a href="#Cfn0235"><sup>*</sup></a><a id="np0235" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0790tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P320" epub:type="pagebreak" title="320" />
<div class="boxg1" id="b0455">
<p class="b1title">Answers</p>
<p class="b1subt">Case 157</p>
<section><a id="s1830" />
<p class="b11hd" id="st1585">Middle Aortic Syndrome</p>
<a id="p6810" />
<a id="l1355" />
<div><?mpslid S1077?>
<p class="b1numlista" id="o5390"><a id="Case0157-1" href="#Case157-1">1</a>.&#160;<a id="p6815" /><strong>B and D.</strong> The images demonstrate aortic coarctation from the level of the diaphragm to the level of the proximal renal arteries. This is consistent with MAS. Takayasu arteritis is one potential cause of acquired MAS.</p><?mpslid E1077?><?mpslid S1078?>
<p class="b1numlista" id="o5395"><a id="Case0157-2" href="#Case157-2">2</a>.&#160;<a id="p6820" /><strong>B.</strong> The primary treatment of MAS is medical management of hypertension, with surgery/endovascular therapy reserved for refractory cases. Observation is not appropriate in a young patient with severe hypertension.</p><?mpslid E1078?><?mpslid S1079?>
<p class="b1numlista" id="o5400"><a id="Case0157-3" href="#Case157-3">3</a>.&#160;<a id="p6825" /><strong>C.</strong> The pressure gradient across the renal arteries from the ostial narrowing results in reduced renal blood pressure. This activates the renin/angiotensin system, which results in the common clinical feature of hypertension.</p><?mpslid E1079?><?mpslid S1080?>
<p class="b1numlista" id="o5405"><a id="Case0157-4" href="#Case157-4">4</a>.&#160;<a id="p6830" /><strong>A.</strong> Trisomy 21 (Down&#8217;s syndrome) is not associated with MAS. The remainder of the listed diseases have an association with acquired MAS.</p><?mpslid E1080?>
</div>
<section><a id="s1835" />
<p class="b12hd" id="st1590">Comment</p>
<section><a id="s1840" />
<p class="b13hd" id="st1595">Main Teaching Point</p>
<p id="p6835" class="b1textfl">First described in 1963, MAS is a rare disease that results in significant narrowing of the abdominal aorta and branches of the abdominal aorta. It typically presents as significant hypertension in a child or teenager. Additional clinical findings may include weak lower-extremity pulses, abdominal bruit, palpable superficial epigastric artery collaterals and findings associated with severe hypertension (hypertensive retinopathy, left ventricular hypertrophy, etc.). If untreated, patients will typically die by the age of 40 related to the complications of severe hypertension. It is most commonly congenital and is proposed to be due to aberrant fusion of the paired embryonic dorsal aortas. There are also acquired etiologies including neurofibromatosis, fibromuscular dysplasia, retroperitoneal fibrosis, Williams syndrome, and the giant cell arteritides.</p>
</section>
<section><a id="s1845" />
<p class="b13hd" id="st1600">Diagnostic Evaluation</p>
<p id="p6840" class="b1textfl">The coarctation is typically easily identified on aortography with segmental aortic pressures demonstrating a significant systolic pressure gradient across the stenotic segment (<a href="chp004_a.xhtml#f3125">Figures S157-1</a> and <a href="chp004_a.xhtml#f3135">S157-3</a>). Computed tomography angiography of the abdominal aorta is also an effective tool for diagnosis.</p>
</section>
<section><a id="s1850" />
<p class="b13hd" id="st1605">Treatment Methods</p>
<p id="p6845" class="b1textfl">Pharmacologic hypertension control is the initial treatment of choice, with surgery and endovascular therapy reserved for severe hypertension that is refractory to medical therapy. Patients with acquired MAS related to a vasculitis should first be treated with corticosteroids or immunosuppressant therapy prior to the consideration of surgical or endovascular therapy. Surgical treatment options include aortic reconstruction with aorto-aortic bypass grafting or patch angioplasty (<a href="chp004_a.xhtml#f3130">Figure S157-2</a>). Cases with significant involvement of the renal arteries may require aortorenal bypass, splenorenal anastomosis, hepatorenal anastomosis or autotransplantation of the kidney into the pelvis. Balloon angioplasty with or without stent placement is the mainstay of endovascular therapy. However, only select cases are amendable to endovascular therapy.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0235" />
<h3 class="ref2hd" id="st1610">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0725">1. Delis KT, Gloviczki P. Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. <em>Perspect Vasc Surg Endovasc Ther</em>. 2005;17:187&#8211;203.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0730">2. Sumboonnanonda A, Robinson BL, Gedroyc WM, et al. Middle aortic syndrome: clinical and radiological findings. <em>Arch Dis Child</em>. 1992;67:501&#8211;505.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr9100" />
<h3 class="ref2hd" id="st9100">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb9100">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 219&#8211;220.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0235" />
<span id="P321" epub:type="pagebreak" title="321" />
<h2 class="h1hd" id="sc0235tit">Case 158</h2>
<a id="p6850" />
<div class="boxg1" id="b0460"><a id="p6855" />
<div class="pageavoid" id="f0460"><figure class="fig"><img src="../images/F000039b03-91-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 158-1</span> <span class="figcredit">Courtesy of Dr. Minhaj S. Khaja.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0465"><figure class="fig"><img src="../images/F000039b03-92-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 158-2</span> <span class="figcredit">Courtesy of Dr. Minhaj S. Khaja.</span>
</figcaption>
</figure>
</div>
<section><a id="s1855" /><section><a id="s1860" /><section><a id="s1865" /><section><a id="s1870" />
<p class="b14hd" id="st1615">History</p>
<p id="p6860" class="b1textfl">A 78-year-old male with a history of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAA) was referred for enlarging aneurysm sac.<a id="l1360" /></p>
<div><?mpslid S1081?>
<p class="b1numlista" id="o5410"><a id="Case158-1" href="#Case0158-1">1</a>.&#160;<a id="p6865" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1365" /></p><?mpslid S1082?>
<p class="b1numlist1a" id="o5415">A.&#160;<a id="p6870" />Type I endoleak</p><?mpslid E1082?><?mpslid S1083?>
<p class="b1numlist1a" id="o5420">B.&#160;<a id="p6875" />Type II endoleak</p><?mpslid E1083?><?mpslid S1084?>
<p class="b1numlist1a" id="o5425">C.&#160;<a id="p6880" />Type III endoleak</p><?mpslid E1084?><?mpslid S1085?>
<p class="b1numlist1a" id="o5430">D.&#160;<a id="p6885" />Type IV endoleak</p><?mpslid E1085?><?mpslid E1081?><?mpslid S1086?>
<p class="b1numlista" id="o5435"><a id="Case158-2" href="#Case0158-2">2</a>.&#160;<a id="p6890" />Which of the following test is most utilized in surveillance of patients with EVAR?<a id="l1370" /></p><?mpslid S1087?>
<p class="b1numlist1a" id="o5440">A.&#160;<a id="p6895" />Magnetic resonance imaging (MRI)</p><?mpslid E1087?><?mpslid S1088?>
<p class="b1numlist1a" id="o5445">B.&#160;<a id="p6900" />Aneurysm sac pressure measurements</p><?mpslid E1088?><?mpslid S1089?>
<p class="b1numlist1a" id="o5450">C.&#160;<a id="p6905" />International normalized ratio</p><?mpslid E1089?><?mpslid S1090?>
<p class="b1numlist1a" id="o5455">D.&#160;<a id="p6910" />Computed tomography (CT) angiography</p><?mpslid E1090?><?mpslid E1086?><?mpslid S1091?>
<p class="b1numlista" id="o5460"><a id="Case158-3" href="#Case0158-3">3</a>.&#160;<a id="p6915" />Which of the following is <em>NOT</em> recommended for persistent type II endoleak?<a id="l1375" /></p><?mpslid S1092?>
<p class="b1numlist1a" id="o5465">A.&#160;<a id="p6920" />Embolization of collateral arterial branches and aneurysm sac</p><?mpslid E1092?><?mpslid S1093?>
<p class="b1numlist1a" id="o5470">B.&#160;<a id="p6925" />Surgical ligation</p><?mpslid E1093?><?mpslid S1094?>
<p class="b1numlist1a" id="o5475">C.&#160;<a id="p6930" />Medical treatment with anticoagulation</p><?mpslid E1094?><?mpslid S1095?>
<p class="b1numlist1a" id="o5480">D.&#160;<a id="p6935" />Continued surveillance with computed tomography angiography (CTA)</p><?mpslid E1095?><?mpslid E1091?><?mpslid S1096?>
<p class="b1numlista" id="o5485"><a id="Case158-4" href="#Case0158-4">4</a>.&#160;<a id="p6940" />What are the CT features of a type II endoleak following EVAR?<a id="l1380" /></p><?mpslid S1097?>
<p class="b1numlist1a" id="o5490">A.&#160;<a id="p6945" />Increased aneurysm sac size without contrast visualization</p><?mpslid E1097?><?mpslid S1098?>
<p class="b1numlist1a" id="o5495">B.&#160;<a id="p6950" />Presence of fracture or junctional separation of stent graft with enhancement of aneurysm sac</p><?mpslid E1098?><?mpslid S1099?>
<p class="b1numlist1a" id="o5500">C.&#160;<a id="p6955" />Opacification of excluded aortic branches with contrast material</p><?mpslid E1099?><?mpslid S1100?>
<p class="b1numlist1a" id="o5505">D.&#160;<a id="p6960" />Dense contrast collection continuous with proximal or distal stent attachment sites<a epub:type="noteref" href="#fn0240" id="Cfn0240">*</a></p><?mpslid E1100?><?mpslid E1096?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0240">
<a href="#Cfn0240"><sup>*</sup></a><a id="np0240" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0795tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P322" epub:type="pagebreak" title="322" />
<div class="boxg1" id="b0465">
<p class="b1title">Answers</p>
<p class="b1subt">Case 158</p>
<section><a id="s1875" />
<p class="b11hd" id="st1620">Embolization of Type II Endoleak</p>
<a id="p6965" />
<a id="l1385" />
<div><?mpslid S1101?>
<p class="b1numlista" id="o5510"><a id="Case0158-1" href="#Case158-1">1</a>.&#160;<a id="p6970" /><strong>A and B.</strong> Specific imaging findings that support type II endoleak include late-phase contrast enhancement as well as a communication with an excluded branch artery like the inferior mesenteric artery (IMA) or lumbars. However, a type I endoleak cannot be excluded, and further investigation with angiography may be warranted.</p><?mpslid E1101?><?mpslid S1102?>
<p class="b1numlista" id="o5515"><a id="Case0158-2" href="#Case158-2">2</a>.&#160;<a id="p6975" /><strong>D.</strong> The most commonly recommended imaging modality for routine follow-up after EVAR is CTA with delayed images. Delayed imaging can help distinguish between type I and type II endoleak in many cases. Acceptable alternatives if contrast use is contraindicated include Doppler ultrasonography, MRI, or unenhanced CT (only to evaluate aneurysm sac size). Aneurysm sac pressure measurement is an invasive test and should only be performed when absolutely necessary.</p><?mpslid E1102?><?mpslid S1103?>
<p class="b1numlista" id="o5520"><a id="Case0158-3" href="#Case158-3">3</a>.&#160;<a id="p6980" /><strong>C.</strong> Type II endoleaks tend to resolve spontaneously and commonly do not require intervention. In the case of aneurysmal expansion, intervention is warranted. All of the above are possible methods of treatment, including continued short-term surveillance. However, studies have shown that continuation or initiation of anticoagulation inhibits resolution of endoleaks.</p><?mpslid E1103?><?mpslid S1104?>
<p class="b1numlista" id="o5525"><a id="Case0158-4" href="#Case158-4">4</a>.&#160;<a id="p6985" /><strong>C.</strong> Type II endoleaks result from retrograde flow through collaterals that communicate with the aneurysm sac, most commonly IMA or lumbar arteries. Following stent-graft placement, occlusion of collateral vessels occurs. On CTA, opacification of excluded aortic branches is a common finding in type II endoleaks. Late-phase enhancement of the aneurysm sac is also more commonly seen in type II endoleaks.</p><?mpslid E1104?>
</div>
<section><a id="s1880" />
<p class="b12hd" id="st1625">Comment</p>
<section><a id="s1885" />
<p class="b13hd" id="st1630">Main Teaching Point</p>
<p id="p6990" class="b1textfl">Patients who undergo endoluminal repair of AAA typically receive close surveillance with CT angiography. Endoleaks are a complication unique to EVAR and can occur in up to 25% of patients, with type II endoleak occurring most frequently. When extraluminal contrast is seen within the aneurysm sac on CT, the presence of an endoleak is confirmed (<a href="chp004_a.xhtml#f3140">Figures S158-1</a> and <a href="chp004_a.xhtml#f3145">S158-2</a>). Precise characterization of the type and etiology of endoleak is critical in planning treatment and usually requires angiography, as described in Case 128.</p>
</section>
<section><a id="s1890" />
<p class="b13hd" id="st1635">Pathogenesis</p>
<p id="p6995" class="b1textfl">Type II endoleaks involve retrograde blood flow traveling through collateral branches that communicate with the aneurysm sac. Commonly involved vessels include the inferior mesenteric artery and intercostal/lumbar arteries (<a href="chp004_a.xhtml#f3150">Figures S158-3</a> through <a href="chp004_a.xhtml#f3160">S158-5</a>). Type II endoleaks are further subdivided into two categories based on flow through the number of vessels involved. A type IIA (simple) endoleak involves a single vessel, while a type IIB (complex) endoleak involves flow through two or more vessels.</p>
</section>
<section><a id="s1895" />
<p class="b13hd" id="st1640">Disease Progression</p>
<p id="p7000" class="b1textfl">Patients with type II endoleaks and evidence of aneurysm enlargement on serial CT scans require treatment due to the risk of aneurysm rupture. The criteria upon which to base treatment of type II endoleaks in the absence of aneurysm enlargement are highly controversial, in part because more than 50% tend to close spontaneously. Hence, some physicians treat all type II endoleaks, some treat only endoleaks that are first detected several months after the procedure, and others believe that close CT follow-up is sufficient.</p>
</section>
<section><a id="s1900" />
<p class="b13hd" id="st1645">Treatment Methods</p>
<p id="p7005" class="b1textfl">Treatment options include embolization of collateral vessels using coils or liquid embolic agents such as <em>n</em>-butyl cyanoacrylate, thrombin, or ethylene vinyl alcohol (Onyx, Covidien, Minneapolis, Minnesota) (<a href="chp004_a.xhtml#f3160">Figures S158-5</a> and <a href="chp004_a.xhtml#f3165">S158-6</a>). Embolization can be performed percutaneously through a transabdominal/translumbar approach using CT or fluoroscopic guidance. Conversion to open surgery is rare and is considered a last resort only used when endovascular repair fails.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0240" />
<h3 class="ref2hd" id="st1650">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0735">1. Baum R, Stavropoulos S, Fairman R, Carpenter J. Endoleaks after endovascular repair of abdominal aortic aneurysms. <em>J Vasc Interv Radiol</em>. 2003;14:1111&#8211;1117.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0740">2. Khaja MS, Park AW, Swee W, et al. Treatment of type II endoleak using Onyx with long-term imaging follow-up. <em>Cardiovasc Intervent Radiol.</em> 2014;37:613&#8211;622.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0745">3. Uthoff H, Katzen BT, Gandhi R, et al. Direct percutaneous sac injection for postoperative endoleak treatment after endovascular aortic aneurysm repair. <em>J Vasc Surg</em>. 2012;56:965&#8211;972.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0750">4. White S, Stavropoulos S. Management of endoleaks following endovascular aneurysm repair. <em>Semin Intervent Radiol</em>. 2009;26:33&#8211;38.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0170" />
<h3 class="ref2hd" id="st1655">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0755">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 208&#8211;209.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0240" />
<span id="P323" epub:type="pagebreak" title="323" />
<h2 class="h1hd" id="sc0240tit">Case 159</h2>
<a id="p7010" />
<div class="boxg1" id="b0470"><a id="p7015" />
<div class="pageavoid" id="f0470"><figure class="fig"><img src="../images/F000039b03-93-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 159-1</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0475"><figure class="fig"><img src="../images/F000039b03-94-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 159-2</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<section><a id="s1905" /><section><a id="s1910" /><section><a id="s1915" /><section><a id="s1920" />
<p class="b14hd" id="st1660">History</p>
<p id="p7020" class="b1textfl">A 59-year-old female with cholangiocarcinoma presents before right hepatectomy.<a id="l1390" /></p>
<div><?mpslid S1105?>
<p class="b1numlista" id="o5530"><a id="Case159-1" href="#Case0159-1">1</a>.&#160;<a id="p7025" />Based on the images provided, what procedure has this patient undergone?<a id="l1395" /></p><?mpslid S1106?>
<p class="b1numlist1a" id="o5535">A.&#160;<a id="p7030" />Transjugular intrahepatic portosystemic shunt</p><?mpslid E1106?><?mpslid S1107?>
<p class="b1numlist1a" id="o5540">B.&#160;<a id="p7035" />Transcatheter arterial chemoembolization (TACE)</p><?mpslid E1107?><?mpslid S1108?>
<p class="b1numlist1a" id="o5545">C.&#160;<a id="p7040" />Right portal vein embolization (PVE)</p><?mpslid E1108?><?mpslid S1109?>
<p class="b1numlist1a" id="o5550">D.&#160;<a id="p7045" />Y-90 embolization</p><?mpslid E1109?><?mpslid E1105?><?mpslid S1110?>
<p class="b1numlista" id="o5555"><a id="Case159-2" href="#Case0159-2">2</a>.&#160;<a id="p7050" />What embolization agent has been used?<a id="l1400" /></p><?mpslid S1111?>
<p class="b1numlist1a" id="o5560">A.&#160;<a id="p7055" />Polyvinyl alcohol (PVA) particles</p><?mpslid E1111?><?mpslid S1112?>
<p class="b1numlist1a" id="o5565">B.&#160;<a id="p7060" /><em>n</em>-butyl cyanoacrylate (<em>n</em>-BCA)</p><?mpslid E1112?><?mpslid S1113?>
<p class="b1numlist1a" id="o5570">C.&#160;<a id="p7065" />Gelfoam</p><?mpslid E1113?><?mpslid S1114?>
<p class="b1numlist1a" id="o5575">D.&#160;<a id="p7070" />Coils</p><?mpslid E1114?><?mpslid E1110?><?mpslid S1115?>
<p class="b1numlista" id="o5580"><a id="Case159-3" href="#Case0159-3">3</a>.&#160;<a id="p7075" />What functional liver remnant/total liver volume (FLR/TLV) ratio is recommended for patients before planned major hepatic resection?<a id="l1405" /></p><?mpslid S1116?>
<p class="b1numlist1a" id="o5585">A.&#160;<a id="p7080" />10% to 20%</p><?mpslid E1116?><?mpslid S1117?>
<p class="b1numlist1a" id="o5590">B.&#160;<a id="p7085" />20% to 40%</p><?mpslid E1117?><?mpslid S1118?>
<p class="b1numlist1a" id="o5595">C.&#160;<a id="p7090" />40% to 60%</p><?mpslid E1118?><?mpslid S1119?>
<p class="b1numlist1a" id="o5600">D.&#160;<a id="p7095" />60% to 80%</p><?mpslid E1119?><?mpslid E1115?><?mpslid S1120?>
<p class="b1numlista" id="o5605"><a id="Case159-4" href="#Case0159-4">4</a>.&#160;<a id="p7100" />Which is an absolute contraindication to this procedure?<a id="l1410" /></p><?mpslid S1121?>
<p class="b1numlist1a" id="o5610">A.&#160;<a id="p7105" />Overt portal hypertension</p><?mpslid E1121?><?mpslid S1122?>
<p class="b1numlist1a" id="o5615">B.&#160;<a id="p7110" />Biliary dilation of the FLR</p><?mpslid E1122?><?mpslid S1123?>
<p class="b1numlist1a" id="o5620">C.&#160;<a id="p7115" />Extrahepatic metastatic disease</p><?mpslid E1123?><?mpslid S1124?>
<p class="b1numlist1a" id="o5625">D.&#160;<a id="p7120" />Renal insufficiency<a epub:type="noteref" href="#fn0245" id="Cfn0245">*</a></p><?mpslid E1124?><?mpslid E1120?>
</div>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0245">
<a href="#Cfn0245"><sup>*</sup></a><a id="np0245" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0800tit">case</a></em></p>
</footer>
</div>
<div class="pagebreak" />
<div id="P324" epub:type="pagebreak" title="324" />
<div class="boxg1" id="b0475">
<p class="b1title">Answers</p>
<p class="b1subt">Case 159</p>
<section><a id="s1925" />
<p class="b11hd" id="st1665">Portal Vein Embolization</p>
<a id="p7125" />
<a id="l1415" />
<div><?mpslid S1125?>
<p class="b1numlista" id="o5630"><a id="Case0159-1" href="#Case159-1">1</a>.&#160;<a id="p7130" /><strong>C.</strong> The patient is undergoing right PVE. TACE and Y-90 embolization are arterial interventions, and no hepatic artery is visualized here.</p><?mpslid E1125?><?mpslid S1126?>
<p class="b1numlista" id="o5635"><a id="Case0159-2" href="#Case159-2">2</a>.&#160;<a id="p7135" /><strong>B.</strong> <em>n</em>-BCA casts can be seen within the right portal venous system. Coils are not seen and Gelfoam and PVA particles would not be seen; rather diminished flow can be seen during embolization.</p><?mpslid E1126?><?mpslid S1127?>
<p class="b1numlista" id="o5640"><a id="Case0159-3" href="#Case159-3">3</a>.&#160;<a id="p7140" /><strong>B.</strong> An FLR of 20% to 40% is recommended before planned major hepatic resection.</p><?mpslid E1127?><?mpslid S1128?>
<p class="b1numlista" id="o5645"><a id="Case0159-4" href="#Case159-4">4</a>.&#160;<a id="p7145" /><strong>A.</strong> Overt clinical portal hypertension is an absolute contraindication to portal vein hypertension as this may increase portal pressure and lead to bleeding complications. The other choices are relative contraindications and not absolute contraindications.</p><?mpslid E1128?>
</div>
<section><a id="s1930" />
<p class="b12hd" id="st1670">Comment</p>
<section><a id="s1935" />
<p class="b13hd" id="st1675">Main Teaching Point</p>
<p id="p7150" class="b1textfl">Major hepatic resection is being performed at an increasing rate in the treatment of primary and secondary hepatobiliary malignancy. One of the potential postoperative complications associated with this type of surgery is fatal liver failure. This can result from the inability of the remaining liver parenchyma after resection to provide adequate function to sustain life. Preresection measures to increase the volume of the FLR have been employed to make some patients eligible for this type of surgery. This has been achieved by surgical ligation of the contralateral portal vein in the past, and, more recently, it is achieved with contralateral PVE.</p>
</section>
<section><a id="s1940" />
<p class="b13hd" id="st1680">Imaging Interpretation</p>
<p id="p7155" class="b1textfl">Preprocedural cross-sectional imaging is obtained to evaluate the TLV and the estimated FLR volume (<a href="chp004_a.xhtml#f3190">Figure S159-5</a>). An FLR/TLV ratio of 20% to 40% is recommended for patients before planned major hepatic resection. An ipsilateral or contralateral approach is used. Follow-up cross-sectional imaging with calculation of the liver volume is obtained in 2 to 4 weeks to assess the degree of FLR hypertrophy (<a href="chp004_a.xhtml#f3190">Figure S159-5</a>).</p>
</section>
<section><a id="s1945" />
<p class="b13hd" id="st1685">Endovascular Management</p>
<p id="p7160" class="b1textfl">Various embolic materials have been used for PVE including NBCA, PVA particles, Gelfoam, and coils (<a href="chp004_a.xhtml#f3170">Figures S159-1</a> and <a href="chp004_a.xhtml#f3175">S159-2</a>). Quantitative, color-coded angiography, processed by syngo iFlow prototype software (Siemens AG, Forchheim, Germany) is demonstrated here, which may aid in evaluating relative perfusion in the portal system (<a href="chp004_a.xhtml#f3180">Figures S159-3</a> and <a href="chp004_a.xhtml#f3185">S159-4</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0245" />
<h3 class="ref2hd" id="st1690">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0760">1. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. <em>J Vasc Interv Radiol</em>. 2005;16:779&#8211;790.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0765">2. Madoff DC, Hicks ME, Vauthey JN, et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. <em>Radiographics</em>. 2002;22:1063&#8211;1076.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0770">3. Saad WE, Anderson CL, Kowarschik M, et al. Quantifying increased hepatic arterial flow with test balloon occlusion of the splenic artery in liver transplant recipients with suspected splenic steal syndrome: quantitative digitally subtracted angiography correlation with arterial Doppler parameters. <em>Vasc Endovascular Surg</em>. 2012;46:384&#8211;392.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0175" />
<h3 class="ref2hd" id="st1695">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0775">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 331&#8211;332.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0245" />
<span id="P325" epub:type="pagebreak" title="325" />
<h2 class="h1hd" id="sc0245tit">Case 160</h2>
<a id="p7165" />
<div class="boxg1" id="b0480"><a id="p7170" />
<div class="pageavoid" id="f0480"><figure class="fig"><img src="../images/F000039b03-95-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 160-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0485"><figure class="fig"><img src="../images/F000039b03-96-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 160-2</span></figcaption></figure></div>
<section><a id="s1950" /><section><a id="s1955" /><section><a id="s1960" /><section><a id="s1965" />
</section>
</section>
</section>
</section>
</div>
</section>
</section>
</body>
</html>
